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ABSTRACT
Sulphate ester and glucuronic acid conjugations are major pathways of 
Phase 2 drug metabolism. Their comparative study, in normal and tumour 
tissues, was undertaken, using various in vitro systems. The major 
xenobiotic used was 1-naphthol, its conjugation by UDP-glucuronosyl- 
transferase and sulphotransferase to 1-naphthyl-/3-D-glucuronide and 1- 
naphthyl sulphate respectively, being investigated.
Normal human lung and colon tissue in short-term organ culture formed 
more 1-naphthyl sulphate, whereas tumours from these organs produced 
more 1-naphthyl-y^-D-glucuronide, there being a change in conjugation 
pathways from normal to tumour tissue. Such biochemical differences in 
human tissues could be exploitable in cancer chemotherapy. Possible 
reasons for this shift in metabolism include: changes in enzyme protein; 
availability of cofactors; alterations in hydrolysing enzymes. It may 
even be connected to alterations in cell-surface glycosaminoglycans.
Normal peripheral human lung in organ culture formed almost exclusively 
1-naphthyl sulphate, whereas tumour tissue from squamous carcinomas gave 
predominantly 1-naphthyl-y^ -D-glucuronide. Normal colon produced a 
different pattern of conjugation from colorectal tumours. Subcellular 
fractions, from lung specimens, reflected the metabolism seen in 
culture, while those from colonic samples did not. Human bronchial 
carcinoma cell lines, but not those from human colon adenocarcinomas, 
generally produced a conjugation pattern suggesting a reasonable model
for surgical tumour samples in culture. Xenografts derived from human 
lung and colon tumours gave a similar conjugation pattern as surgical 
samples in culture.
Species differences occurred with short-term organ cultures from normal 
rodent lung and colon tissues, which produced conjugation patterns 
unlike those obtained from normal human tissues. For these pathways, 
rodent tissues would provide unsatisfactory models for humans. These 
results emphasised the difficulties in extrapolating from animal data to 
man and the importance of studying human tissues.
Thus, using organ culture of human tissue, improved understanding of 
human metabolism, target organ toxicity and individualising treatment by 
testing chemosensitivity of drugs may be obtained.
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A: THE NATURE OF CANCER
During this century, cancer has become a major cause of death in 
Western society. The taboo associated with this disease arises from 
both the poor prognosis of many cancers and the pain, suffering and 
disablement the disorder can cause. The Latin word "cancer" means 
"a crab". It is from this original use of the word that we refer to 
the disease known as cancer by employing this term, because it 
describes the way it progresses: spreading and invading neighbouring 
tissues.
Cancer has existed over the centuries and has probably always been 
prevalent in older people. However, prior to the twentieth century, 
lives tended to be shortened by other acute disorders such as polio, 
diptheria, cholera and tuberculosis. Thus, until relatively 
recently, cancer was not considered a great risk. Today, in the 
Western World, medical science has produced "magic bullet" drugs or 
treatments to cure or prevent many acute diseases (1). The major 
health problems in our industrialized society are now the diseases of 
degeneration like arthritis, cardiovascular disease and cancer which 
tend, by their very nature, to be more prevalent in the older age 
groups. For these diseases, it is unlikely that there will be magic 
bullet therapies. Nevertheless, in less industrialised and poor 
parts of the world, cancer is not unknown, although the medical 
diseases in the Third World are much more associated with poverty, 
poor nutrition and parasitic infection.
A cancerous growth is often referred to by alternative names, the
most commonly used being "neoplasm" and "tumour". The former term is 
of Greek origin and means "new growth", whilst the latter merely 
means "swelling". Both terms reflect the fact that cancer often 
produces a visible lump.
Cancer or neoplasia is a disorder of cellular behaviour whereby a 
proliferation of cells produces an abnormal growth. Such a growth 
can be benign (i.e. it does not spread to other parts of the body) or 
malignant, producing secondary growths (metastases). If the cancer 
is of epithelial origin, the disease can spread in four different 
ways:- „
(i) The cancer cells can invade the surrounding tissue directly.
(ii) Either fragments of tumour or single cancer cells can break 
away in the blood and be carried to other parts of the body.
(iii) Single cells and tumour fragments can be spread through the 
lymphatic system to nearby lymph glands and then to more distant 
areas, the progress through this system being dependent on the body’s 
muscular movements.
(iv) Metastases can be produced transcoelomically, i.e. a tumour can 
break through the stomach wall and produce seedling deposits all over 
the intestines.
If the neoplasm is a sarcoma, i.e. originating in the connective 
tissue, it will be spread in one of two ways:-
(i) The tumour can infiltrate the surrounding tissue directly.
(ii) Either fragments of the tumour or single cancer cells can be
carried by the blood to other parts of the body, which produces an
extremely rapid spread.
Accordingly, the term ’cancer’ really represents a complex group of 
diseases producing different symptoms, originating from any tissue in 
the body. Undoubtedly, there is a need to understand the mechanisms 
by which cancer arises, the way it thrives and can become resistant 
to treatment. It is only then that preventative or curative measures 
can be taken and thereby forestall the suffering the disease does 
cause.
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B: EPIDEMIOLOGY OF HUMAN COLON CANCER
Various environmental and host factors have been examined for their 
aetiological significance to colon cancer in man. The aetiology of 
the majority of cases of human colorectal cancer is environmental
(2). Evidence for this is available from two main sources, the first 
related to populations in different parts of the world and the second 
being concerned with certain kinds of emigration.
From the first of these sources, surveys of the incidence of the 
disease have shown that there are large variations in different 
geographical locations (3, 4). There is a high incidence of
colorectal cancer in populations with a Westernized life-style, 
whilst Eastern European countries have an intermediate rate of the 
disease. On the other hand, in Asia, Africa and South America, with 
the exception of Argentina and Uruguay, there is a low incidence of 
this type of neoplasia. It has been shown that there are striking 
differences in the composition of the diet in these population groups 
and it has been suggested that these differences may have some 
significant relationship with the incidence of the disease (2). In 
the high risk industrialized countries, North-West Europe and North 
America, a great deal of animal fat, protein and refined 
carbohydrates are consumed. However, in the low risk populations, 
diets contain much less meat, but more vegetable fibre (5,6,7*8). 
World-wide, the highest incidence is in the United States of America, 
New Zealand and Scotland.
The second source of evidence of environmental aetiology for
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colorectal cancer has come from studies of migrants who emigrate from 
countries of low incidence to live in a society with a high-rate of 
disease. For example,Japanese migrants adopting the life-style of the 
U.S.A., including a Westernized diet, take on the high incidence of the 
disease which occurs in the U.S.A.(9). Additional evidence, in this 
context, has been produced by Haenszel et.al. (7), who found that in a
study of Japanese migrants in Hawaii, there was a higher incidence of
colorectal cancer observed in individuals who no longer continued the
practice of eating at least one Japanese style meal daily.
Doll (5) has shown that, in Scotland, there is a high risk from 
colorectal cancer, this being much higher than the corresponding risk 
in England. However, in contrast to studies in Scandinavia and the 
U.S.A., where there is increased risk associated with urbanization (2), 
in Scotland, the disease is not urban but rural, and on an incidence 
map the high risk areas seem to form a contiguous band across north- 
central Scotland(10).
Low-risk communities appear to have an excess of right-sided 
(ascending) cancer of the colon, whereas high-risk populations have 
excess left-sided (descending) cancer of this organ (11). Thus, the 
role of environmental factors, not only increases the incidence of the 
disease, but also alters the anatomical location of the tumour within 
the colon.
In high risk populations, there is a greater prevalence of colon 
cancer in females at a younger age but a higher male cancer incidence 
at an older age (2). These facts suggest the possibility of female
sex hormones having a promoting action on colon cancer.
Although host factors, like hormone levels, probably do influence the 
tumour incidence, the evidence clearly shows that environment does 
play a major aetiological role. Many researchers have thereby 
concentrated on determining the influential environmental factors. 
In this context, Higginson (12) showed that economic development and 
the risk of large-bowel cancer appear to be closely paralleled, 
internationally. With his experience in Africa, Burkitt (13,14) 
hypothesised that the lack of carbohydrate fibre was the major 
aetiological factor associated with colon cancer, having first 
observed that bowel cancer in most African populations was rare. 
Burkitt appears to have felt instinctively that no other site for 
tumour development would be so closely linked with the dietary 
alterations that may occur with a move to rich Western society from 
poorer countries. There is clear logical reasoning behind Burkitt*s 
hypothesis. He argued that an increase in consumption of refined 
carbohydrates is usually concomitant with a reduction in bulk and 
fibre of a diet. In this respect, it has, for example, been found 
that cellulose depletion in the diet produces colonic abnormality: 
diverticular diseases(15). The reduction of fibre leads to an 
increase in transit time through the bowel, and excess refined 
carbohydrates alter the bacterial composition of faeces. In this 
context, metabolism of bile salts by bacteria may produce carcinogens 
which, due to the refined diet, would be held in a concentrated form 
for a prolonged period (because of the reduced transit time) for 
interaction with the colonic mucosa. The combination of bacterial 
activity and colonic stasis may account for the anatomical location
of tumours found in those with a Western diet, i.e. the descending 
arm of the colon where faecal retention is most prolonged and 
bacterial action pronounced.
Although this reasoning collected into a coherent argument, provides 
evidence to support Burkitt*s hypothesis, there may be a fundamental 
weakness in his thinking. This may be in highlighting low residue 
diets and refined carbohydrate (and thus lack of fibre) as the 
reason for the critical difference in food consumption patterns 
between high risk populations and low risk ones.
In examining other differences in diet between high and low risk 
populations, Gregor et.al. (16) drew attention to the high positive 
correlation between animal protein levels in the diet and mortality 
from intestinal cancer. Various researchers have investigated the 
correlations between other food items and colon cancer. For example, 
Armstrong and Doll (17) established that the environmental variables, 
which were most closely correlated with colon cancer, were meat and 
animal protein consumption. These investigators also claimed a 
small positive correlation for total fat and a small negative 
correlation for cereal fibre.
As colon cancer incidence is high in Westernized cultures, there is a 
close association between this disease and atherosclerosis. However, 
in Argentina, the normal diet has a high meat (beef) intake and the 
fraction of calories from refined carbohydrates is relatively low(2). 
This South American country presents an exception to the normal 
positive correlation between colon cancer and atherosclerosis,
Argentina having a mortality from colon cancer of the same order as 
the U.S.A., but the death rate from cardio-vascular disease in 
Argentina is much lower than that in the U.S.A.
It is certainly worthy of note that no populations with a high beef 
intake and a low rate of bowel cancer have been found. Doll (5) 
considered the Scottish population to have the world*s highest bowel 
cancer incidence. It is interesting that although the people of 
Scotland eat less meat overall than the English, they consume 20$ 
more beef (18). A similar situation is found in New Zealand with a
high beef intake and high disease incidence. Australia used to have
the same colon cancer rate as New Zealand, but, in recent years, the 
incidence is 10$ lower than it was formerly, which is thought to 
reflect a drop in beef consumption in the 1950s and 1960s (19).
There have been many studies carried out to find differences in the 
types of species of the intestinal flora, the number of such 
organisms and the catabolic products of bile salts formed by bacteria 
in high and low-risk populations. The results of such investigations 
are equivocal: some findings show differences in types of bacteria 
between populations on Western and Eastern diets (20), while other 
workers find no significant alteration in numbers or species with
different diets (21). Differences in metabolic products of bile
salts between those eating a meat diet and those with a meatless diet 
have been found by some workers (22), while others found that meat 
consumption had a minimal effect on the production of these compounds 
(21). The quantity and type of fat in the diet may have an influence 
on gut microflora and thus on the metabolism of bile salts(20,22,23)•
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However, the position remains equivocal and confusing with the many 
different approaches taken to try and clarify the influence of fat in 
the diet on the aetiology of colon cancer (24).
Some research groups have placed great emphasis on faecal 
concentrations of total bile salts and bacterial-metabolising enzymes 
which can convert primary bile acids to secondary ones thereby 
producing unsaturated compounds. This is due to the consideration of 
the role of carcinogen and cocarcinogen for saturated and unsaturated 
bile acids (25). Bile acids and their metabolites have been 
implicated as promoters of carcinogenesis in experimental systems 
(26,27). It is possible that one of the nitrosamines is the 
initiating carcinogenic compound (28). Nitrosamines are ubiquitous, 
can be taken in with the diet and be formed in the gut from dietary 
precursors (29). Dimethylhydrazine, used to induce colonic tumours 
in experimental animals, is thought to have a mechanism of action 
which has some similarity to the action of nitrosamines (30). N- 
nitroso compounds might be associated with mutagenic activity which 
has been detected in human faeces (31). If such compounds were 
important in the aetiology of colon cancer, the metabolic potential 
of the intestinal flora may be less relevant to the initiation of 
tumours.
The aetiology of large-bowel cancer may not necessarily be linked 
with excesses in the diet. A deficiency of protective factors may be 
crucial. Epidemiologic studies have shown a high positive 
correlation between geographic regions having a deficiency of 
selenium and increased incidence of colon cancer (32). Chemical
carcinogenesis studies have produced results which suggest that 
selenium administration inhibits the production of dimethylhydrazine 
and methylazoxymethanol induced rat colonic tumours (32).
For some people in Western society, the environmental factors for the 
production of colon cancer are not as important as genetic factors. 
Certain inherited diseases increase susceptibility to colon cancer. 
In familial polyposis, which is associated with innumerable 
adenomatous polyps, these structures have a propensity for malignant 
transformation. Ulcerative colitis can also be predisposing towards 
colonic cancer (2). Wynder and Shigmatsu (8) have observed a 
familial aggregation in the incidence of large-bowel cancer, 
unrelated to familial polyposis.
Epidemiological investigation of the incidence of this cancer has 
given many clues to some of the possible factors involved in its 
aetiology. However, much more research needs to be done to clarify 
the important environmental factors associated with the disease so 
that sound preventative action would be possible. Nevertheless, 
because of the difficulties of preventing colon cancer, work is also 
needed to provide a suitable cure.
C: EPIDEMIOLOGY OF HUMAN LUNG CANCER
Unlike human colon cancer, the aetiology of the majority of lung 
cancer is known. As the origin of lung cancer is environmental, most 
cases of this disease should be preventable. Lung cancer is a common 
cause of death in Western society and, during the twentieth century, 
has reached epidemic proportions. Evidence for an environmental 
aetiology comes from a dramatic alteration of incidence of the 
disease. At the beginning of this century, lung cancer was regarded 
as a rare disease (33). Even up to the end of the 1930s, such a 
malignancy was considered uncommon. However, in the 1970s and 1980s, 
it has become one of the commonest forms of cancer in Western 
society. There is considerable geographical variation throughout the 
world, but the highest incidence is in the U.K. (34). In England and 
Wales, mortality from lung cancer has increased steadily during this 
century so that, at present, the disease causes over thirty thousand 
deaths per annum. All other cancer incidence in the U.K., over the 
same period of time, has remained steady or decreased, with the 
exception of pancreatic cancer. However, the reason for the small 
gradual increase in pancreatic neoplasia is unknown. The incidence 
of lung cancer in women has always been less than that in men. 
Nevertheless, recently, the number of cases of women with lung cancer 
has risen so that the incidence of this disease may eventually become 
the same as it is for men (33). Doll (35) has cited other reasons 
for an environmental aetiology for lung cancer. According to Doll’s 
findings, the increase in male lung cancer points to men born in 
successive periods in the first part of this century being exposed to 
increasing amounts of an enviromental carcinogen. The rise in the
incidence in female lung cancer is thus explained by a similar 
exposure which began at a later stage. Also, the rise in lung cancer 
has seen the increase of specific pathological types of tumour: 
squamous and oat-cell carcinoma.
Many epidemiological studies have established a striking positive 
correlation between the number of cigarettes smoked daily and the 
death rate from lung cancer (33). If a person gives up cigarette 
smoking, the relative risk of lung cancer falls, with time, to become 
not very different from that of a non-smoker of similar age. The 
incidence of lung cancer deaths increases with the number of years 
someone has smoked. Doubling the number of years smoking raises the 
incidence to the fourth power, whereas doubling the number of 
cigarettes smoked per day only doubles the disease incidence.
Cigarette smoke contains four thousand compounds, many of which are 
known to be toxic to experimental animals (33). Examples of 
compounds in tobacco smoke are arsenic, cadmium, tar, nitrosamines,
nicotine, hydrogen cyanide and carbon monoxide. Some of the
constituents thought to be related to lung cancer include the 
polycyclic hydrocarbons, e.g. benzo(a)pyrene and nitrosamines. 
Cigarette smoke condensate is known to contain mutagens and
carcinogens, initiators and promoters of carcinogenesis(33).
In contrast to the effects of cigarette smoking, only a small
proportion of lung cancer deaths are due to occupational aetiology, 
i.e. to those whose work brings them in contact with some tars, 
nickel, arsenic chromates and haloethers (34). However, the
contribution such exposures make to the incidence of lung cancer is 
difficult to establish as the effect of smoking masks other causes. 
It is interesting to note that workers who smoke, and are exposed to 
asbestos, are highly likely to develop lung cancer, as the two 
factors show a multiplicative synergism in the development of 
bronchial tumours in the lung (36). Similarly, radioactive 
irradiation interacts with cigarette smoking, again in a 
multiplicative way (37), this being demonstrated in studies of 
uranium miners.
Clearly, lung cancer and colon cancer are common causes of mortality 
and morbidity in our society. However, people seem reluctant to stop 
smoking and, thus, a drug to cure lung cancer is still needed. 
Accordingly, methods of curing and preventing these diseases should 
be seriously investigated. As patients with these common lung and 
colon tumours are often subjected to surgical procedures, tissues 
from such operations are available quite readily. Thus, in the 
present investigation, such a source of tissue from hospitals was 
utilized in an attempt to understand the drug metabolism pathways 
present in tumours and in the normal tissue removed with the growth 
at the time of surgery.
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D: BIOTRANSFORMATION OF XENOBIOTICS
(1) Introduction
The study of metabolism of foreign compounds is an essential pre­
requisite to any investigation into the drug treatment of cancer. 
The form of therapy someone receives, when cancer is diagnosed, 
depends on the use of one or more of surgery, radiation and 
chemicals. A greater understanding of xenobiotic metabolism in 
normal human and tumour tissues should lead to an improved design of 
cancer chemotherapeutic agents. In the treatment of cancer, many 
drugs are utilized as they inhibit metabolic pathways involved in 
nucleic acid synthesis. Tumours, which are rapidly dividing, and 
growing tissues have a high rate of DNA synthesis and cell division. 
Cancer chemotherapeutic drugs often exploit such characteristics of 
growing cells to exert their action. Thus, normal tissues which are 
continually turning over and shedding cells,e.g. skin, hair follicles 
and the whole alimentary canal, are attacked by these drugs. 
Unfortunately, patients can often suffer distressing side-effects as 
a result of the drugs acting on these normal, dividing tissues.
The metabolism of xenobiotics, foreign compounds, appears to be a 
mechanism provided by evolution to protect the host tissues. Other 
animals and plants have detoxification mechanisms as well as 
mammalian species (38). Evolution has produced enzymes to provide a 
chemical defence to a species. Detoxification reactions are normally 
discussed with respect to exogenous compounds which are anutrients 
providing no energy yield or essential dietary factor. However,
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endogenous substances are detoxified to maintain survival of a 
species, e.g. ammonia conversion to urea. Interestingly, some 
species, by physical compartmention or by exploiting metabolic
differences between species, can manufacture chemicals which are 
toxic to other species’without being harmful to themselves,e.g. plant 
toxins like ricin (39) or snake venoms which contain hydrolytic
enzymes(40).In comparatively recent times, the industrial revolution
has deluged the environment with many new chemicals. Living
organisms had not previously encountered such compounds. Chemicals 
are detoxified according to their molecular structure. This 
determines the compartments of the body the compounds may enter, for 
which enzymes they can be substrates, the type of metabolites 
produced and the ease with which they can be excreted. Thus, with 
some chemicals,it is not surprising that the metabolic pathways used 
for detoxification can actually produce metabolites possessing 
increased toxicity. Evolution has had no time to select biologically 
advantageous changes in the "detoxification” metabolic pathways. 
Thus, it is important to remember that these drug metabolising 
pathways can be activating, toxificating reactions and not 
detoxificating. An example of this is tetraethyl lead which 
undergoes dealkylation to triethyl lead (41), this latter compound 
being responsible for the toxicity to the nervous system.
Xenobiotics are ingested in food and drink, in inspired air and 
through the skin. The detoxification mechanisms have been divided 
into two phases of reaction (42). Phase 1 consists of tranformations 
such as oxidations, hydrolyses and reductions whereby the molecule 
achieves a "handle", a grouping like -OH , -C00H or -NHp. The
metabolite, now more polar, enters Phase 2 of the metabolism where 
this new grouping is utilized in a conjugation reaction with a highly 
polar molecule. These include glucuronic acid donated to the 
xenobiotic by UDPGA and sulphate by PAPS. This usually enables 
excretion in urine, bile or expired air. The xenobiotic must cross 
cell membranes in order to come into contact with these metabolising 
enzymes. Thus, the compound has to have some degree of 
lipophilicity.However, some highly lipid soluble chemicals, like DDT, 
persist for many months in adipose tissue as their structures are not 
readily metabolised (43). Ethylenediaminetetraacetic acid is an 
example of a strongly polar compound, which does not enter cells and, 
thus, is not metabolised.
(2) Phase 1 Metabolism
Within the liver cell, some of the enzymes responsible for the Phase 
1 reactions are located in the endoplasmic reticulum (44). During 
homogenization of liver tissue, the endoplasmic reticulum is broken 
up to form vesicles, usually termed microsomes. These microsomes can 
be separated from the other organelles of cells by differential 
centrifugation. The microsomal fraction has been used extensively to 
study Phase 1 metabolism. Liver is the most active xenobiotic 
metabolising organ, but it is now realized that such reactions can be 
carried out by extra-hepatic tissues (45). Studies on the 
requirements of the Phase 1 oxidative system have shown that the 
enzymes mixed function oxidases need both reduced pyridine 
nucleotide and molecular oxygen (46). The reaction catalysed by 
mixed function oxidases (MFO) is summarised in Fig. 1.
Figure 1
NADPH
The Reaction Catalysed By MFO
+  M F Q  +
+ H +  RH +  0 „-r— t  NADP + ROH +
RH = xenobiotic
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This type of enzyme reaction is catalysed by a series of 
haemoproteins, known as cytochrome P-450 (cyt P-450). (This 
cytochrome was labelled P-450 because it exhibits an absorbance peak 
at 450 nm in the reduced state when complexed with carbon monoxide). 
Cytochrome P-450 was first discovered to metabolise endogenous 
substrates, steroids, but then it was found to be responsible for the 
oxidation of xenobiotics (47, 48).
The MFO have an extremely wide substrate specificity,being relatively 
non-specific. They perform a variety of metabolic reactions (Table 
1). The mixed function oxidases have now been purified (50). However, 
it appears that the cytochrome P-450 is only part of a large enzyme 
complex containing the flavoprotein: NADPH - cytochrome P-450
reductase and phosphatidylcholine (51). The way in which this system 
oxidizes a substrate is illustrated in Fig. 2. Cytochrome P-450 
occurs in multiple forms (52). Two major forms have been identified, 
as they have different substrate specificities and possess slightly 
differing carbon monoxide difference spectra. In rat liver, pre­
treatment with phenobarbitone produces one type of P-450; whilst with 
3-methylcholanthrene (3-MC) cyt P^-450 is induced (53). Cytochrome 
P-450 has been found to be present in the membrane of rat liver 
nuclei (54) and can be induced by 3-MC and phenobarbitone (55). The 
production of reactive, electrophilic metabolites, in close proximity 
to the nuclear material of a cell, may play a vital role in 
carcinogenesis. It is important to remember that oxidations of 
xenobiotics by enzymes of the cytosol can also occur, e.g. alcohol 
dehydrogenase, aldehyde dehydrogenase, monoamine and diamine oxidase.
TABLE 1: Examples of Metabolic Reactions Bv Cvtoohrome P-450
Enzvmes to Illustrate the Versatility of the System.
(Adapted from table 2 in reference 49)
Tvpe of Reaction Substrate Product
aromatic hydroxylation acetanilide p-hydroxyacetanilide
aliphatic hydroxylation phenobarbitone hydroxyphenobarbitone
O-dealkylation codeine morphine
N-dealkylation aminopyrine 4-aminoantipyrine
S-oxidation chiorpromazine chlorpromazine sulphoxide
N-hydroxylation aniline phenylhydroxylamine
desulphuration parathion paraoxon
S-demethylation 6-methylthiopurine 6-mercaptopurine
deamination amphetamine phenylacetone
arene oxide formation bromobenzene bromobenzene epoxide
N-oxidation dimethylaniline dimethylaniline-N-oxide
dechlorination carbon tetrachloride chloroform
dealkylation of 
metalloalkanes tetraethyl lead triethyl lead
Figure 2
Drug Hydroxylation By Cytochrome F-450
Product
ROH
Substrate
RH
P-450. Fe3t
P-450. Fe3+ P-450. Fe3+ 
RH \
e-
P-450. Fe‘
I
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P-450
reductase
P-450. Fe2+
R H . O - A
e-
R H  " 0 - 0
(3) Phase 2 Metabolism
Phase 2 metabolism is separate and distinct from the reactions of 
MFOs. Different enzymes are involved in this second phase of 
metabolism which involves synthetic reactions resulting in an 
expenditure of energy. Also, the products of Phase 1 reaction are 
still partially lipid soluble, often possessing biological activity; 
while those of the second phase are usually much less active. There 
are two reasons for this: first, the product is more water soluble
or less lipophilic allowing rapid excretion, and secondly, the 
chemical groups responsible for biological action are masked by 
superimposition or by steric hindrance from the conjugation group.
The conjugating molecules may be sugars (e.g. glucose, glucuronic 
acid), acids (e.g. sulphuric, acetic) amino acids and peptides (e.g. 
glycine, glutamine, glutathione) and alkyl groups (e.g. methyl). 
Such conjugation reactions are associated with enzymes located in the 
endoplasmic reticulum (e.g. UDP-glucuronosyltransferases) or in the 
cytosol (e.g. sulphotransferases, glutathione-S-transferases, methyl 
transferases).
(i) Glucuronic Acid Conjugation
Glucuronidation is quantitatively the most important conjugation 
reaction, for two main reasons. First, many reactive groups like - 
OH, -COOH, “NH2, -SH will form glucuronides (56) and secondly, 
there is a close proximity of the UDP-glucuronosyltransferase to the 
MFOs. UDP-glucuronosyltransferase, like cyt P-450, is thought to be 
found predominantly in the microsomal fractions of cells (57>58).
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The essential cofactor or donor of glucuronic acid to xenobiotics to 
form conjugates is uridine diphosphate glucuronic acid (UDPGA) (59) 
which is synthesised from readily available carbohydrate (Fig. 3). 
Although UDPGA has an oc-configuration at the glucuronic acid- 
phosphate link, the conjugate produced from UDPGA and the xenobiotic 
has a /^-configuration. Thus, /3-glucuronidase can attack the 
conjugate but not the essential cofactor. However, there are several 
types of glucuronides (Fig. 4), phenolic hydroxyl groups and 
aliphatic alcohols being conjugated with UDPGA to form ether 
glucuronides, whilst ester glucuronides are formed from the 
conjugation of carboxylic acids through the carboxyl group. N- 
glucuronides can be formed, but they appear to be synthesised by a 
different glucuronosyltransferase. Evidence for this comes from the 
fact that the Gunn rat, which cannot form ester or ether 
glucuronides, is able to produce an N-glucuronide with aniline (60). 
As well as aromatic amines, even a sulphydral group can be conjugated 
(61). More recently, evidence has been found that C-glucuronides can 
be formed, too (62).
This conjugating enzyme is thought to be constrained in the E.R. 
membrane and so UDP-glucuronosyltransferase activity can be markedly 
activated in a microsomal preparation from cells (63). This is done 
by a variety of chemical membrane pertur bants and by physical 
processes in the preparation of microsomes, the degree of activation 
depending on the substrate (56).
There is evidence that UDP-glucuronosyltransferase exists in multiple 
forms. Two types have been separated and partially purified. One of
Figure 3 : Glucuronic Acid Conjugation
a Synthesis Of The Cofactor UDPGA
G-1-P
uridylyltransferase
«-Glucose-i- phosphate(G-i-P) + UTP------> UDP- -D -glucose(UDPG)
UDPG
dehydrogenase
UDPG + 2NAD++ H O  >UDP-«-D-glucuronic acid(UDPGA)+
GOOH
2NADH + 2H
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I
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OH OH
b Conjugation UDP-
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Figure 4 = Types Of Glucuronic Acid Conjugates
a Hemiacetal (Ether) Glucuronide
COOH
a
O NH—CCH.
e.g. of P-hydtoxyacetanilid
b Ester Glucuronide 
COOH
e.g. of benzoic acid
c N-Glucuronide 
COOH
NH— <
^  "//
e.g. of aniline
d S~Glucuronide 
COOH
S-—-c
e.g. of 2-mercaptobenzothiazole
e C GIucuronide
COOH e.g. of phenylbutazone
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these utilizes morphine as a substrate and is induced by 
phenobarbitone, while the other form prefers 1-naphthol as a 
substrate and is induced by 3-MC (64,65). UDP-
glucuronosyltransferase activities are present in all mammalian 
species investigated, though some species of Felidae, including the 
domestic cat, exhibit a very low capacity to produce phenolic 
glucuronides (66). However, the enzyme activity is present in the 
microsomal fraction of many tissues such as liver, lung, adrenals, 
kidney, spleen and intestine (56).
(ii) Sulphate Ester Conjugation
Sulphate conjugation is another major pathway of Phase 2 metabolism. 
However, the sulphotransferase enzyme responsible for drug metabolism 
is located in the cytoplasm (67). The essential cofactor, the donor 
of sulphate, for sulphate ester conjugation being S^phosphoadenosine 
- 5f-sulphatophosphate (PAPS) which is generated from inorganic 
sulphate (68) (Fig. 5). Sulphate is absorbed from the gut and can be
obtained from the cysteine pool (69). It is also required for other
metabolic processes and, so, the drug detoxification pathway was 
considered to be readily saturable. Bray et.al.(1Q52) first showed 
that increasing substrate concentration leads to an increased
proportion of glucuronide rather than sulphate being excreted 
(70,71). The sulphate supply was rate limiting in phenol sulphation 
so that, with increasing substrate concentration, the conjugation 
became a zero order reaction. However, more recently, Mulder and 
Meerman (72) have questioned this reasoning. They consider that 
enzyme affinity (K^) is the reason for the decreasing proportion of 
sulphate and increasing proportion of glucuronide as phenolic
Figure 5 : Sulphate Ester Conjugation
a Synthesis Of The Cofactor PAPS
 2-  ATP-sulphurylase,
ATP + S04    —-----“Mdenosine 5 -
phosphosulphate( APS)+P0£
a no Am ATP-kinase ' . , #APS + ATP ------------ —-> Adenosine 3-phosphate 5 -
sulphatophosphate (PAPS)+ADP 
NH.
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0 — s — o —  P—0 —CH
0  OH PAPS
b Conjugation
_ Sulphotransferase 
PAPS + R -O H —  ---------  > ROSO H +
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phosphoadenosine 5 - phosphate (PAP)
substrate concentration is raised. The values for phenols of
sulphotransferases are lower compared with UDP-glucuronosyl- 
transferases. Thus, sulphation has greater affinity for phenolic
substrate, but glucuronidation the greater capacity. Mulder and
Meerman also believe that plasma inorganic sulphate is available for 
drug sulphation by liver and that plasma levels can be replenished 
from other sulphate pools (72). Infusion of sulphate and pre­
treatment with phenol, in an attempt to exhaust the sulphate pool, 
did not alter the ratio of the two conjugation pathways when
measured.
Evidence is available for multiplicity of the cytoplasmic 
sulphotransferase activity. Phenolic steroids, alcoholic steroids, 
simple phenols and aromatic amines are all known to be conjugated via 
separate enzymes (69»73). Other sulphotransferases are involved in
the detoxication of cyanide (7*0- This mitochondrial
sulphotransferase enzyme (75) catalyses the reaction shown in Fig 6,
utilizing thiosulphate as sulphate donor. The enzyme is found in 
liver, kidney and other tissues, although blood has a low activity. 
Cyanide may be present in small quantities in food, and cigarette 
smoke certainly has large amounts (33). Thus, the enzyme may have a 
protective role in inactivating cyanide.
Another cytoplasmic sulphotransferase has been found in liver, kidney 
and blood cells, but this utilizesy^-mercaptopyruvic acid as sulphate 
donor (Fig 7). This cytoplasmic enzyme can also generate thiosulphate 
from sulphite which could then be used by the mitochondrial enzyme. 
Both these enzymes can be involved in cyanide inactivation.
Figure 6 =
Reaction Catalysed By Mitochondrial Sulphotransferase
CN + S2032 Rhodanese> CNS + Sq32
cyanide + thiosulphate ■ > thiocyanate + sulphite
Figure 7 =
Reaction Catalysed By A Cytoplasmic Sulphotransferase
CN + HS-C^-C-COOH —  - ) CNS~+ CFFC-COOH
cyanide+B-mercaptopyruvic— -4  thiocyanate + pyruvic acid
acid
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The sulphotransferases located in the endoplasmic reticulum and Golgi 
membrane apparatus are not involved in drug metabolism. It is 
thought that these enzymes are involved in synthesis of glycoproteins 
and the sulphation of sugars (76, 77).
(iii) Glutathione Conjugation
Glutathione conjugation can be important in metabolism of some 
compounds. Glutathione (GSH) is a tripeptide: )f-glutamyl-cysteinyl- 
glycine (Fig. 8) which has several functions as well as conjugation. 
It serves to protect thiol groups in proteins from oxidation (78), 
serves as a cysteine reservoir (79)> can act as a coenzyme for 
certain enzymes e.g. formaldehyde dehydrogenase and glyoxylase I (80) 
and can function as an intracellular redox buffer (81). The 
detoxification of xenobiotics by conjugation with GSH is enzyme- 
mediated by a group of cytoplasmic enzymes known as glutathione-S- 
transferases (GSH transferases) (82). However, recently,a microsomal 
GSH-transferase has also been described (83). These enzymes catalyse 
the addition of GSH to a variety of electrophilic centres, including 
potentially toxic epoxides, to produce conjugates (Fig. 8).
GSH conjugates are further metabolised prior to excretion. The 
glutamate and glycine residues are cleaved and the resultant free 
amino group of the cysteinyl residue is acetylated so that a 
mercapturic acid is produced (84). The GSH-transferases have 
different but, overlapping, substrate specifities (85). It is now 
known that the cytosolic anion-binding hepatic protein, ligandin, is 
identical with GSH-transferase B in rat liver (86). In addition, GSH- 
transferases are present in many vertebrate species (85). Most
Figure 8 : Addition Of GSH To Electrophilic Centres
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emzyme activity is associated with liver, but it has been detected in 
other body tissues. It is thought that GSH conjugation has a 
protective role against some toxic metabolites and it has been shown 
clearly that GSH prevents hepatic necrosis induced by halobenzenes 
(87).
(iv) Other Conjugation Pathways
There are some other minor conjugation pathways. N- and 0- 
methylation, using S-adenosylmethionine as methyl donor, conjugates 
many endogenous amines like catecholamines (88). Acetylation via 
acetyl-coenzyme A occurs for some drugs like sulphanilamide (89) and 
is a general pathway for aromatic amines. Aromatic carboxylic acids 
can undergo conjugation with glycine and other amino acids to form 
peptide conjugates, e.g. hippuric acid from benzoic acid. Phosphate 
conjugation is a rare pathway, which is surprising as there are high 
cellular levels of adenosine triphosphate. One example of phosphate 
conjugation is the formation of bis(2-amino-1-naphthyl)phosphate from 
the carcinogen, 2-naphthylamine (90). Other carbohydrates can be 
used for these synthetic reactions (74). Ribonucleosides and 
ribonucleotides are formed with analogs of purines and pyrimidines 
often used as anti-cancer agents (91). The enzymes responsible for 
this are thought to be those used for the synthesis of endogenous 
nucleosides and nucleotides (74). Allopurinol, used in the treatment 
of gout, is converted to a ribonucleotide by reaction with 5- 
phosphoribosyl 1-pyrophosphate (PRPP) (Fig. 9).
(v) Activation bv Conjugation Pathways
Although all these conjugation mechanisms are widely regarded as
Figure 9 = The Reaction Of Allopurinol With PRPP
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detoxification mechanisms,leading to inactive products,there are some 
examples of metabolites more reactive than their parent compounds. 
The N-O-glucuronide and sulphate esters of 2-acetylaminofluorene (2- 
AAF) covalently bind to protein and nucleic acids (92). The sulphate 
ester conjugate is thought to be the ultimate carcinogenic metabolite 
from 2-AAF (93). The N-O-glucuronide and sulphate esters of N- 
hydroxyphenacetin bind covalently to protein (94). The reactive 
glucuronide is concentrated in the kidney and as a consequence could 
explain the nephrotoxicity of paracetamol. Vicinal dihalogen 
compounds, like 1,2-dichloroethane, are converted into mutagens by 
conjugation with glutathione, yielding -halogen thioethers, or 
sulphur mustards (95). Thus, these pathways of Phase 2 metabolism 
can be used to activate, as well as detoxificate, a drug. This may 
be exploitable beneficially in some circumstances of therapy.
(4) Drug Metabolism in Tumours
Studies of drug metabolism have been carried out, using tumours grown 
in animals, some of which have been initiated in the animals and 
then, subsequently, passaged into other animals. Other tumours, 
having originated in human patients, are maintained by growing 
portions in animals who lack immune-responsiveness. These are called 
xenografts. Other experiments utilize tumour cell lines, some of 
which have been derived from animal tumours and some from human 
cancerous tissues. There are various difficulties which arise when 
trying to interpret the significance of the metabolism reported for 
these tissues in relation to human tumour metabolism in vivo. For
example, xenograft metabolism may be changed from that in humans,
being influenced by the surrounding animal tissues.
Examples of drug metabolism studies in tumours are given in table 2. 
The majority of studies in normal and tumour tissues have 
concentrated on Phase 1 oxidative reactions. Most of these 
experiments tend to be carried out in rodent hepatomas of different 
growth rates.
These studies show that the tumour tissue or tumour cell lines 
derived from the rodent hepatoma possess cyt P-450 MFO activity 
(96,97>98,99). However, in comparison with the normal rodent tissue, 
the tumours have much lower activity. The Phase 1 activity does not 
appear to correlate with the growth rate of the hepatoma (97»99)• 
The activity of the MFOs in preneoplastic liver nodules is lower than 
in normal control hepatic tissue. It has been suggested that this 
gives these nodules a selective growth advantage by virtue of the 
reduced activity to metabolically activate chemicals to toxic 
products (100). Some studies have compared enzyme activity in normal 
and tumour tissue from human patients. In a limited study, Sultatos 
and Vesell (101) have found that various enzyme activities of Phase 1 
metabolism (ethylmorphine N-demethylase and aniline hydroxylase) in 
human liver tumours were decreased in comparison with normal liver 
tissue. However, somewhat surprisingly, these researchers claimed 
that normal tissue adjacent to the tumoiir has a higher activity 
compared to tissue further removed from the tumour. The authors 
found the same alterations in rat liver with intrahepatically 
implanted tumours, rather than extrahepatic hepatomas, which many 
experiments have utilized (101,102). A more recent study has used
TABLE 2: revamp!es of Drug Metabolism Studies in Tumours
Tumour Tvne of Metabolism Reference
Rodent Hepatoma Phase 1 (oxidative) 96, 97, 98, 99
Human Liver Phase 1 (oxidative) 101
Phase 1 (azo-reductase) 105
Human Lung Phase 1 (oxidative) 103
Human Colon Phase 1 (oxidative) 104
Human Breast Phase 1 (oxidative) 106
Rodent Hepatoma Glucuronidation and 
Sulphation
99, 107, 108, 
109, 110
Human Breast Sulphation 111
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normal and tumour tissue from human patients with lung cancer (103). 
The activity of aryl hydrocarbon hydroxylase was significantly lower 
in homogenates from the tumours compared with the corresponding 
normal tissue from the same patients. However, a study with normal 
and tumour tissue from human patients suffering with adenocarcinoma 
of the colon found no significant difference between the levels or 
types of metabolites of benzo(a)pyrene by the two tissue types in 
culture (104).
A high activity of hepatic azo-reductase has been reported (105) in 
human hepatocellular carcinoma and in chemically-induced primary 
hepatomas. Azo-and nitro-reductase activities in microsomes appear 
to be retained more consistently than drug-oxidative activities in 
hepatic tumour tissue.
In contrast to most studies, metabolism of benzo(a)pyrene has been 
found to be higher in a human breast tumour cell line compared to 
normal human breast epithelial cells (106).
Similar studies have been carried out, examining Phase 2 metabolism. 
Various rodent hepatomas have been demonstrated to possess increases 
in UDP-glucuronosyltransferase activity when compared with the 
corresponding normal tissue (107,108). With different rodent 
hepatomas, it has been established that there are increases in 
activities of UDP-glucuronosyltransferase, to 1-naphthol, p- 
nitrophenol and o- and p-aminophenol, together with a greatly 
decreased phenol sulphotransferase activity to p-nitrophenol in a 
Reuber H-35 hepatoma in comparison to levels in controls (99»107,108,
109,110). In human mammary neoplasms, it has been claimed that these 
tumours have a variable pattern of steroid-sulphating activity which 
differed from either normal breast tissue or normal liver (111). The 
enzyme UDP-glucuronosyltransferase, in animal tumour cells, appears 
to be less well activated compared to normal tissue indicating that 
the enzyme in the tumour may be less constrained and thereby exist in 
a different membrane environment (112).
Some studies have been carried out to examine the effect of tumours 
on the drug-metabolising system of the animal bearing the cancer. 
The ability of the liver to perform Phase 1 metabolism under such 
circumstances appears decreased, although variation does exist 
depending on the tumour-type (113). The activities of
sulphotransferase and glucuronosyltransferase in vitro from hepatoma 
host livers do not differ significantly from control animals (109). 
Such studies may be of interest to clinicians when administering 
certain drugs to cancer patients. However, as illustrated in the 
following section, many conventional cancer chemotherapeutic agents 
are not handled by the usual drug metabolism pathways in order to be 
active.
E: CANCER CHEMOTHERAPY
Drugs used for the treatment of cancer are often given immediately 
after surgery or radiotherapy. This adjuvant chemotherapy has 
significantly increased the proportion of long-term survivors of 
various cancers (114). The purpose of such therapy is to destroy any 
metastases, usually at a distance from the primary site, when they 
consist of small numbers of cells. A major difficulty associated 
with the use of cancer chemotherapy is the possible production of 
horrific side-effects. Such effects are due to the fact that anti­
cancer agents are not specifically toxic for cancer cells in the way 
that penicillin is selectively toxic to bacteria. As these drugs 
have a basic property to kill dividing cells in general, by 
preventing tumour growth they also attack tissues with a high mitotic 
index like bone marrow, lymphoid tissue, gut mucosa, testes, ovaries 
and hair follicles. Thus, anti-cancer agents are known as cytotoxic 
agents, although the dose can be managed to produce tumour death with 
limited toxicity.
The agents used in the treatment of cancer are many and various. 
These chemotherapeutic agents can be classified into five groups, 
according to their chemical structure and mechanism of action 
(Table 3).
(1) Eleotrophilic Reactants
Electrophilic reactants include bifunctional alkylating agents like 
the aromatic nitrogen mustard, melphalan (Fig. 10). Such compounds 
attack nucleophilic sites in cells, e.g. ionised acidic and thiol
TABLE 'R: Classification of Cancer Chemotherapeutic Agents According
to Structure and Action
Tvoe of Cancer Chemotherapeutic Aeent Example
Electrophilic Reagents Melphalan
Cyclophosphamide
Dimethyltriaenoimidazole
carboxamide
Procarbazine
Hexamethylmelamine
Methylnitrosourea
Cis-Platinum co-ordination 
complexes
Anti-tumour antibiotics Actinomycin D
Daunomycin
Adriamycin
Anti-metabolites Methotrexate 
6-Mercaptopurine 
Cytosine Arabinoside
Spindle poisons Vinblastine
Vincristine
Other Agents Asparaginase
Figure 10 :
The Structure Of Melphalan
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groups and unchanged amine groups of nucleic acids and proteins. 
There is an absolute requirement for a minimum of two alkylating 
groups in the molecular structure. This suggests that the 
cytotoxicity is due to cross-linking reactions involving nucleophilic 
centres in the same, or different, molecules. It is unknown which is 
the critical target for cytotoxicity as there are so many reactive 
sites, but DNA is thought to be the most sensitive. Inter-or intra­
strand cross-linking takes place. The fact that these compounds can 
kill cancer cells with such an interaction does not preclude them 
entering "normal” cells, binding with DNA and thus, subsequently, 
causing cancer.
To overcome some of the side-effects and increase the action of the 
drug on cancer cells, rather than normal dividing cells, some drugs 
have been designed to be activated in cancer cells. Primary liver 
cancer, having a higher concentration of azo-reductase (105), can 
convert a non-toxic azo-mustard (Fig. 11) into a cytotoxic amine. 
This compound, if it leaves the liver, can react harmlessly in the 
plasma or will be hydrolysed before reaching the bone marrow (115). 
Cyclophosphamide is thought to be selectively toxic to cancer cells 
due to the absence of an enzyme when compared with normal cells. 
This drug is hydroxylated by Phase 1 metabolism and the metabolite is 
in equilibrium with its tautomeric aldehyde (Fig. 12). This latter 
compound can be converted by aldehyde dehydrogenases in normal cells 
to the propionic acid which is also non-cytotoxic. Without enzymic 
detoxification,the aldehyde chemically converts to form phosphoramide 
mustard and acrolein, both of which are toxic. Thus, some selectivity 
is thought to be produced by tumour cells having lower dehydrogenase
Figure 11 : Metabolic Activation Of An Azo-mustard
HN
2
CH.
? " 3
N(CH2CHBr)2
Non-cytotoxic Azo-mustard
? " 3
N(CHCHBr)
2 2
Cytotoxic Amine
<?H3
N(CHCHOH)
2 2
Hydrolysis Metabolite
Figure 12 : Cyclophosphamide Action
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enzymes (116) and thereby having less ability to detoxify the mustard 
and acrolein compared with normal cells.
(2) Anti-tumour Antibiotics
An example of this type of drug is Actinomycin D. This antibiotic 
intercalates non-covalently with DNA by being inserted between 
stacked base pairs of the double helix. This, of course, grossly 
interferes with the processes of replication and transcription, 
producing an imbalance in the cell which can cause cell death.
(3) Antimetabolites
Antimetabolites (Fig. 13) are antagonists for normal metabolites in 
various biochemical pathways and their cytotoxicity is greatly 
influenced by the level of the compounds with which they are 
competing. These drugs are designed to competitively inhibit enzymes 
in pathways of anabolic metabolism which are vital for growing tissue 
like tumours. Methotrexate is an inhibitor of tetrahydrofolic acid 
(THF) reductase and is known as an antifolate. It causes a lack of 
thymidylate which is essential for DNA synthesis. 6-Mercaptopurine 
is an antimetabolite for purine synthesis. Cytosine arabinoside is 
an antimetabolite for pyrimidine synthesis. A novel approach has 
produced a drug which is an antagonist of a transition state analogue 
(117)- N-Phosphonacetyl-L-aspartate (PALA) is an analogue of the 
proposed transition state between aspartate and carbamyl phosphate, 
the intermediate to the production of carbamyl aspartate in 
pyrimidine biosynthesis (Fig. 14).
Figure 13 = Structures Of Anti-metabolites And The
Corresponding Endogenous Metabolites
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(4) Spindle Poisons
Vinblastine and vincristine condense with microtubular protein vital 
for the formation of the spindle apparatus for cell division. Thus, 
the cells become arrested in metaphase and then die.
(5) Other Agents
With some tumours, enzymes like asparaginase can be effective if the 
tumour cannot synthesise its own asparagine and relies on 
extracellular sources. However, not many tumours are deficient in 
asparagine synthetase and those that are, often become resistant. 
Glutaminase has been used, but is more toxic to normal tissue. 
Another enzyme, methioninase, may be useful with some cancers as 
normal cells can utilize THF and homocystine in place of methionine, 
whereas some tumours are unable to substitute for methionine.
A summary of the mode of action of various anti-cancer drugs is given 
in Fig. 15. This shows that many of them attack features of tumour 
cells which are present in normal growing tissue. As a consequence, 
certain side-effects can be observed with the use of some of these 
drugs. These include a drop in peripheral white blood cells, gastro­
intestinal disturbances, mucasia, alopecia and either temporary or 
permanent infertility.
Due to the lack of selectivity demonstrated by many anti-cancer 
agents, better drugs are required which can attack cancer cells 
according to a property that is not characteristic of growing, 
dividing tissue. Thus, further research is required to find out more 
about the metabolic character of tumour cells in comparison with
Figure 15 = A Summary Of The Action Of Various Anti-cancer
Drugs
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normal tissue. In this way, biochemical differences may be 
established which are potentially exploitable in cancer chemotherapy. 
Also, it is vital to such research that human tissue is studied. 
This is because, despite the difficulty associated with the 
interpretation of in vitro data with human tissue, in order to 
understand the la vivo situation, an increased knowledge of human 
metabolic pathways can only benefit the design of drugs to be given 
to humans. In addition, of course, an equal or greater difficulty is 
that of extrapolating data from animals to man. At present, much of 
our knowledge of tumour metabolism is based on animal tumours. It 
cannot be assumed that the metabolic pathways in human tumours are 
the same as those in the experimental animal tumour models. Drug 
metabolism, in particular, when compared with endogenous metabolism, 
can vary between species in normal tissues, so it is probable that 
tumour metabolism could also vary.
Human tissue can be studied in a variety of ways and, accordingly, 
one of the aims of the present investigation has been to compare 
different methodological approaches.
F: METHODS AVAILABLE FOR STUDY OF METABOLISM IN HUMAN TUMOURS
Undoubtedly, widespread In vitro experimentation on human volunteers 
is unethical. However, tissue removed from human patients during 
surgery or autopsy is ah excellent source of material for in vitro 
study. Classic biochemical sub-cellular fractionation can be used to 
study drug metabolism. In this context, however, greater reliance 
can be placed on experiments which have maintained cellular 
integrity, and also tissue architecture. Thus, explant organ culture 
can be used to study surgical samples. Also, cell lines established 
from human tumours can be used to study metabolism. Human tumours 
can be maintained in mice whose immunological responses are depressed 
either genetically ('nude* athymic mice) or artifically (T- 
lymphocyte-deprived mice).
Cell suspensions or cultures and explant organ culture as intact 
systems have advantages in that the full complement of drug- 
metabolising enzymes is present and possible rate-limiting phenomena 
such as cofactor levels, control mechanisms and cellular transport 
systems are preserved intact. However, studies with sub-cellular 
fractions are simpler to perform and the results are easier to 
interpret. Further detailed discussion of the advantages and 
limitations of the various methods will be given at relevant and 
appropriate stages throughout this thesis.
G: THE PRESENT INVESTIGATION
The main aim of the work carried out for this thesis has been to 
examine Phase 2 drug metabolism (sulphation and glucuronidation) in 
human tissue, both normal and tumour, especially from lung and colon, 
using a variety of methods. As a result of investigations made in 
this area it is hoped to present evidence which may offer an extended 
knowledge of human tissue metabolism and this could lead to improved 
drug design, particularly in the production of more selective anti­
cancer drugs. Hopefully, this, in turn, may produce a better 
prognosis of lung and colon cancer. Both diseases generally have a 
poor prognosis, as often tumours in these organs can arise and grow 
extensively before giving rise to symptoms. Thus, treatment is often 
begun after metastatic spread has occurred.
In particular, this study has tried to find biochemical differences 
between normal and tumour tissues for exploitation, to produce a 
selective cancer chemotherapy.
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MATERIALS AND METHODS
Having considered the nature of cancer, related relevant literature 
and a proposal for the present research, the actual materials and 
methods used will now be outlined.
A: MATERIALS
(1) Human Surgical Samples
Normal human lung and tumour were obtained from several hospitals: 
The Royal Surrey Hospital, Guildford; The Brompton Hospital, London; 
The North Middlesex Hospital, Edmonton. Normal human colon and 
tumour were supplied by: The Royal Surrey Hospital, Guildford; The
Farnham Road Hospital, Guildford and St. Marks Hospital, London. 
Bronchial bronchoscopy samples came from The Royal Free Hospital, 
Hampstead, London.
(2) Cell Lines
Seven cell lines, originally derived from human bronchial carcinomas 
(Ben, Gri, Min, Poc, Mar, Mor, Dre), were supplied by Dr. Morag 
Ellison of the Ludwig Institute for Cancer Research. An eighth human 
bronchial carcinoma cell line (E14) was provided by Dr. Monica 
Vetterlein, Vienna.
Three cell lines, derived from human colonic adenocarcinomas, were 
given by Dr. Bridget Hill, Imperial Cancer Research Fund, Lincoln1s
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Inn Field, London. These latter cell lines were called COLO 205,
COLO 206 and LoVo. The LoVo cell line was used with the permission
of Dr. B. Drewinko, Houston, Texas.
(3) Xenografts
Nude athymic mice with implanted xenografts were obtained from the 
Institute of Cancer Research and provided by M. Jones.
(4) Animals
Male Wistar rats were obtained from the animal units at The 
University of Surrey, The School of Pharmacy, University of London 
and ICI Central Toxicology Laboratory.
(5) Chemicals
Amersham International Limited supplied the following radio-labelled
14 14compounds: [1- C]-1-naphthol, (Sp Act 19.4 mCi/mmole), [4- C]-
14oestrone (Sp Act 55.8 mCi/mmole), and [4- C]-oestradiol (Sp Act 55 
o
mCi/mmole). [ H]-3-Hydroxybenzo(a)pyrene (Sp Act 19.2 Ci/mole) was 
kindly provided by the Midwest Research Institute, Kansas City, USA. 
Sigma Chemical Company, Poole, Dorset, U.K., provided 1-naphthyl 
sulphate (potassium salt), hydrocortisone, retinyl acetate, insulin 
(from bovine pancreas), gentamicin sulphate, BSA (for Lowry assays), 
fZ -glucuronidase (from bovine liver), arylsulphatase (type H-1 
extracted from Helix pomatia) D-saccharic acid 1,4-lactone,oestrone, 
{Z-oestradiol, adenosine 5 *-phosphosulphate (sodium salt) and
adenosine 3 -phosphate 5 -phosphosulphate (lithium salt). 
Leibovitz L-15 and Hams culture media were obtained from Flow 
Laboratories, Irvine, Ayrshire, U.K. Foetal calf serum, RPMI and 
CMRL-1066 culture media, penicillin - streptomycin, L-glutamine, 
tricine and fungizone (amphotericin B) were purchased from Gibco- 
Biocult Ltd, Paisely, Glasgow, U.K. Also, foetal calf serum was 
obtained from Sera Laboratories, Crawley Down, Sussex, U.K. For the 
purpose of addition to culture media, BSA (Pentex Bovine Albumin) was 
bought from Miles Lab Inc Research Products, Slough, Bucks, U.K. 
Ketodase came from General Diagnostics, Warner Lambert, U.K. Limited, 
Eastleigh, Hants. Koch-light Labs Ltd, Colnbrook, U.K. provided the 
1-naphthyl-/3 -D-glucuronide, whilst 1-naphthol was obtained from each 
of the following: Hopkin and Williams Ltd., Chadwell Heath, U.K.,
Sigma Chemical Company, BDH Chemicals Ltd. The Chemical Repository, 
ITT Research Institute, Chicago, 111, U.S.A. donated gifts of 
3-hydroxybenzo(a)pyrene, 3-hydroxybenzo(a)pyrene- ft -D-glucopyrano- 
siduronic acid and benzo(a)pyren-3-yl-hydrogen sulphate.
Fluorescent silica gel TLC plates (200 x 200 mm; Kieselgel 60F2^,
0.2mm thickness, aluminium-backed) and non-fluorescent silica gel TLC 
plates (200 x 200 mm Kiesgel 60, 0.2 mm thickness, aluminium-backed) 
were initially obtained from E. Merck, Darmstadt, W. Germany, but 
later these became available from BDH Chemicals Ltd, Poole, Dorset. 
The following scintillants were used: either 0.5$ w/v PP0, 0.025? w/v 
dimethyl POPOP in 33$ v/v Metapol (Durham Chemicals Distributors 
Limited, Birtley, Tyne & Wear, U.K.) in toluene (sulphur free) or 
Aquasol from New England Nuclear, Boston, Mass, U.S.A. Gelfoam 
sponge (size 12-3mm) was kindly provided by The Upjohn Company,
Crawley Down, Sussex, U.K.
(6) Equipment
High speed centrifugation was achieved using High Speed 18 (M.S.E), 
M.S.E. Europa 50M centrifuges MSE Ltd., Crawley, Sussex, U.K. or 
Beckman Model L5-65 ultracentrifuge (Beckman RIIC Ltd., High 
Wycombe, Bucks, U.K.) Liquid scintillation counting was performed 
using a Rackbeta Scintillation Spectrometer Model 1216 (LKB
Instruments Ltd., Selsdon, South Croydon, Surrey, U.K.)
Homogenisations of tissues were carried out by the use of either 
Atomix blender (M.S.E. Ltd., Crawley, Sussex, U.K.) or a Polytron PT- 
10-OD homogeniser (Northern Media Supply Limited, Hull, North 
Humberside, U.K.). Short-term organ culture of tissue was possible 
by using a Bellco Incubator Model 77^1-10010 and Bellco Rocker
Platform Model 6K2-1083 (supplied through R.A. Horwell Ltd., Kilburn, 
London, U.K.). Radiochromatogram scanning was carried out on either 
a Varian-Berthold Radiochromatogram Scanner or a Panax
Radiochromatogram Scanner RTLS-1A, from Panax Equipment Ltd., 
Redhill, Surrey, U.K.
Culture vessels or dishes were purchased from Sterilin Ltd., 
Teddington, Middlesex, U.K. and Nunc (Gibco-Biocult).
B: METHODS
1) Culture Methods
(i) Cell Lines
The eight cell lines, Ben, Gri, Min, Poc, Mar, Mor, Dre, E14, 
originally derived from human bronchial carcinomas were routinely 
cultured (118) in 90$ Dulbecco*s modified Eaglefs medium, 10$ bovine 
foetal calf serum, kanamycin (100 mg/1) and fungizone (1.25mg/l) in 
plastic tissue culture flasks (Nunc) maintained at 37°C in an 
atmosphere of 10$ carbon dioxide in air.
The cell lines COLO 205 and COLO 206 were cultured in RPMI 1640 
containing 10$ bovine foetal calf serum, penicillin (100 units/ml) 
and streptomycin (100yug/ml), in plastic tissue culture flasks 
(Sterilin) maintained at 37°C in an atmosphere of 5$ carbon dioxide 
in air. These cell lines were established by Semple et.al. (119).
The LoVo cell line was cultured in Hams medium containing 10$ bovine 
foetal serum, glutamine (ImM), penicillin (100units/ml) and 
streptomycin (100 yug/ml) in plastic tissue culture flasks (Nunc) 
maintained in an atmosphere of 5$ carbon dioxide in air at 37°C. 
This cell line was established by Drewinko et.al. (120,121).
The bronchial carcinoma and LoVo cells were passaged in the following 
way. The culture medium was decanted and the cells washed twice or 
three times with sterile phosphate-buffered saline (PBS). Trypsin
(0.25$) in PBS was then added to the cells and the dish placed at 
37°C for about five minutes. When the cells were seen to be 
floating in the medium, the dish was removed from the incubator. 
More PBS was added and then the cells were suspended in this medium. 
At this stage the cells were centrifuged (at less than 1000 rpm) to a 
pellet, having transferred the suspension to a centrifuge tube, 
after which the supernatant was decanted and the pellet resuspended 
in culture medium to get a single cell suspension. This suspension 
was then divided between several new culture vessels. The COLO cell 
lines did not need treating with trypsin as these do not adhere to 
the base of culture flasks, but grow in suspension. Otherwise, the 
procedure for dividing the cells into new dishes was the same as 
above.
(ii) Short-term explant of surgical specimens
Human specimens, from patients with lung cancer or colon cancer, were 
collected from hospitals and cultured within a period of three hours 
of surgical removal. Peripheral lung tissue, bronchus, lung tumours, 
normal colonic mucosa and colonic adenocarcinoma were all cultured in 
a similar way as follows. The tissue was transported to the 
laboratory in either phosphate-buffered saline (lacking calcium and 
magnesium salts) or Leibovitz L-15 medium containing the antibiotics 
gentamicin sulphate (50 yug/ml) fungizone (25 /%/ml), penicillin (100 
Units/ml) and streptomycin (100 /xg/ml). The cancerous character of 
the tissue was established by histopathological examination. The 
bronchus and lung tissues were cultured essentially as described by 
Barrett et.al. (122) and Stoner et.al. (123). The colon tissues were 
cultured in a similar way to that suggested by Autrup et.al. (124).
The surfaces of plastic petri dishes (either 5 cm single ones (Nunc) 
or six 3.5 cm multi-well dishes (Sterilin)) were prepared by- 
scratching two small areas on opposite sides of the dish with a 
scalpel (Fig. 16). Pieces of Gelfoam sponge measuring approximately 
12 mm x 3 mm x 5 mm, which had previously been soaked in Leibovitz L- 
15 culture medium at 37°C, were placed on the abrasive surfaces,
i.e. two sponges per dish. The tissues were cut into small pieces 
(2-3 mm ) and put on to the sponges in the dish. CMRL-1066 culture 
medium (2.5ml in the larger culture dishes and 1 ml in the smaller 
culture wells) containing various additives. When normal lung tissue 
and lung tumour were being cultured 5? (w/v) bovine foetal calf 
serum, insulin (1 yAg/ml), hydrocortisone (0.1 yug/ml), fb -retinyl 
acetate (0.1 yug/ml), penicillin (100 units/ml), streptomycin (100 
yug/ml), trieine buffer (40 mM) and glutamine (1 mM) were added to 
the CMRL-1066 medium.
When culturing colonic tissue and tumours, the following additions to 
the CMRL-1066 with 2mM glutamine were made: trieine (40mM), glucose 
(15mM), BSA (1.25?), L-glutamine (1mM), pencillin (100 units/ml), 
streptomycin (100 /Ag/ml), gentamicin sulphate (50 jd. g/ml), 
hydrocortisone, (10"^M) and fungizone (0.25 ^M.g/ml) (final 
concentrations) were made to the CMRL-1066 medium. The dishes were 
placed in a Bellco incubator and gassed with filtered 95? 02 and 5? 
C02 for colon samples and 50? 02: 45? N2: 5? C02 for lung
samples. This gassing maintained the medium at a physiological pH of 
about 7.4. The incubator was placed on a Bellco rocker platform, 
maintained at 37°C and rocked at 10 cycles/minute for 24 hours so 
that the explants were in the medium for 50? of each cycle. The
Figure 16 : Preparation Of Culture Dishes For Tissue
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position of the explants was always at the sides of the dishes and 
the rocking always took place in the same direction to ensure 
that the tissue is covered for 50% of the time (Fig. 16),
Tissue samples of bronchial epithelium from bronchoscopy were 
prepared and cultured, using the same method as the one adopted with 
the surgical samples of lung. The culture medium for the xenograft 
samples was decided by the tissue from which the xenograft 
originated. In addition, the same overall procedure was used with 
animal tissues.
(2) Metabolism of 1-Naphthol and 3-Hvdroxvbenzo(a)Dvrene with cell 
lines
Having decanted the culture medium from each flask or dish, the same
3
medium containing 0.28 yu.Ci per ml of [ H]-3-hydroxybenzo(a)pyrene 
(2 yuM final concentration) or 0.1-0.4yuCi per ml [1- C]-1-naphthol, 
at a range of concentrations, was added to the cell cultures, 
incubations being carried out at 37°C for a specified time. At the 
end of the time period (90 minutes to 24 hours), the medium was 
decanted from the cells and stored frozen until it was analysed. The 
cells from each incubation were lysed by the addition of 0.1M sodium 
hydroxide. Protein was determined, on the broken cell preparations 
in sodium hydroxide, using bovine serum albumin as a standard, 
employing Lowry*s method (125).
(3) Metabolism of 1-Naphthol In Short-term Explant Culture of
Sureioal and Bronchoscopy Samples.Xenografts and Animal Tissues
After culture for a period of 24 hours, at 37°C, the medium was
14removed and replaced with one containing [1- C]-1-naphthol, at
various concentrations, multiple incubations being carried out. The
tissue was then cultured in this media, again at 37°C, and also for
24 hours. At the end of this period, the medium from each dish was
removed and stored, frozen at-20°C, prior to the analysis of 1-
naphthol metabolites. The tissue was either removed and stored
frozen at -20°C for protein determination by Lowryfs method or
homogenised to determine the metabolites retained in the tissue. In
some cases, the tissue was cultured still further by replacing the
14media containing [1- C]-1-naphthol with fresh culture media.
Metabolism controls were obtained by culturing media containing 
14[1- C]-1-naphthol for 24 hours in the absence of tissue and the 
media removed and analysed. In order to determine the amount of 
protein per dish, following explant culture, the tissue was dissolved 
in ,100 fxl of 1M sodium hydroxide in a sealed tube at 37°C. 
Aliquots of the resulting solution were employed for a protein assay 
(125), using BSA as a standard.
Tissue for histology was placed in either 10% neutral buffered 
formalin or a fixative containing glutaraldehyde. These solutions 
fixed tissue ready for histological preparation on slides for light 
microscopy. The fixative containing glutaraldehyde prepares the 
tissue for electron microscopy as well as light microscopy.
(4) Chromatography of 1-Naphthol Conjugates
The conjugates in culture media were analysed by thin layer 
chromatography (TLC) essentially as described by Mehta et.al. (126) 
Aliquots (50ywl) of the culture medium from one incubation together 
with 50 yml of authentic standards of 1-*naphthol, 1 -naphthyl-y3 -D- 
glucuronide and 1-naphthyl sulphate in methanol were applied to 
silica gel TLC plates (200 mm x 50 mm; Kieselgel 60F2^^, 0.2mm
thickness, aluminium-backed plates) and the metabolites separated 
using a solvent system of toluene: glacial acetic acid: acetone
(2:1:2 by volume) at room temperature. The metabolites associated 
with radioactivity were detected by radiochromatogram scanning, while 
the quantitation of the conjugates present in each medium was carried 
out by cutting the chromatogram at the position of the UV-absorbing 
standards on the fluorescent background, when examined under UV 
light. This was followed by liquid scintillation counting, the 
amount of radioactivity detected at similar Rf positions as the 
conjugates, in the appropriate controls, being subtracted from the 
corresponding values obtained in the experimental determinations. 
The Rf values for the compounds 1-naphthol, 1-naphthyl sulphate and
1-naphthyl--D-glucuronide were as follows: 0.85, 0.47 and 0.19 
respectively.
(5) Chromatography of ^-Hvdroxvbenzo(a)pvrene (3-OH-BP) Conjugates
The conjugates in the culture media were analysed by TLC. An 
equivolume mixture of culture medium and methanol:acetone (4:1 by 
volume) was made up together with unlabelled standards of 3-OH-BP, 3- 
0H-BP-/3 -D-glucopyranosiduronic acid and benzo(a)pyren-3-yl-hydrogen 
sulphate. After centrifugation, in a bench centrifuge (2500rpm) 
aliquots (100 jJil) of the supernatant fraction were applied to non- 
fluorescent silica gel TLC plates (200 x 40 mm: Kieselgel 60, 0.2 mm 
thickness, aluminium backed plates without fluorescent indicator). 
The metabolites were separated using a solvent system of propan-1-ol: 
ammonia: toluene (7:3:1 by volume) at room temperature. The
quantitation of the conjugates was carried out in the same manner as 
that described for 1-naphthol. The amounts of radioactivity detected 
at similar Rffs as the conjugates in the appropriate controls were 
substracted from the corresponding values obtained in the 
experimental determinations. The Rf values for the compounds 
3-OH-BP, benzo(a)pyren-3-yl-hydrogen sulphate and 3-OH-BP-y3 -D- 
glucopyranosiduronic acid were as follows: 0.73> 0.47 and 0.25
respectively.
6) Hvdrolvsis of Conjugates for Further Identification of
Metabolites
Equal aliquots of culture media were incubated with either Ketodase 
(or ^-glucuronidase; 5000 units/ml) in 0.1M acetate buffer, pH 5.0; 
or with arylsulphatase (700 units/ml) and D-saccharic acid 1,4- 
lactone (40 mM) in 0.1M acetate buffer, pH 5.0; or with 0.1M acetate 
buffer, pH 5.0, alone. Saccharic acid 1,4-lactone was included with
arylsulphatase. The hydrolyses were carried out in sealed tubes in a
quantitate the conjugates formed, the hydrolyses were then analysed 
by TLC. The TLC procedure was carried out as already explained, but 
without radiochromatogram scanning. A metabolite was identified as a 
glucuronide if it was hydrolysed by /(3-glucuronidase and as a sulphate 
ester if it was hydrolysed by arylsulphatase.
arylsulphatase to inhibit a known contaminant of
37°C incubator for periods between 20 and 24 hours. In order to
(7) Preparation of Subcellular Fractions
The methodology of preparing subcelluar fractions is based on the 
work of Schneider (127) and De Duve et.al. (128) Homogenates (50%) 
of tissue in 1.15$ potassium chloride were centrifuged at 10,000g for 
30 minutes, the supernatant fractions being then either used in 
enzyme assays or centrifuged at 100,000g for 60 minutes. The 
subsequent microsomal fractions and cytosolic (supernatant) cell 
fractions were utilised to assess either glucuronic acid or sulphate 
ester conjugation.
(8) 1-Naphthol Conjugation bv Subcellular Fractions
For glucuronic acid conjugation, the reaction mixture (total volume
14
500 y u l )  consisted of 0.02-0.2 yuCi [1- C]-1-naphthol at a range of
concentrations from 2-20ymM, 1,5mM UDP-glucuronic acid in 0.05M Tris-
HC1 pH 7.4 containing 4mM magnesium chloride (final concentrations).
To measure sulphation, the reaction mixture (total volume 500 yul) 
14consisted of [1- C]-1-naphthol at a range of concentrations from
2-20 yuM; 2mM sodium sulphate; 5mM magnesium chloride; 5mM ATP and 
0.05M Tris-HCl pH 7.4 (final concentrations). In one experiment 
(Chapter 5), 2mM sodium sulphate was replaced with either 2mM APS or 
2mM PAPS. In the latter case, ATP was omitted from the reaction 
mixture. The reactions were initiated by the addition of enzyme and 
incubated at 37°C in a shaking water bath for periods of time 
between 10 to 60 minutes in order to ensure linearity of the 
reaction. Control incubations contained no enzyme fractions. 
Reactions were terminated by the removal of 100 yul aliquots of the 
incubation media into tubes with an equal volume of methanol 
containing the unlabelled standards 1-naphthol, l-naphthyly3 -D- 
glucuronide and 1-naphthyl sulphate.
The analysis of the 1-naphthol conjugates formed by the subcellular 
fractions were carried out using the same procedure as that employed 
with the culture media, but without the use of radiochromatogram 
scanning.
(9) Qestrone and Oestradiol Conjugation bv Subcellular Fractions
The method using oestrone and oestradiol as substrates was based on
that of Rao et.al. (129). The reaction mixtures for glucuronic acid
conjugation and sulphate ester conjugation were obtained by using the
same approach as the one adopted for 1-naphthol, except that the 1-
14
naphthol was omitted and 30^M-120yu.M of either 0.05-0.19y*Ci [4- C]-
14oestrone or 0.03-0.13 Ci [4- C]-oestradiol was added to the
incubation tubes. These steroid substrates were placed in the tubes 
first. The solvent mixture (toluene:ethanol 4:1 by volume), in which 
those oestrogens were dissolved, was then evaporated with nitrogen 
gas, the remainder of the reaction mixture being then added. The 
reaction was initiated with the appropriate subcellular fraction 
containing the enzyme and carried out in a shaking water bath, at 
37°C, for 60 minutes. Termination of the reactions was achieved by 
the addition and mixing of 5 ml dichloromethane, the tubes then being 
placed in ice. The controls were incubated with boiled enzyme. The 
aqueous and organic layers were mixed to extract the unconjugated 
steroid into the dichloromethane, the layers then being separated by 
bench centrifugation. Aliquots, in duplicate, were taken from the 
upper aqueous layer to assess for radioactivity. The unconjugated 
steroid was extracted into the organic solvent, while conjugates 
remian in the aqueous layer.
(10) Urethane-Treated Mice
A single injection of urethane given to certain strains of mice 
produces multiple lung adenomas within several weeks (130). Male 
AJAX mice, about 12-14 weeks old, were injected intraperitoneally 
with urethane in saline at a dose of 1.08 mg/g body weight, the 
control animals being male AJAX mice of the same age.
The animals were killed at either 17 or 19 weeks post treatment, by 
cervical dislocation of the neck. The urethane-treated mice had 
pearly-white nodule growths (adenomas) throughout their lung tissue. 
Adenomas, normal-appearing lung tissue adjacent to these tumours, 
normal-appearing lung tissue distant to these tumours and tracheas 
from the treated mice were removed. In order to compare the treated 
and control mice, normal-appearing lung tissue and tracheas were 
dissected out from the control mice. The tissues were all cultured 
as explants using the procedure employed with the surgical samples.
- 72 -
.CHAPm . 3.
ROUTES OF CONJUGATION OF 1-NAPHTHOL BY NORMAL AND 
TUMOUR TISSUE IN SHORT-TERM EXPLANT CULTURE
A: INTRODUCTION
B: RESULTS
(1) Lung
(a) Morphology
(b) Metabolism of [1-^C]-1-Naphthol
(i) Human Lung and Tumours 
(ii) Human Bronchus
(iii) Heterogeneity of Human Tumour Samples In 
Explant Culture 
(iv) Tissue Metabolites
(2) Colon
(a) Morphology
(b) Metabolism of [ 1-^C]-1-Naphthol
(i) Human Colon and Tumours
(ii) Tissue Metabolites
C: DISCUSSION
(1) Lung
(2) Colon
D: CONCLUSION
A: INTRODUCTION
For ethical reasons, it is not possible to make an extensive study 
in vivo with human beings of xenobiotic metabolism and toxicity. 
However, there is certainly a need for information concerning drug 
metabolism in man. Once detailed information is available, it will 
aid improved extrapolation of data obtained by use of animal models 
to humans. Nevertheless, there are many difficulties which tend to 
arise when examining drug metabolism either in man in vivo or in 
human tissues from surgery. Not the least of these difficulties is 
the fact that there are large interindividual variations in response 
to xenobiotics in human beings. Despite such difficulties, 
scientists must clearly endeavour to increase understanding and basic 
knowledge about metabolism and toxicity in humans. Under such 
circumstances, it would be easier for toxicologists to make more 
logical extrapolations of experimental data from animals, to find the 
potential risk of these chemicals to man.
Accordingly, for the purposes of the present research, to understand 
conjugation pathways in human tissue, surgically removed tissue from 
hospital patients has been utilized. The human tissue, normal and 
tumour, has been set up in short-term explant tissue for metabolic 
studies. However, this is an in vitro system in which any tissue 
from man could be used to obtain information about the metabolic 
pathways present. The way in which xenobiotics are handled by 
individual organs in humans could be found and, also, whether the 
diseased tissue from these organs alters the drug-metabolising 
ability. In addition, in this context, normal and diseased human
tissue from specific organs can be compared morphologically and 
biochemically with animal tissues. Thus, an assessment of animal 
models of human disease could be made and probably an improved 
extrapolation from animal data to man should be possible.
In this context, it seems appropriate to use organ culture in the 
maintenance or growth of tissue in vitro to allow differentiation and 
preservation of the architecture and/or function (131). The purpose 
of this technique is to retain the tissue’s integrity of cellular 
relationships. Thus, it may be hoped that the system gives data 
reflecting drug metabolism or, indeed, drug sensitivity in a testing 
context, that could be seen in vivo more accurately than in other 
culture systems.
Undoubtedly, there are certain clear advantages of short-term explant 
culture for in vitro studies. First, tissue three-dimensional 
architecture is maintained so that the study of the metabolism of 
test compounds occurs in organized tissue. By this means, it is 
possible to take into account the influx and efflux of a substance 
and its metabolite(s); this being impossible in subcellular 
fractionation studies. Secondly, this technique is particularly 
useful as Phase 1 and Phase 2 metabolic pathways can be studied in 
the same system. Thirdly, organs which are targets for either toxic 
chemicals or carcinogens can be studied, enabling an understanding of 
the potential of these tissues to activate or detoxify xenobiotics, 
rather than using data from whole animal studies. Also, the ability 
of the chemical or metabolites to react with macromolecules in the 
tissue and the possible consequences of such interactions may be
examined. Furthermore, the explant culture technique gives exposure 
of all cell types in a tissue to a chemical. Thus, data obtained in 
this way shows the ability of an organ to metabolise as a discrete 
entity, rather than examining one cell type within the tissue. Also, 
another advantage is that, histopathological changes in the tissue 
can be monitored after exposure to a toxic chemical. When comparing 
this technique with that of monolayer culture of cells, the advantage 
of the explant procedure is that,in the preparation of the tissue, 
there is no use of collagenase or pro tease. These enzymes can be 
damaging to the cell membranes. Furthermore, another advantage is 
that as there is minimal cell division, the chance of transformation 
is low. Finally, the technique may be applicable to understanding 
tumour metabolism and response to drugs in individual patients.
It is important to stress that there are a variety of problems which 
arise when using human tissues. Unlike the situation possible when 
working with animals, a day of experimental work with human tissues 
is impossible to plan precisely, as surgical samples are not 
available on request. Often, a hospital, having taken tissue for 
their own analysis, tend to provide insufficient tissue to enable 
research work to be carried out with many experimental variables. In 
culture, the human tissue is deteriorating and will, over a few days, 
tend to become totally necrotic. Each piece of tissue is individual 
and so some tissue may be in a poor condition from the time it is 
placed in culture, while other pieces are both healthy and viable. 
Central necrosis of explants can occur with poor diffusion of gas and 
nutrients. Thus, it is difficult to examine sequentially, different 
tissues over a period of time for histopathological change in the
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culture system. In experimental work with human tissue, a major 
difficulty of examining histology and metabolism is that cancerous 
tissue tends to be heterogeneous. Accordingly, the interpretation of 
data using explants culture is by no means straightforward. A 
further disadvantage is that the high oxygen tension could alter 
oxidative metabolism in the tissues. The major advantages and 
disadvantages of using human tissue in short-term explant culture are 
summarised in tabular form (table 4, p 77)•
During the period when the work for the present research was 
undertaken, there was a change in the way in which the tissue from 
surgery was used. At first, much of the tissue was set up in culture 
for various lengths of time and then removed to be examined 
histopathologically. This was done in order to establish that tissue 
would be viable in culture for the length of time over which 
metabolism would be studied. Also, tissue was used to compare 
whether either standing or rocking the tissue in culture was the more 
beneficial method of maintaining viable cells over several days.
For the metabolism studies, the first lung samples were cultured in 
5cm diameter dishes, while the later samples were set up in smaller 
3cm dishes. Thus, the volume of culture medium was decreased when 
the latter dishes were used. In the first studies, five explants per 
dish (each about 10mg) were used, while later the number of explants 
per dish was two to four, depending on the availability of tissue. 
Initially, the time used for metabolism experiments was 90 minutes. 
However, eventually it was found that 24 hours was a better time 
period to observe metabolism of 1-naphthol, and so this longer period
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TABLE 4: The Advantages and Disadvantages of Using Short-term
Explant Culture with Human Surgical Samples
Advantages
Metabolism can be studied in 
organized tissue with intact 
cells.
Both Phase 1 and 2 drug 
metabolism pathways are present 
in tissue. Metabolism in intact 
tissue represents a balance of 
the relative rates of synthesis 
and degradative pathways.
Specific organ metabolism can 
be studied.
All cell types in a tissue 
contribute to the metabolism 
of xenobiotics. Chemical/ 
macromolecule interactions can 
be studied.
Histopathological change is 
detectable.
In preparation of the explants, 
there is no use of enzymes like 
collagenase or protease which 
can be damaging.
The chance of transformation is 
low as cell division is minimal.
It may be possible to understand 
tumour metabolism in individual 
patients.
Disadvantages
It is difficult to plan 
experimental work as samples are 
not available on request.
Often, there is insufficient 
tissue to carry out many 
experimental variables.
Individual tissue can become 
necrotic, producing misleading 
results. Central necrosis can 
occur with poor diffusion of gas 
and nutrients.
The heterogeneity of tissue can 
cause difficulties in the 
interpretation of varying 
metabolism.
The high oxygen tension conditions 
under which the tissues are 
cultured could alter oxidative 
metabolism.
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of time was used with the remainder of samples from lung and all 
colon specimens.
B: RESULTS
(1) U MK
(a) Morphology
The culture conditions were satisfactory for the maintenance of both 
normal peripheral lung and tumour tissue for 48 hours and in some 
cases longer. An illustration of normal peripheral lung, obtained 
fresh, fixed and stained for histopathological examination, can be 
seen in Fig. 17, while Figs. 18 and 19 depict this tissue after being 
cultured for 42 hours and 8 days respectively. Figs, 20, 21 and 22 
illustrate the histological appearance of a squamous cell carcinoma 
fresh, at 48 hours and at 7 days respectively. Similarly, Figs. 23, 
24 and 25 represent the histological appearance of a non-squamous 
carcinoma of the lung (most probably an oat cell carcinoma), fresh at 
42 hours and at 8 days respectively.
Figure 17 : Normal Human Peripheral Lung = Fresh xi60
Figure 18 = Normal Human Peripheral Lung : 42 h xi60
Figure 19 = Normal Human Peripheral Lung : 8 days x 160
necrosis
carbon particles
Legend to Figures 17 - 1Q
These photographs are of histopathological sections from the same 
normal human peripheral lung sample. They are fresh (i.e. prior to 
culture) (Fig. 17), cultured for 42 hours (Fig. 18) and cultured for 
8 days (Fig. 19). When the tissue was fresh, the alveolar structures 
of the peripheral lung can be seen (Fig. 17). There are three major 
types of cells in alveolar walls: endothelial cells of capillaries, 
squamous alveolar epithelial cells (type I cells) and great alveolar 
cells (type II cells). As the time of incubation increased, there 
was a progressive tendency for the alveolar structures to collapse 
and form a solid mass of tissue (Fig. 18 and 19). However, with some 
peripheral portions of the explants, intact alveolar structures could 
be observed (Fig. 18). Often, the central portions of the explant 
became necrotic (Fig. 19). However, necrosis was observed less in 
peripheral portions of explants, presumably because this tissue had 
closest contact with medium and atmosphere. Even though the tissues 
were necrotic some viable cells were able to metabolise 1-naphthol 
after 8 and 14 days culture (Tables 6 and 7). It is interesting to 
note that carbon particles can be seen in Fig. 19. Cigarette smoking 
is probably the reason for this deposit.
These observations confirm a similar trend to those reported by 
Stoner et.al.(123)-
Figure 20 Human Squamous Cell Carcinoma: Fresh xi6o
Figure 21 ; Human Squamous Cell Carcinoma : 48h x 160
gelfoam
Figure 22 = Human Squamous Cell Carcinoma : 7 days *160
Legends to Figures 20 - 22
These photographs are of histopathological sections of a squamous 
cell carcinoma from a human patient (K - see table 6.) Tissue prior 
to culture is shown in Fig. 20, while that cultured for 48 hours is 
illustrated in Fig. 21. Fig. 22 gives a picture of this tumour 
cultured for 7 days. As the time of incubation increased, the 
central portions of the explant sometimes become necrotic, as for the 
normal peripheral lung. These photographs of a squamous cell 
carcinoma illustrate the heterogeneity of tumour tissue. Where 
necrosis was not observed, sometimes a loss of staining was seen, 
indicating some form of degeneration. Sometimes, keratin was 
observed in the squamous cell carcinomas. This is a substance that 
some squamous cell carcinomas secrete.
Viable tissue was maintained for 8 days, as tissue cultured for this 
time was able to metabolise 1-naphthol (see Table 6).
Figure 23 • Human Non-squamous Carcinoma = Fresh xi60
%
V\ v. -w •'
Figure 24 ; Human Non-squamous Carcinoma : 42hxi60
necrosis
Figure 25 ; Human Non-squamous Carcinoma : 8 days xi6o
Legends to Figures 23 - 25
These photographs are of histopathological sections of a non-squamous 
carcinoma from a human patient (M - see Table 7). This tumour was 
most probably an oat cell carcinoma. Fig. 23 shows tumour prior to 
culture, while Fig. 24 illustrated the tissue cultured for 42 hours. 
Tumour maintained for 8 days is shown in Fig. 25. Again, these 
photographs illustrate the heterogeneity of tumour tissue. As with 
the other tissues, the central portions of the explants become 
necrotic. - There are clear areas of necrosis on Figs. 24 and 25. 
However, viable tissue was maintained for as long as 14 days, as 
tissue cultured for this time was able to metabolise 1-naphthol (See 
Table 7).
(b) Metabolism of ri-^Cl-1-naphthol 
(i) Human Lung and Tumours
Lung tumours can be categorised under a whole range of
histopathological classifications. Table 5 shows the histological
diagnosis made on the samples used for metabolism studies. Fig. 26
illustrates the metabolism of 1-naphthol to its sulphate ester and
14glucuronic acid conjugates. The results of conjugation with [1- 
C]-1-naphthol, by short-term organ cultures of normal peripheral lung 
and squamous type tumours, are listed in table 6. Table 7 shows the 
results from the same metabolism studies, when the tumours were 
classified as non-squamous.
When short-term organ cultures of peripheral human lung were
14incubated with [1- C]-1-naphthol, the major metabolite formed was
the sulphate conjugate, 1-naphthyl sulphate, with either little or no 
glucuronic acid conjugate being formed (tables 6 and 7). This 
information is illustrated in Fig. 27. However, in the case of
tumour tissue, the metabolism of 1-naphthol varied with the 
histological classification of the tumour (tables 6 and 7).
Particularly striking was the finding that tumour tissue from
patients with squamous cell carcinomas metabolised 1-naphthol 
predominantly to its glucuronic acid conjugate, with little or no 
sulphate conjugate being formed (table 6). These results are
illustrated in Fig. 28. However, the tumour tissue from patient I 
appears to be an exception to this generalisation, in this case 
showing more sulphation than glucuronidation. Also, in table 6, the
TABLE 5: Histopathological classifioation of the lung tumours
used in metabolism studies
Patient HistoDathological Diagnosis
A Moderately well differentiated squamous cell carcinoma
B Undifferentiated large cell anaplastic carcinoma
C Undifferentiated large cell anaplastic, possibly 
squamous.
D Poorly differentiated adenocarcinoma (possibly 
metaplastic from breast)
E Undifferentiated large cell anaplastic, possibly 
adenocarcinoma
F Very poorly differentiated squamous cell carcinoma
G Small (large) cell anaplastic carcinoma
H Large (small) cell anaplastic carcinoma
I Squamous carcinoma
J Large cell anaplastic carcinoma
K Squamous cell carcinoma
L Squamous carcinoma
M Poorly differentiated squamous cell carcinoma
N Poorly differentiated squamous cell carcinoma
* 0 Squamous
P Moderately differentiated squamous cell carcinoma
* Q Non-squamous
£ R Squamous
£ S Non-squamous
£ T Squamous - metastatic tissue from lymph node, primary 
in bronchus
* Samples 0, Q, R, S, T are awaiting confirmation of the 
histopathological diagnosis from the hospitals.
Figure 26 : 1-Naphthol And Its Conjugates
1-Naphthyl sulphate
1-Naphthol
COOH
1 - Naphthyl -6-D-glucuronide
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14TABLE 6; Conjugation of H-  Cl-1-naphthol bv short-term organ
cultures of normal human lung and sauamous-tvpe tumours
1-
Patient
NaDhthol 
(uMl Previous % of total radioactivity nmoles/QO minutes/
time of recovered in medium as mg Drotein
culture conjugates in the
kung 
1-NS 1-NG
Tumour
J=NS JdKG
Lung
_1=N£ _1 =85.
Tumour 
1-NS 1-NG
A 10 Oh 9.5(2) ND (2) 0.4(2) 7.7(2) 10.6 ND 0.3 7.1
10 I8h 14.2(2) ND (2) 0.5(2) 7.4(2) 15.5 ND 0.5 6.6
C 5 Oh 11.2(2) ND (2) 1.3(2) 5.6(2) 1.6 ND 0.1 0.4
10 Oh 7.4(2) 1.3(2) 1.5(2) 5.7(2) 2.1 0.4 0.3 1.1
5 I8h 9.1(2) ND (2) 0.3(2) 11.4(2) 1.2 ND <0.1 1.0
10 I8h 7.6(2) 1.4(2) 0.5(2) 9.5(2) 2.2 0.4 0.1 1.9
F 5 Oh 9.6(2) ND (2) 9.3(2) ND (2) 1.2 ND 1.8 ND
10 Oh 6.0(2) 0.3(2) ND (2) 1.0(2) 1.2 <0.1 ND 0.5
5 I8h 14.1(2) ND (2) 1.6(2) 2.2(2) 1.6 ND 0.3 0.3
10 I8h 10.1(2) 1.0(2) 0.6(2) 4.5(2) 2.6 0.3 0.2 1.2
nmoles/24hours/
mg Drotein
10 I8h 82.2(2) ND (2) 26.2(2) 40.5(2) 16.9 ND 3.7 5.9
100 I8h 87.2(2) ND (2) 15.3(2) 53.2(2) 166.7 ND 24.0(1) 59.7(1)
I 10 24h 58.5(2) 12.3(2) 12.9(2) 10.6(2) 27.7 6.1 3.7 2.8
20 24h 70.4(2) 7.8(2) 33.0(2) 20.1(2) 26.8 3.4 15.2 11.8
10 7 days - - 59.6(2) ND (2) - - 24.3 ND
20 7 days - - 48.4(2) 3.5(2) - - 30.6 2.1
K 5 24h 61.0(4) ND (4) 10.2(4) 22.1(4) 26.3 ND 2.9 6.1
10 24h 54.1(4) 1.7(4) 3.1(4) 22.1(4) 49.5 1.3 1.6 11.2
20 24h 51.4(4) 1.5(4) 3.3(4) 23.3(4) 91.6 2.5 3.7 24.5
50 24h 42.6(4) 1.0(4) 2.9(4) 34.1(4) 193.6 3.6 20.1 172.6
100 24h 42.6(4) 1.6(4) 1.3(4) 24.4(4) 360.9 10.5 5.3 129.8
10 8 days 74.9(3) ND (3) 10.1(3) 23.5(3) 62.9 ND 9.7 25.9
L 5 24h 20.6(4) 0.1(4) 8.5(4) 2.4(4) 9.0 <0.1 1.7 0.6
10 24h 29.8(4) 0.2(4) 3.3(4) 5.2(4) 26.1 0.2 1.2 1.8
20 24h 19.6(4) 0.3(4) 4.2(4) 6.7(4) 33.5 0.4 2.8 5.2
50 24h 17.5(4) ND (4) 2.6(4) 3.7(4) 85.3 ND 5.9 8.6
100 24h 19.6(4) 1.7(4) 4.6(4) 8.9(4) 188.5 17.5 27.4 56.4
10 7 days 19.6(4) 0.5(4) 2.9(4) 3.3(4) 20.6 0.7 1.4 1.4
M 20 24h 24.5(3) 1.2(3) 1.1(3) 6.6(3) 35.9 2.2 1.4 8.3
N . 20 24h 44.6(3) ND (3) 3.5(3) 9.7(3) 30.2 ND 2.5 8.3
0 20 24 h 72.4(3) 0.1(3) 0.6(3) 27.5(3) 14.2 <0.1 0.1 5.5
P 5 24h 42.9(2) ND (2) 2.6(2) 24.3(2) 4.2 ND 0.2 2.0
10 24 h 51.9(2) 0.4(2) 0.8(2) 30.8(2) 8.9 0.1 0.1 3.7
20 24h 45.7(2) 1.3(2) 1.2(2) 22.2(2) 29.3 1.0 1.0 13.7
R 20 24h 45.3(3) 0.1(3) 1.8(3) 17.6(3) 71.3 0.2 1.3 20.7
100 24h 12.7(3) 1.8(3) 0.3(3) 0.7(3) 40.0 1.3 0.7 2.3
T 10 24h 75.7(2) ND (2) 4.5(2) 38.9(2) 9.3 ND 0.4 4.1
20 24h 74.3(2) ND (2) 3.7(2) 46.4(2) 38.1 ND 1.1 15.4
100 24 h 45.4(2) 0.4(2) 0.9(2) 43.1(2) 43.9 0.4 0.7 37.4
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TABLE 7: Conjugation of l~ 1- Cl-1-naphthol bv short-term organ
cultures of normal human lung and non-sauamous-tvpe tumours
1-NaDhthol 
Patient (uM) Previous i of total radioactivity nmoles/QO minutes/
time of recovered in medium as mg Drotein
culture conjugates in the
Lung 
1-NS 1-NG
Tumour 
.1-NS. .1.-N.C
Lung 
_1=N.§. J-N£
Tumour 
1-NS 1-N(J
B 10
10
Oh
I8h
12.4(2)
9.0(2)
ND (2) 
ND (2)
5.6(2)
2.8(2)
4.1(2)
5.2(2)
30.0
12.3
ND
ND
9.4
1.7
6.8
3.2
D 10
10
Oh
I8h
10.8(2)
15.1(2)
ND (2) 
1.5(2)
0.3(1)
0.8(1)
1.7(1)
2.4(1)
2.5
3.3
ND
0.3
0.1
0.7
0.4
2.0
E 5
10
5
10
Oh
Oh
I8h
I8h
6.1(2)
4.9(2)
7.9(2)
9.4(2)
ND (2) 
0.6(2) 
ND (2) 
2.9(2)
1.8(2)
1.6(2)
1.7(2)
1.3(2)
ND (2) 
0.8(2) 
ND (2) 
2.6(2)
1.3 
1.8
1.4
3.4
ND
0.2
ND
1.1
0.1
0.5
0.2
0.3
ND
0.2
ND
0.5
nmoles/24hours/ 
mg Drotein
G 5
10
100
24h
24h
24h
79.6(2)
84.3(2)
83.4(2)
ND (2) 
ND (2) 
ND (2)
53.1(1)
24.6(2)
8.8(2)
ND (1) 
ND (2) 
ND (2)
10.3
19.6
293.8
ND
ND
ND
4.6
3.6 
13.8
ND
ND
ND
H 5
10
20
50
100
20
24h
24h
24h
24h
24h
14 days
69.9(4)
57.0(4)
47.1(4)
46.7(4)
37.0(4)
42.1(1)
ND (4) 
0.3(4) 
0.5(4) 
0.3(4) 
ND (4) 
ND (1)
18.6(4)
17.9(4)
14.0(4)
7.0(4)
7.1(4)
6.7(2)
4.2(4)
3.0(4)
6.3(4)
2.2(4)
12.4(4)
15.4(2)
14.2
19.5 
40.8 
89.4
149.1
37.6
ND
0.1
0.3
<0.1
ND
ND
2.6
4.2(3)
7.0
7.6
12.9(3)
2.8
0.6
0.4(3)
1.0
2.0
5.0(3)
6.4
J 20
5
10
50
100
20
24h 
3 days 
3 days 
3 days 
3 days 
8 days
49.2(4)
65.5(4)
56.4(4)
60.7(4)
57.9(4)
58.1(4)
ND (4) 
ND (4) 
ND (4) 
0.9(4) 
2.0(4) 
0.5(4)
18.5(4)
61.8(4)
52.2(4)
22.7(4)
23.2(4)
19.4(4)
0.1(4) 
ND (4) 
ND (4) 
1.0(4) 
ND (4) 
ND (4)
68.2
27.6
43.7
223.9
467.1
120.6
ND
ND
ND
3.1
12.8
0.8
37.4 
23.2
47.5 
107.8 
172.7
77.9(2)
0.2
ND
ND
5.4
ND
ND(2)
Q 20
100
20
24h
24h
6 days
72.2(3)
25.5(2)
49.1(5)
0.1(3)
3.0(2)
2.0(5)
36.9(3)
10.4(2)
31.5(5)
28.7(3)
11.0(2)
11.8(5)
51.5
77.3
33.7
0.1
9.4
1.6
28.4 
39.1
25.5
26.5
44.8
10.1
S 10
20
100
24h
24h
24h
70.9(2)
71.2(2)
48.5(2)
ND (2) 
ND (2) 
ND (2)
21.9(2)
5.2(2)
1.2(2)
3.1(2)
3.6(2)
1.0(2)
11.4
35.9
65.6
ND
ND
ND
5.2
1.2 
1.8
0.5
0.8
0.8
Legend to Tables 6 and 7
ND : not detectable; - : not determined; 1-NS : 1-naphthyl
sulphate; 1-NG : 1-naphthyl-y3 -D-glucuronide.
Peripheral lung tissue and tumours from patients with * lung cancer
were cultured within approximately 3 hours of surgical removal.
Short-term organ cultures of these were generally cultured for either
18 or 24 hours, at 37°C, as described in Materials and Methods
(Chapter 2, p 53)• After this time, the culture medium was changed
14for one containing [1- C]-1-naphthol and incubated for a further 
90 minutes or 24 hours. However, with the first few experiments some 
tissues were incubated with 1-naphthol fresh without prior culture 
for 90 minutes. Other tissues were cultured for several days before 
incubation with the substrate. The amount of radioactivity in the 
medium at the end of the culture was 7055—9055 of the total. Aliquots 
of the media were analysed for 1-naphthol conjugates by TLC, as 
explained in Materials and Methods (Chapter 2, p 53). The results 
are generally expressed as the mean values from a number of 
incubations, this being added in parenthesis. Where the number of 
incubations is different between the column of percentage of 
conjugates and the column with nmoles product formed/24 hours/mg 
protein, this is due to the fact that quantitation of protein in each 
incubation was not possible as some explants were examined 
histopathologically. The patients, from whom tissue was utilized, 
had not received any cancer chemotherapy prior to surgery.
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Figure 28 = Conjugation Of 1-Naphthoi By Short-Term 
Organ Culture OF Squamous Carcinomas
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total metabolism shown by the squamous cell tumours can be seen to be 
lower than that in the normal tissue from the same patients.
Other types of lung tumours showed a greater variability in the 
routes of conjugation (table 7). Generally, these other types of 
tumours produced a predominance of sulphation, with some 
glucuronidation. These results are illustrated in Fig. 29. However, 
the amounts of 1-naphthyl sulphate produced by the tumours were less 
than the amounts produced by the corresponding normal tissues, in 
agreement with the results from the squamous cell carcinomas (tables 
6 and 7).
Figure 29 = Conjugation Of 1 - Naphjthol By 
Short-Term Organ Culture Of Non- 
Squamous Carcinomas
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(ii) Human Bronchus
As many lung cancers arise from the bronchial epithelium, samples of 
human bronchus were also obtained and cultured. An illustrated 
example of the histological appearance of fresh bronchus is shown in 
Fig. 30. Sometimes, whole bronchus was cultured, but, in addition, 
some samples were split into two: the surface layer containing
bronchial epithelium and the cartilage. The results obtained from
ill
the incubation of these samples of bronchus with [1- C]-1-naphthol 
are summarised in table 8.
In these cases, it is difficult to make an appropriate generalization 
about the conjugation routes seen with the whole bronchus. With some 
of the incubations, the whole bronchus tissue showed both pathways, 
but sulphation predominated (patients F, P and U). However, others 
showing formation of both conjugates, produced a prevalence of 
glucuronidation (patients 0, N and R). Some bronchus specimens 
(patients M and S) gave more 1-naphthyl sulphate than l-naphthyl-y<3 - 
D-glucuronide at lower concentrations, but the latter predominated at 
higher concentrations. Specimen K showed equal quantities of each 
conjugate. Even though these statements are true when considering 
the data quantitatively, it should be noted that some of the absolute 
observed differences between the two pathways are small, possibly 
being within the limits of experimental error.
However, taking all the data with the bronchus at a 1-naphthol 
concentration of ^ 20 jyM and subjecting the figures to a simple 
statistical analysis, sulphate ester conjugation was established
Figure 30 : Human Bronchus : Fresh x 55
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Legend to Figure 30
This photograph illustrates a longitudinal section of human bronchus 
prior to culture. The many, different layers can be seen. The line 
along which the cartilage and the upper layer containing the 
epithelium were split is indicated.
On the culture samples of bronchus, there was deterioration similar 
to that described for other explants, there being a tendency for 
central necrosis in an explant. However, the cartilage was always 
very well maintained.
- 102 -
14TABLE 8: Conjugation of f1- Cl-1-naphthol bv short-term organ
cultures of normal human bronchus: whole and divided
1-NaDhthol
Patient Tissue (uM) Previous i of total radioactivitv Rate of conjugation:
time of recovered in medium nmoles/24 hours/
culture as conjugates mg Drotein
1-NS 1-NG 1-NS 1-NG
F Whole 10 I8h 53.2(2) 13.2(2) 6.3 1.6
100 I8h 32.8(2) 9.5(2) 25.0 7.5
K Whole 10 24h 28.0(2) 24.6(2) 6.0 5.1
10 8 days 32.1(2) 35.7(2) 10.9 10.0
H Whole 5 24h 14.4(3) 2.1(3) 2.8 0.4
10 24h 3.6(3) 1.9(3) 1.5 0.8
20 24h 5.3(3) 1.9(3) 4.5 1.6
50 24h 1.2(3) 2.6(3) 2.7 5.7
100 24h 0,7(3) 2.0(3) 3.5 9.7
N Whole 20 24h 10.8(3) 14.7(3) 4.7(3) 6.5(3)
0 Whole 20 24h 16.7(3) 21.6(3) 1.9 2.6
P Whole 5 24h 21.0(2) 13.5(2) 1.9 1.3
10 24h 15.0(2) 7.0(2) 2.8 1.3
20 24h 20.0(2) 16.1(2) 42.9 34.1
Cartilage 5 24h 8.7(2) 2.0(2) 1.5 0.4
10 24h 7.5(2) 1.0(2) 1.9 0.2
20 24h 1.9(2) 1.2(2) 0.7 0.5
Epithelial 5 24h 13.0(2) 14.9(2) 6.1 6.3
Layer 10 24h 18.7(2) 23.5(2) 11.5 15.2
20 24h 10.6(2) 25.7(2) 15.0 36.2
R Whole 20 24h 21.3(3) 21.8(3) 11.4 48.1
100 24h 8.8(2) 26.0(2) 8.0 35.6
Cartilage 20 24h 5.6(3) 0.6(3) 1.5 0.2
100 24h 2.0(2) 0.5(2) 4.2 1.2
Epithelial 20 24h 8.0(3) 38.0(3) 9.1 37.7
Layer 100 24h 3.8(2) 17.2(2) 14.8 68.4
S Whole 10 24h 17.7(2) 5.1(2) 1.2 0.4
20 24h 28.7(2) 36.1(2) 4.7 5.9
100 24h 7.3(2) 9.7(2) 4.9 6.3
U Whole 20 24h 8.7(2) 1.1(2) 2.3 0.2
Cartilage 20 24h 0,4(2) ND (2) 0.3 ND
Epithelial 20 24h 3.9(2) 9.0(2) 6.4 16.0
Layer
Legend to Table 8
ND: not detectable; 1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyly3-D-glucuronide.
The experiments giving the above results were carried out exactly as described 
for tables 6 and 7. "Whole" refers to whole bronchus, while "cartilage” and 
"epithelial layer" refer to the two layers obtained when the latter was stripped 
from the underlying cartilage.
as significantly higher than glucuronic acid conjugation (at the 
level p = 0.05), using the Wilcoxon matched pairs signed ranks test.
The three samples, (P, R and U) which were cultured whole and split, 
all showed a similar pattern of metabolism in the cartilage and the 
upper layer containing bronchial epithelium. The cartilage gave a 
very low rate of metabolism in all cases, showing sulphation with 
little, if any, glucuronidation. The tissue containing the bronchial 
epithelium produced both conjugates, but always had a prevalence of 
formation of 1-naphthyl-y3 -D-glucuronide.
To extend the data obtained with the bronchial samples, tissue from
bronchoscopy was examined together with a primary cell culture of
human bronchial epithelial cells produced from outgrowths of explants
14
(132). Table 9 lists the results of the incubation of [1- C]-1-
naphthol with tissue samples from bronchoscopy. An illustrative 
example of the histological appearance of a bronchial epithelium 
specimen from bronchoscopy is shown in Fig. 31. These samples were 
either taken from the bronchus wall and, thus, contained some 
epithelial cells or removed from the surface of a tumour. Although 
variation between samples was very great, the overall pattern of 
metabolism appears to be that glucuronidation predominated, but both 
pathways of conjugation were present. Statistically, the glucuronic 
acid conjugation is significantly higher than the sulphate ester 
pathway, at the level of p = 0.005, using the Wilcoxon matched pairs 
signed ranks test.
There appears to be no difference in the metabolic profile from
14TABLE Q: Conjugation of l~1- Cl-1-naphthol bv short-term organ
cultures of bronchial epithelium and lung tumours from bronchoscopy
Patient Type of _1-NaDhthol £ of total radioactivity Rate of conjugation:
Tissue ( jjM) recovered in medium nmoles/24 hours/
as conjugates 
1-NS 1-NG
mg Drotein 
1-NS 1-NG
B1 Normal 20 8.8 24.4 1.8* 4.9*
B2 Bronchitic 5
10
20
20A
13.7(2)
11.0(2)
6.6
2.9
24.8(2)
31.5(2)
27.2
22.7
11.9
0.5*
44.0
0.1*
22.1
1.4*
181.3
0.8*
B3 Normal 10 10.7 28.2 1.1* 2.8*
B4 Bronchitic 20 0.6 ND 0.2* ND *
B5 Normal 20 ND 0.7 ND * 0.7*
B6 Normal 20 1.3 8.5 5.2* 34.0*
B7 Bronchitic 5
10
20
20
4.3(2)
3.6(2)
3.3(3)
0.9
10.0(2)
16.2(2)
14.4(3)
7.2
7.2
7.2 
16.3
1.8*
16.6
34.2
72.2 
14.4*
B8 Bronchitic 5
10
20
20A
1.1(2)
2.4(2)
0.4(2)
1.1(2)
6.9(2)
30.2(2)
4.2(2)
3.2(2)
0.4
2.6
1.2
3.7
2.5
31.9
13.9 
10.5
B9 Bronchitic 20 0.4 0.8 2.0 4.0
B10 Bronchitic 20
20
2.9(3)
4.4
8.7(3)
10.5
14.8
1.5*
38.1
3.5*
B11 Normal 20 13.0 16.7 1.5 2.0
B12 Bronchitic 20 2.4(2) 12.1(2) 12.0 60.3
B13 Normal 20 3.2(3) 23.0(3) 28.7 196.9
B14 Normal 20 1.4(2) 5.1(2) 8.8 26.5
T1 Tumour 20 1.5 7.9 6.0 31.6
T2 Tumour 5
10
20
0.6(2) 
1.4(2) 
ND (2)
ND (2) 
1.9(2) 
5.2(2)
0.2
1.5
ND
ND
2.0
20.6
T3 Tumour 20 ND (3) 0.6(3) ND 3.0
T4 Tumour 20 0.2(2) ND (2) 1.0 ND
Legend to Table Q
ND: not detectable; *: nmoles product/24 hours/mg tissue (wet
weight); 1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3-D-glucuronide; 
A : cultured for five days, not 24 hours before metabolism studies.
Tissue from bronchoscopy was cultured within approximately 3 hours of 
removal. Each sample was very small and few explants, if any, could 
be made. Thus, the tissue was cut in half and placed straight on the 
gelfoam and cultured for 24 hours, at 37°C as explained in 
Materials and Methods (Chapter 2, p 53).
After this time period the culture medium was changed for one 
14containing [1- C]-1-naphthol and incubated for a further 24 hours. 
The amount of radioactivity in the medium at the end of the culture 
was rf0%-90% of the total. Aliquots of the media were analysed for 1- 
naphthol conjugates by TLC, as described in Materials and Methods 
(Chapter 2, p 53). Where more than two explants from a sample were 
cultured, the result is given as a mean value, with the number of 
incubations added in parenthesis. Some tissue was used for 
histopathological examination and so was unavailable for protein 
determination. These results were then expressed per mg tissue (wet 
weight).
Figure 31 : Human Bronchoscopy Sample :48hxi6o
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Legend to. figure 31
This photograph is of a histopathological longitudinal section of 
bronchial epithelium with the underlying tissue. This tissue was 
obtained by bronchoscopy and had been cultured for 48 hours prior to 
fixation for histopathological examination. The sample was from 
patient B2 and had been cultured for 24 hours prior to 1-naphthol 
metabolism for a further 24 hours. The tissue has been maintained 
well with little, if any, evidence of degeneration or necrosis.
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1-naphthol when the bronchial mucosa was normal or bronchitic. The 
samples of tumour from bronchoscopy showed little, if any, metabolism 
in some cases (specimens T3 and T4). However, the others, T1 and T2, 
produced a predominance of glucuronidation. This followed the 
pattern seen with the short-term explant cultures of human squamous 
tumours from surgery (Table 6, p 92).
Primary cell cultures, derived from human bronchial epithelium (132), 
were incubated with 1-naphthol. The results are shown in table 10. 
All three cell cultures produced almost exclusively the glucuronide 
conjugate, although in two of these cultures (351 and 244), sulphate 
was detectable and, in 347, a higher amount of sulphoconjugation was 
observed. With the primary cell cultures 244 and 347, toxicity of 1- 
naphthol was observed at 100 jxM as many cells (up to 2550 rounded 
up and floated in the medium instead of adhering to the base of the 
dish. This toxicity was also reflected in the decrease in the 
metabolism of 1-naphthol, at increasing concentrations of substrate. 
Noticeably, the cell culture 351 was the only one which gave an 
increasing glucuronic acid production with increased 1-naphthol 
concentration. The other cell cultures, 244 and 347, showed no 
concentration dependent increase in 1-naphthyl-/3 -D-glucuronide 
formation and thus the UDP-glucuronosyl-transferase was working under 
saturated conditions.
Ill
TABLE 10: Con jugation of l~1- Cl-1-naphthol bv Human Bronchial
Epithelial Cells
Primary Ho of cell 1-Naphthol £ of total radioactivity Rate of conjugation:
Cell (x 10“3) L^M) recovered in medium pmoles/24 hour
Culture as conjugates 
1-NS 1-NG
mg protein 
1-NS 1-NG
351 600 20 0.7 89.7 0.7 89.7
425 20 0.3 91.1 0.4 128.6
600 50 0.2 63.6 0.6 159.1
244 250 5 0.7 15.1 0.5 9.0
250 10 0.4 7.2 0.5 8.6
250 20 ND 3.1 ND 7.5
425 20 0.2 2.7 0.2 3.8
250 50 ND 1.3 ND 8.0
250 100 ND 0.2 ND 0.2
347 250 5 7.7 77.9 4.6 46.7
250 10 2.8 42.6 3.4 51.2
250 20 1.7 23.8 4.1 57.0
425 20 3.1 35.7 4.3 50.4
250 50 0.3 11.1 1.7 66.8
250 100 0.1 4.0 0.1 47.5
Legend to Table 10
ND: not detectable; 1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3-D-glucuronide.
The cells were grown in monolayer culture in 6cm diameter dishes and incubated
with [1-^C]-1-naphthol for 24 hours (244 and 347) or alternatively for 26 hours 
(351) in the USA (see Acknowledgements). The medium was decanted and stored 
frozen at -20 C and sent to this laboratory. An aliquot of each medium was 
analysed by TLC as described in Materials and Methods (Chapter 2, p 53).
(iii) Heterogeneity of Human Tumour Samples in Explant Culture
As noted in Table 4, a disadvantage of the short-term explant culture 
methods is that heterogeneous tissue can give variable metabolism in 
different incubations. Table 11 illustrates the variability in 
conjugation of 1-naphthol seen at each concentration of substrate, 
which was due to the heterogeneity of tumour tissue. The range of 
percentage conversion to a metabolite by different incubations with 
normal lung was narrower than that with the tumour and partially 
explained by variable amount of protein per dish. This variation was 
clearly inevitable, although an effort was made to try to keep the 
explants the same size in each dish. However, the tumour shows 
variability even to the extent of the predominating pathway changing, 
for example, in the four incubations at 54M 1-naphthol concentration. 
In such circumstances as these, the use of multiple incubations of 
the tissue, and varying substrate concentrations, does make general 
conclusions possible. The variability displayed by the different 
incubations of a tissue was not due to variation in the method of TLC 
to separate and quantitate the metabolites. For example, a culture 
media which contained both conjugates, 1-naphthyl sulphate and 1- 
naphthyl-/^-D-glucuronide, was analysed eight times by TLC, as 
described in Materials and Methods (Chapter 2, p 53). The mean 
values - the standard deviations of these determinations of the 
percentages of the conjugates were as follows: 41.1% - 2.1$ for
the glucuronide and 31.9$ - 1.3$ for the sulphate conjugate.
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14TABLE 11: Conjugation of [1- Cl-1-naphthol bv normal lung and
tumour tissue from patient K to illustrate the variable metabolism
seen in explant culture
1-NaDhthol la of total radioactivity Rates of conjugation
( uM) recovered in medium as nmoles/24 hours/mg Drotein/ conjugates in the
Lung Tumour Lung Tumour
1-NS 1-NG 1-NS 1-NG 1-NS 1-NG 1-NS 1-NG
5 66.2 ND 5.4 25.7 27.6 ND 2.3 10.7
55.6 ND 17.5 17.5 27.8 ND 4.3 4.3
64.1 ND 5.7 34.9 28.6 ND 1.0 5.8
57.9 ND 12.2 10.4 21.3 ND 4.1 3.5
10 57.1 2.7 3.3 30.3 40.8 1.9 1.1 10.4
53.9 1.3 0.9 6.7 43.5 1.1 0.5 3.8
49.3 2.7 4.3 37.1 44.0 2.4 2.6 22.6
55.9 ND 3.9 14.3 69.9 ND 2.2 8.1
20 46.9 0.4 0.7 29.9 106.6 0.9 0.6 24.9
52.3 1.3 3.2 26.2 90,2 2.2 2.6 21.1
59.1 1.7 5.2 27.7 82.1 2.4 8.1 43.3
47.3 2.4 4.0 9.4 87.6 4.4 3.7 8.7
50 32.9 0.3 1.4 51.0 195.8 1.8 5.0 182.1
50.6 ND 5.9 36.4 218.1 ND 67.1 413.6
50.7 3.7 3.2 21.2 171.3 12.5 6.2 40.8
36.3 ND 1.2 28.0 189.1 ND 2.3 53.9
100 37.0 ND 0.1 30.9 385.4 ND 0.5 160.9
44.9 5.8 3.2 20,8 295.4 38.2 8.0 52.0
38.4 0.4 0.8 17.5 384.0 4.0 5.7 125.0
50.0 ND 1.1 28.3 378.8 ND 7.1 181.4
Legend to Table 11
ND: Not detectable; 1-NS: 1-naphthyl sulphate;
1-NG: 1-naphthyl-/3 -D-glucuronide.
This experiment was carried out as described in the legends to tables 6 and 7.
(iv) Tissue Metabolites
Some tissue, which had been used in incubations, was homogenized and 
analysed for 1-naphthol conjugates. This procedure was carried out 
to see if tissue metabolites reflected those seen in the medium 
(Table 12). From this approach only, two tissue samples (L2 and L3) 
showed a different pattern of metabolites when compared with the 
corresponding medium. These were from bronchus which were very 
difficult to homogenize and may not have broken up fully, thus 
explaining the difference in metabolite profile. The percentage of 
radioactivity trapped in the tissue was small (not more than 2%). 
Accordingly, this was not the reason why only an average of 70% of 
radioactivity was recovered from the incubations. The percentages of 
tissue metabolites given in table 12 were higher than the percentages 
seen in the medium. For example, L12 had 17*4$ 1-naphthyl-^ -D- 
glucuronide in the tissue, but this metabolite was not detectable in 
the medium. There were no control values to subtract from the 
percentages found for the tissue metabolites.
TABLE 12: Summary of Metabolites of 1-Naohthol found in LungT Bronchus
and Tumour tissues
Sample of total radioactivity 
recovered in tissue as
*t> of total radioactivitv 
recovered in medium as
conjugates conjugates
1-NS 1-NG 1-NS 1-NG
L1 58.4 9.1 49.8 2.5
L2 6.1 64.8 2.3 28.0
L3 27.7 28.2 20.2 16.0
L4 26.8 28.0 26.4 16.5
L5 59.0 3.8 59.7 ND
L6 22.9 12.3 29.9 14.2
L7 45.8 2.8 51.5 0.2
L8 5.0 19.6 1.3 32.2
L9 17.1 26.1 15.9 25.3
L10 12.3 25.5 9.1 30.0
L11 15.8 2.6 22.7 ND
L12 65.4 17.4 75.9 ND
L13 7.3 60.1 3.9 62.4
L14 62.8 2.0 83.0 ND
Legend to table 12
ND: not detectable; 1-NS: 1-naphthyl sulphate;
1-NG: l-naphthyl-/3 -D-glucuronide.
Tissue used in short-term cultures was homogenized in Tri-HClpH7.4 and 
this was centrifuged at 2000 rpm in a bench centrifuge. The supernatant 
was analysed for 1-naphthol metabolites by TLC, as previously described 
in Materials and Methods (chapter 2, p 53).
(2) Colon
(a) Morphology
For the maintenance of both normal-appearing and tumour tissue from 
the human colon, for up to 48 hours, the culture conditions were 
satisfactory. Fig. 32 illustrates normal colon mucosa fixed for 
histopathologieal examination as soon as the sample arrived from 
surgery; i.e. it was fresh. Fig. 33 depicts the appearance of a 
tumour * fresh1 from surgery. Examples of tissue which had been 
maintained in culture for 48 hours are photographically illustrated 
in Figs. 34 (normal colon) and 35 (tumour). Sometimes, tissue was 
cultured in a viable condition for several days. The histopathology 
of tissues after 8 days in culture was generally poor: necrosis and 
degeneration being present. However, in some cases, a part of the 
tissue explants must have been kept in a viable condition as tissue 
cultured for 7.5 days was able to metabolise 1-naphthol (see Table 
13).
(b) Metabolism of n-^Cl-1-Naphthnl
(i) Human Colon and Tumour
Short-term organ cultures of both human normal colon and tumour 
tissue metabolised 1-naphthol to both its sulphate ester and 
glucuronic acid conjugates (Table 13). At a naphthol concentration 
of 20 jjM, the normal colon formed more 1-naphthyl sulphate than 1- 
naphthyl-^3-D-glucuronide (Fig. 36). The difference in biochemical 
pathways was statistically significant at the p = 0.005 level, using
the Wilcoxon matched pairs signed ranks test.
Figure 32 : Normal Human Colonic Mucosa : Fresh : * 160
Crypts of Lieberkuhn epithelium
glands
Legend to Figure 32
This photograph illustrates the histopathological appearance of a 
longitudinal section of normal human colonic mucosa prior to culture; 
i.e. when it was fresh. The mucosa of the large intestine lacks 
villi, in contrast to the small intestine. It has deep straight 
glands (about 0,5mm (133)). Often, not seen in this photograph 
though, lymphatic nodules are observed towards the base of the 
mucosa. The surface epithelium consists of a mixture of columnar 
absorptive cells, with striated borders and mucous goblet cells. The 
Crypts of Lieberkuhn consist principally of tall mucous cells. 
Epithelial proliferation occurs in the lower part of these crypts to 
provide cells needed for the constant replacement. This turnover 
time for cells has been estimated as 5 to 6 days for human large 
intestine (133).
Figure 33 : Human Colonic Adenocarcinoma:
Fresh x 160
Legend to. Figure 33
This photograph illustrates the histopathological appearance of a 
poorly differentiated colonic adenocarcinoma from a human patient, 
prior to culture. The tumours often contained some normal looking 
cells. This was certainly true of well differentiated colonic 
tumours.
This particular tumour showed no glandular organization of any kind 
like that seen in normal tissue.
Figure 34 : Normal Human Colonic Mucosa :
48h x 160
glands
lymphatic tissue
Legend to Figure 34
This photograph illustrates the histopathological appearance of a 
transverse section of the normal human colonic mucosa (seen in Fig.
32) after 48 hours in culture. The tissue has been quite well
maintained. There was a loss of staining between the glandular 
structure and some epithelial cells from the glands had stripped off,
having become necrotic. A lymphatic nodule can be seen in the
photograph.
Figure 35 : Human Colonic Adenocarcinoma
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Legend to Figure 35
This photograph illustrates the histopathological appearance of the 
poorly differentiated adenocarcinoma (seen in Fig. 33)> after being 
cultured for 48 hours. This explant shows a loss of staining, 
probably indicating some type of degeneration. Again, no organization 
of cells into glandular structures was seen.
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TABLE 13: Conjugation of f1- Cl-1-naphthol by short-term organ
cultures of normal oolonio muoosa and adenooaroinoma
Pat. 1-NaDhthol Previous t of Total Radioactivity Glucuronic Rate of conjugation
Lph) culture in the medium as Acid nmoles/24h/ms
time conjugates in Conjugate as nrotein
•a -f* Tnf nl
Normal Rumour
a. % OX lOUal
Metabolites Normal Tumour
1-NS 1-NG 1-NS 1-NG NormalTumour 1-NS 1-NG 1-NS 1-NG
C1 20 24h 53.6(3) 3.3(3) 23.0(2) 21.7(2) 5.8 48.5 18.6 1.2 8.3 8.8
C2 20
100
24h
24h
39.8(3)
24.6(1)
6.0(3)
10.5(1)
7.1(4)
3.4(2)
11.2(4)
11.0(2)
13.1
29.9
61.2
76.4
16.3
67.6
2.4
28.8
2.2
3.3
3.5
11.0
C3 20 24h 37.8(3) 6.0(3) 6.6(3) 10.7(3) 13.7 61.8 15.0 2.3 2.0 3.2
ck 20
100
20
100
16h
I6h
7.5days
7.5days
22.1 (4) 
14.8(4) 
11.8(4) 
7.4(4)
6.2(5)
8.1(4)
2.2(4)
3.1(4)
24.2(4)
18.0(4)
6.2(4)
6.7(4)
7.5(4)
9.1(4)
2.0(4)
1.8(4)
27.1
35.4 
15.7
29.5
24.4 
33.6
24.4 
21.2
29.0
144.8
18.4
70.6
11.0
85.9
3.3
60.7
29.7 
122.9
11.8 
61.4
9.1 
63.0
4.1 
16.4
C5 20 24h 20.1(3) 2.6(3) 3.0(3) 19.1(3) 11.5 86.4 32.8 3.9 7.2 59.0
C6 20 24h 9.4(3) 15.3(3) 3.0(3) 6.9(3) 61.9 69.7 12.9 14.9 3.5 8.5
C7 20 24h 26.2(3) 7.3(3) 12.5(3) 32.9(3) 21.8 72.5 10.9 3.1 5.8 14.7
C8 20
20
24h
5 days
48.5(2)
24.3(3)
5.6(2)
6.0(3)
1.7(2)
<0.1(3)
15.1(3)
1.6(3)
10.7
19.8
89.9
94.0
31.9
11.3
3.5
3.1
2.2
<0.1
19. i
0.9
C9 5
10
20
100
24h
24h
24h
24h
46.1(3)
50.0(3)
31.9(3)
23.0(3)
13.3(3)
15.1(3)
22.5(3)
31.8(3)
20.1(3)
12.6(3)
17.9(3)
13.9(3)
25.2(3)
31.3(3)
18.4(3)
19.1(3)
22.4 
23.2
41.4 
58.0
55.6 
71.3
50.7
57.8
2.8
5.4
13.3
66.2
0.9
1.6
10.7
80.6
1.7
2.0
12.1
47.2
2.2
4.9
17.4
76.7
C10 20 24h 39.4(2) 4.7(2) 12.0(2) 28.2(2) 10.7 70.1 7.0 0.9 4.1 9.6
C11 20
100
24h
24h
37.3(2)
46.2(2)
2.2(2)
4.1(2)
14.1(2)
8.8(2)
14.5(2)
12.4(2)
5.6
8.2
50.7
58.5
13.5
38.3
0.8
3.4
3.5
11.3
3.7
16.7
C12 20
100
20h
24h
25.0(2)
26.8(2)
5.3(2)
6.2(2)
8.6(2)
8.0(2)
3.4(2)
6.4(2)
17.5
18.8
28.3
44.4
14.8
24.5
2.9
5.8
2.1
10.2
0.8
9.2
C13 20 24h 19.0(2) 9.5(2) 9.3(2) 4.6(2) 33.3 33.1 6.3 3.2 2.7 1.3
C14 20
100
24h
24h
60.5(2)
21.6(2)
6.2(2)
14.2(2)
5.6(2)
7.2(2)
10.6(2)
9.3(2)
9.3
39.7
65.4
56.4
26.8
46.1
2.8
30.5
3.0
22.9
5.8
29.3
C15 20 24h 35.8(1) 5.7(1) 38.0(1) 26.0(1 13.7 40.6 12.1 1.9 9.3 6.3
C16 20 24h 6.7(3) 2.7(3) 0.7(3) 1.3(3 28.7 65.0 3.8 1.5 0.7 1.1
<717 20 24h 26.4(2) 7.8(2) 11.9(2) 36.5(2 22.8 75.4 14.0 4.1 11.6 35.6
C18 20 24 h 33.5(2) 11.1(2) 17.2(2) 16.3(2 24.9 48.7 18.1 6.0 7.6 9.2
C19 20
100
24h
24h
47.9(2)
32.2(2)
11.6(2)
26.5(2)
4.6(2)
4.1(2)
40.0(2
31.8(2
19.5
45.1
89.7
88.6
14.7
48.9
3.6
40.4
2.6
10.5
21.6
81.8
C20 20
100
24h
24h
36.6(2)
22.4(2)
14.1(2)
33.2(2)
4.9(2)
3.7(2)
39.4(2
17.5(2)
27.9
59.7
87.9
80.8
10.2
22.6
3.9
34.1
2.6
7.1
23.3
30.5
Legend to Table 13
Pat.: Patient; 1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3 -D-
glucuronide
Short-term organ cultures of normal-appearing human colonic tissue 
and tumour tissue were set up within approximately 3 hours of the 
tissue being removed by surgery. The normal colonic mucosa was 
stripped off the underlying muscle, and the tumour was dissected free 
from fatty and necrotic tissue. The normal and tumour tissue was cut 
into thin slices with a surgical blade. Two small explants of each 
tissue (approximately 2 x 2 x 1 mm) were placed on gelatin sponge. 
One or two sponges were placed in a single dish.
Generally, the tissue was cultured for 24 hours, at 37°C, in
1-2.5ml of a supplemented CMRL-1066 medium^as explained in Materials
and Methods (Chapter 2, p 53). After this initial period, the
14culture medium was changed for one containing [1- NC]-1-naphthol 
(20-100yU.M) and incubated for a further 24 hours. At the end of this 
time period, the medium was removed and stored, at -20°C, for 
further analysis. The conjugates in the media were analysed by TLC, 
essentially as described in Materials and Methods (Chapter 2, p 53). 
The amount of radioactivity in the medium at the end of the culture 
was, on average, approximately 70%, The results in table 13 are 
expressed as mean values of 2-4 determinations (dishes), the number 
of these being added in parenthesis. The patients, from whom tissue 
was utilized, had not received any prior cancer chemotherapy.
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With an increased concentration of 1-naphthol (100 MM), the normal
colon still gave significantly (at the level p = 0.05) more sulphate 
ester conjugate than glucuronic acid conjugate. However, at this 
substrate concentration, the percentage metabolism to glucuronide 
increased when compared with that seen at 20jjlM. In one sample, C9 
(see Table 13), an increase in the glucuronic acid conjugation was 
observed from 5-100yaM 1-naphthol. Nevertheless, in most cases, when 
the substrate concentration was increased to 100 yuM from 20 ^ MM^the 
percentage of substrate conjugated with PAPS decreased, although the 
actual amount of product increased. Noticeably, samples C11 and C12 
showed an increase in the percentage formation of both conjugates.
When tumour tissue from the same patients was cultured with 1-
ester conjugates was observed (Table 13) with the exception of the 
tumours from samples C4 and C15. Often the tumours showed a higher 
percentage conjugation with UDPGA than with PAPS in the tumours (with 
the exception of samples C1, CUl, C13 and C15). However, in all but 
two cases (C4 and C13)> the percentage of glucuronic acid conjugates, 
expressed as a proportion of the total metabolites formed, was 
increased significantly when compared with normal tissue (Table 13 
and Fig. 37).
naphthol a marked decrease in the percentage of sulphate
Fig
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(ii) Tissue Metabolites
\
A summary of the proportion of tissue metabolites found in colon 
samples is shown in Table 14. The metabolic profile in the tissue 
was again that seen in the medium, with the exception of samples X2, 
X3, XI19 X13 and X14, the percentage of radioactivity trapped in the 
tissue being very small.
- 129 -
TABLE 14: Summary of Metabolites of 1-Naphthol found in Colon and Tumour
tissues
SamDle % of total radioactivity 
recovered in tissue as
£ of total radioactivity 
recovered in medium as
conjugates 
1-NS 1-NG
conjugates 
1-NS 1-NG
X1 4.4 45.5 1.3 17.6
X2 10.0 11.2 16.2 1.6
X3 2.8 57.5 33.3 23.8
X4 0.1 35.7 11.6 20.3
X5 1.7 63.6 20.5 23.9
X6 1.0 49.1 15.6 37.4
X7 4.5 71.7 14.8 18.0
X8 2.5 52.8 12.2 24.2
X9 18.1 14.5 50.3 5.0
X10 13.2 34.8 1.9 18.2
X11 61.3 15.4 11.1 12.7
X12 23.7 20.2 39.2 2.2
X13 5.2 20.7 26.2 4.8
X14 9.5 32.6 7.2 3.2
Legend to Table 14
1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3-D-glucuronide.
The tissue used in short-term cultures was homogenised in Tris-HCl pH 7.4 
and this was centrifuged at 2000 rpm in a bench centrifuge. The 
supernatant was analysed for 1-naphthol metabolites by TLC, as previously 
explained in Materials and Methods (Chapter 2, p 53).
C: DISCUSSION
( 1 )  Lung,
By using the short-term explant system to examine 1-naphthol 
conjugation in vitroT some interesting results have emerged. Normal 
peripheral lung produced 1-naphthyl sulphate almost exclusively. 
This confirmed findings by other researchers (134, 162). On the 
other hand, rodent lung has been found to produce only 1-naphthyl-/3 - 
D-glucuronide (reference 134 and results in Chapter 7> P 220). Thus, 
in this context, there is a clear biochemical difference between 
rodent and human lung which may have important implications for 
comparing metabolism of xenpbiotics in these different species (134).
Even more interesting, is the evidence which has arisen to show that 
human lung tumours possess Phase 2 drug-metabolising pathways. This 
evidence is important because it makes it possible to know the range 
of drug-metabolising enzymes which human tumours possess, thus 
enabling an improved design of anti-cancer drugs. To date, such 
drugs could have been created on the false basis that neoplastic 
cells do not have the ability to metabolise foreign compounds (107). 
It is known that human tumours from lung are capable of Phase 1 drug 
metabolism (103).
In experiments carried out for this present investigation, the human 
lung tumours showed a variable pattern of metabolism of 1-naphthol, 
which seemed to depend on the histopathological classification of the 
tumour. Generally, squamous cell carcinomas produced 1-naphthy1-^3 - 
D-glucuronide, virtually exclusively, while a more variable pattern
c
was found with other tumour types. However, with all these latter
specimens, a decrease in sulphation and an appearance of 
glucuronidation was observed in contrast to almost exclusive 1- 
naphthyl sulphate formation in the normal lung.
Included in these non-squamous type tumours were two that showed 
histopathological characteristics of oat cell carcinomas (samples G 
and H: Table 4). It has been suggested that oat cell carcinomas 
originate from Kultschitzky or APUD (amine precursor and uptake 
decarboxylase) cells (135) and that these cells are involved in the 
metabolism of catecholamines (136). The formation of adrenaline 
involves the donation of a methyl group from S-adenosyl methionine. 
This latter compound is made from ATP and methionine and thus reliant 
on the availability of PAPS to make methionine. Thus, it is perhaps 
not surprising that such cells can metabolise other compounds using 
PAPS as a sulphate donor.
Since most lung cancers arise from the bronchial epithelium, it was 
decided to examine the metabolism of 1-naphthol by bronchus. 
However, the results displayed in Table 8 do show a great variation 
between samples. Some specimens gave more sulphation than 
glucuronidati^on and others produced more glucuronic acid than 
sulphate ester conjugates. Nevertheless, taking the data as a whole, 
it does appear that sulphation predominates at lower concentrations 
(up to 20 ymM). Autrup et.al. (137) found that sulphate ester 
conjugation was quantitatively more important than glucuronic acid 
conjugation for cultured human bronchus using benzo(a)pyrene as 
substrate. The concentration of this xenobiotic that was used by 
Autrup et.al. (137) was 1.5MM and thus,lower than the concentrations
of 1-naphthol used for these present experiments. Accordingly, the
results from 1-naphthol incubations with human bronchus can be
claimed to be in general agreement with previous findings at low
concentrations. In the experiments reported here, as the substrate
concentration was increased, there was a rise in the glucuronide
formation. The reason for this is probably due to the availability
of sulphate. Sulphation, arising mainly because of a limited
availability of the sulphur-containing amino acids required for the
synthesis of the sulphate donor, PAPS, has been thought a readily
saturable process. Thus, when the level of substrate is increased,
there is a decline in the amount being conjugated with sulphate, and
a complementary increase in that conjugated with glucuronic acid. On
the other hand, glucuronidation is a first-order process since the
cofactor, UDPGA, derived from carbohydrate sources, can be made
readily available (70, 71). However, as previously discussed in
Chapter 1, the preference for sulphation at lower substrate
concentrations may be connected to a lower K value form
sulphotransferase than glucuronosyltransferase for 1-naphthol (72).
The experiments carried out with the upper epithelial layer of the 
bronchus, bronchoscopy samples and bronchial epithelial cell cultures 
all demonstrated that glucuronidation was the predominating pathway. 
However, since the cartilage from whole bronchus produced only small 
amounts of metabolites, the difference between the metabolic profile 
from the upper layer and that from the whole bronchus cannot be 
simply explained by adding together the metabolism of the two 
separate pieces. It would appear that bronchoscopy samples, which
are mostly the epithelium with some underlying tissue, and the
bronchial epithelial cells, prefer glucuronidation, even at low 
concentrations (10-20julM) of 1-naphthol. Thus, it would appear that 
the cartilage of the whole bronchus may be supplying sulphate, in 
some form, to the bronchial epithelial layer to enable sulphation to 
take place. On removal of the underlying cartilage, the availability 
of sulphate decreases and, accordingly, the sulphate ester 
conjugation declines. As yet, there appears to be no evidence that 
PAPS can be transported across membranes (69).
Therefore, although there seemed to be a dramatic biochemical 
difference between the normal peripheral lung and squamous type 
tumours, if the latter were derived from the bronchial epithelium, 
the change in pathway from bronchial tissue to tumour, as from 
peripheral lung to tumour, is not as striking.
However, these tumours do seem to metabolise 1-naphthol differently 
from the whole bronchus, preferring glucuronidation with little, if 
any, sulphation at all concentrations.
(2) Colon
1-Naphthol was metabolised by normal-appearing colon to both sulphate 
ester and glucuronic acid conjugates. At a low concentration (20 yuM), 
sulphation predominated, which supports the results obtained by 
Autrup (138). Autrupfs findings showed that when benzo(a)pyrene was 
incubated at a low concentration (1.5yUM) with normal colon, sulphate 
ester and glutathione conjugates were the major product, with only 
small amounts of glucuronic acid conjugates being formed. However, 
with the present work, with 1-naphthol at a higher concentration 
(100 ^1M), the percentage of sulphate ester conjugate production 
declined whilst the glucuronic acid conjugate increased. This again, 
was probably a reflection of the fact that sulphation is saturable, 
whilst glucuronidation is not (70, 71), or alternatively, that the 
Km for sulphotransferase is lower than that for glucuronosyl- 
transferase with 1-naphthol (72).
When the adenocarcinoma tissues were incubated with 1-naphthol at 
20 ju.M, generally a much higher percentage of the total metabolites 
formed was due to glucuronic acid rather than sulphate ester 
conjugates, although both were formed (Table 13).
At 100 yuM, the same relationship was true in most samples. With the 
colon, the significance of these alterations in conjugation is not 
clear, although it may be related to changes in mucous secretion. In 
normal human colon, a large proportion of the mucins produced in the 
mucous consists of sulphomucins. However, in colonic tumour tissue a 
marked decrease or absence of sulphomucins is accompanied by an
increase in sialomucins (138). The alteration in conjugation 
pathways, and the change in glycoprotein secretion between normal and 
tumour tissue from human colon, may be due to various reasons. These 
include an absence or decrease in one or more sulphotransferases in 
the tumour; but the alteration may be because of a decreased 
availability, less ability, to form PAPS.
It is worthy of note, that in short-term explant culture, the 
conjugation pattern of both lung and colon samples, after 7-8 days in 
culture, was the same as that seen after 24 hours. Thus, the 
metabolism observed after the shorter time period is not an artefact, 
resulting from the tissue settling into culture.
With both squamous lung tumours and colon tumours there was more 1- 
naphthyl-^/3-D-glucuronide formed than 1-naphthyl sulphate, which 
contrasted with normal tissue where sulphation was the major pathway. 
The differences in conjugation observed between normal and tumour in 
these tissues may be due to alterations in aryl— sulphatase and //3- 
glucuronidase activities. Also, there could be alterations in the 
enzyme protein(s) or in the ability to generate the cofactors needed 
for conjugation. All these possibilities will be discussed further 
in the final chapter, in the context of all the findings of the 
present work.
D: CONCLUSION
The metabolism in these human tumours may have important implications 
in the successful chemotherapy of neoplastic disease. With some 
anti-cancer agents which require metabolic activation it is critical 
to know how a tumour will handle the xenobiotics. The balance of 
oxidative and conjugating enzymes in cancer tissue will be an
important factor in determining the amounts of active drug produced 
and, thus, the efficiency of the treatment. Further, the fact that 
the tumours produce a different metabolic profile to normal tissue,
with 1-naphthol as substrate, may be exploitable in cancer
chemotherapy. By utilizing such biochemical differences, and 
carefully controlling dosage, a drug could be designed to be
activated by, and thus selectively toxic to, the tumour.
CHAPTER 4
ROUTES OF CONJUGATION OF 1-NAPHTHOL. OESTRONE AND OESTRADIOL 
BY SUBCELLULAR FRACTIONS FROM HUMAN LUNG AND 
COLON. NORMAL AND TUMOUR TISSUES
INTRODUCTION
RESULTS
(1) Normal Human Lung and Tumour Tissue
(i) Metabolism of 1-Naphthol
(ii) Metabolism of Oestrone and Oestradiol
(2) Normal Human Colonic Mucosa and Tumour Tissue
(i) Metabolism of 1-Naphthol
(ii) Metabolism of Oestrone and Oestradiol
DISCUSSION
(1) Lung
(2) Colon
CONCLUSION
A: jENJ^QPU-C-TJOlj
An important experimental approach, often used in biochemical 
studies, is that of breaking up a tissue and then studying fractions 
of the resulting homogenate. Usually, the starting material for 
subcellular fractionation is either a population of free-living cells 
or a solid tissue. The latter is sometimes thought of as a 
homogeneous population of cells. However, tissues are often
heterogeneous, due both to the presence of blood and to the existence 
of more than one intrinsic cell population. This is to be found, for 
example, in a highly specialized differentiated tissue like lung, 
this organ having about forty cell types (139).
To carry out a subcellular fractionation, the cells in a tissue must 
be ruptured before the organelles can be separated by differential 
centrifugation. The homogenization procedure must provide an 
efficient breakage of cellular plasma membranes, but preserve intact 
intracellular organelles. There are several ways of homogenization, 
including a liquid shearing force produced by passing the cell 
suspension through either a narrow orifice or by rotating a 
cylindrical pestle in a concentric tube containing the tissue. Cells 
are also broken up by equilibrating them with high pressure nitrogen 
and, then, abruptly releasing the pressure. Alternatively, rotating 
metal blades of a blender can be used, vibration in a sonicator and 
freeze-thawing cycles providing further options for cell breakage.
Centrifugation techniques, which exploit differences in size and 
density between particles, are then used to separate organelles and
membrane fragments that are present in the homogenates. Differential 
centrifugation sediments particles at different rates which depend 
largely on the sizes of the particles. Isopycnic density-gradient 
centrifugation separates particles by centrifuging through media of 
graded densities until they float in media of their own densities.
The major use of subcellular fractions is to enable the study of 
biochemical processes to be carried out in a simplified system. 
Thus, the possible role for individual membranes, or organelles, in 
the functioning of either an organism or its tissues can be easily 
examined if a portion of cells involved is isolated from the 
complexity of the animal or organ selected. Such a simplification of 
the systems to be analysed can be most valuable in the 
characterization of a biochemical reaction. However, the use of 
isolated organelles from subcellular fractionation can cause certain 
difficulties. These include the removal of constraints imposed by 
the inter-relationships of a particular reaction sequence with other 
systems within the whole cell. Also, with subcellular fractions, 
many of the spatial and functional controls imposed by membrane 
structure and organization are lost.
Furthermore, subcellular fractions have been shown to produce 
different metabolic profiles of certain xenobiotics when compared 
with systems where cellular integrity was preserved. For example, it 
has been found that the deoxyritfbonucleoside adducts formed from 
benzo(a)pyrene with whole cells systems are different from those 
produced by activating the substrate with microsomal fractions in the 
presence of exogenous DNA (140). Such findings have important
- 140 -
consequences for the interpretation of systems using subcellular 
fractions like microsomes as metabolic activating systems for short­
term mutagenicity and carcinogenicity tests, for example, the Ame*s 
test.
For the purposes of the present work, subcellular fractions from 
human lung, lung tumour, human colonic mucosa and colonic 
adenocarcinomas were prepared. These were used for the assay of 
sulphotransferase, and UDP-glucuronosyltransferase. 1-Naphthol,
oestrone and oestradiol were the substrates used for conjugation.
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B: RESULTS
(1) Normal Human Lung and Tumour Tissue
Tissue, which was not used for short-term organ culture, was 
homogenized and centrifuged at 10000g. The 10000g supernatant 
fractions were used to measure the rates of conjugation of 1- 
naphthol, oestrone and oestradiol, with PAPS and UDPGA. The number 
of substrates and the range of concentrations employed in these 
experiments depended on the availability of tissue. In some cases, 
the tissue was limiting. However, on some occasions there was 
sufficient to make 100000g supernatant and microsomes from normal 
lung. The histological types of the tumours used in these 
experiments are summarised in table 15.
14
(i) Metabolism of f1- Cl-1-Naphthol
The rates of conjugations of 1-naphthol with either PAPS or UDPGA by 
10000g supernatant fractions of normal human lung and tumour tissue 
are reproduced in Table 16. The subcellular fractions were always 
prepared fresh, i.e. on the same day, but were not always assayed 
immediately. Sometimes, the fractions were either kept on ice after 
preparation for a period of time (1-2 hours) and then frozen, or, 
alternatively, frozen immediately after preparation. Before being 
used, these fractions had to be thawed on a subsequent day.
The normal lung preparation from patient A showed the formation of 1- 
naphthyl sulphate predominately with small amounts of the glucuronic 
acid conjugate. The corresponding tumour produced the same pattern
TABLE 15: The Diagnosis and Histological Types of the Lung Tumours
Patient Diagnosis Histological TvDe
A Multicentric 
Lymphocytic lymphoma
Poorly differentiated lymphoblastic 
lymphoma
B Bronchial Carcinoma Poorly differentiated epidermoid 
carcinoma
C Bronchial Carcinoma Squamous cell carcinoma
D Bronchial Carcinoma Undifferentiated large cell 
carcinoma
E Bronchial Carcinoma Undifferentiated large cell, possibly 
squamous carcinoma
F Bronchial Carcinoma Very poorly differentiated squamous 
cell carcinoma
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14TABLE 16: Rates of oon.iugation of f1- Cl- 1-naphthol bv IQQOQg
supernatant fractions of normal human lung and tumour tissue
1-NAPHTHOL 
Patient ( jjM)
Rates of conjugation (pmol per min per mg 
10000g supernatant fractions) 
in
protein in
Lung 
With PAPS With UDPGA
Tumour
With PAPS With UDPGA.
A; Fresh 2 2.9 0.3 1.1 0.1
4 6.0 0.6 1.9 0.2
6 9.0 0.4 2.4 0.4
8 10.9 0.7 3.0 0.5
10 11.7 0.8 3.8 0.4
20 16.3 0.9 4.7 0.4
B: Fresh 6 25.7 1.9 13.9 10.4
10 26.3 1.7 11.6 9.5
20 27.6 1.6 18.1 9.9
Frozen 2 <0.1 0.1 1.3 1.2
4 0.1 0.1 2.0 2.1
6 <0.1 0.2 3.0 3.0
8 0.1 0.2 3.4 3.1
10 0.1 0.2 4.1 4.5
20 <0.1 0.3 6.7 4.2
C: Frozen 2 12.0 0.7 8.6 <0.1
4 25.6 1.4 12.9 ND
6 22.0 1.8 9.6 ND
8 18.7 2.1 20.1 ND
10 26.2 1.9 19.0 ND
20 29.2 2.0 17.9 ND
D: Fresh 6 58.8 2.6 7.5 26.8
20 84.4 3.5 7.6 28.1
Frozen 2 4.7 1.8 1.2 21.1
4 4.9 2.3 0.9 27.5
6 3.0 3.2 0.5 29.3
8 0.4 3.3 0.2 28.8
10 0.9 2.7 0.6 31.2
20 0.3 2.2 ND 33.6
E: Fresh 20 8.6 3.5 ND 29.6
Frozen after
1.5 h on ice 20 2.1 4.8 ND 33.9
Frozen 2 0.9 1.8 0.1 20.2
4 0.4 2.1 0.3 32.0
6 1.0 2.4 0.3 48.9
8 0.7 2.2 0.1 21.3
10 0.4 3.3 0.1 23.8
20 0.1 3.4 ND 24.8
F: Fresh 20 ND 0.4 ND 0.8
Frozen after
2 h on ice 20 6.9 1.3 <0.1 100.3
Frozen 20 9.0 0.5 0.1 67.7
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Legend to Table 16 
ND: not detectable.
Homogenates (50%) of normal lung and tumour tissue were centrifuged 
at 10000g for 30 minutes and the supernatant fractions were either 
frozen overnight, at -20°C, before analysis or used as soon as they 
were prepared. UDP-glucuronosyltransferase and phenol sulpho- 
transferase activities were measured as described in Materials and 
Methods (Chapter 2, p 53). The control incubations contained no 
enzyme fractions. Incubations were carried out for 10-60 minutes to 
ensure linearity of the reaction. The rates of reaction given in the 
table are the means of up to four determinations. Reactions were 
stopped by removal of 100 yjil aliquots of the incubation media into 
tubes with an equal volume of methanol containing authentic 1- 
naphthol and metabolites, which were separated and analysed, as 
explained in Materials and Methods (Chapter 2, p 53).
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of conjugation, but the rates were lower. The fresh fractions used 
from patient B showed a predominance of sulphate ester conjugation, 
with a low appearance of A -naphthyl-/3 -D-glucuronide in the normal 
lung. The tumour from patient B produced both conjugates. However, 
compared with the normal tissue, the sulphate ester conjugate was 
lower and the glucuronic acid conjugate formation was increased. The 
results from the frozen fractions, from patient B, produced 
contrasting results. The rate of conjugation in both pathways, in 
each tissue, was greatly decreased. The effect was more dramatic in 
the normal lung.
The fractions, from patient C, were only assayed from preparations 
which had been frozen. The normal tissue showed a predominance of 1- 
naphthyl sulphate formation with a small amount of 1-naphthy 1-^ /3 -D- 
glucuronide being produced. The tumour had little, if any, 
glucuronic acid conjugate production, although the sulphate pathway 
was present, giving slightly lower rates of conjugation when compared 
with the normal tissue.
The fresh fractions from the normal lung of patient D formed large 
quantities of the sulphate ester conjugate with a low rate of 1- 
naphthyl- -D-glucuronide production. The tumour produced both 
conjugates, but the glucuronic acid conjugation pathway predominated. 
When compared with the normal tissue, the rates of conjugation with 
sulphate were decreased and those with the glucuronic acid increased. 
However, the total metabolism in the tumour was lower than in the 
normal lung. The frozen fractions from this patient produced results 
which were strikingly different from those with the fresh
preparation. The sulphate ester conjugation was decreased rather 
dramatically in both normal lung and tumour tissue.
The fresh lung preparation from patient E showed a predominance of 
sulphate conjugation with a little glucuronic acid conjugation. The 
tumour showed no detectable 1-naphthyl sulphate formation, but a 
greatly increased production of glucuronic acid conjugates when 
compared with the normal tissue. The tissue fractions frozen after 
1,5 hours on ice showed the same pattern of conjugation. However, 
the supernatant fractions frozen immediately on preparation produced 
less enzyme activities. There was a small appearance of 
glucuronidation with the tumour.
The fractions prepared from patient F showed little, if any, 
conjugation when incubated fresh. Those which had been frozen showed 
a predominance of sulphate conjugation in normal lung, but glucuronic 
acid conjugation was the major pathway in the tumour. For both this 
patient, F, and patient E, the rates of conjugation were much greater 
in the tumours than those seen in the corresponding normal lung.
Table 17 shows the rates of conjugation with 1-naphthol by the 
100000g supernatant and microsomal fractions of normal lung. 
However, there was insufficient tumour to make these fractions. The 
rates of 1-naphthyl sulphate production by the 100000g supernatant 
lung fraction reflect those rates seen with the 10000g fraction of 
normal lung. Where low rates of conjugation were observed with the 
10000g supernatant fraction, little, if any, conjugation was detected 
with the corresponding 100000g fraction. Otherwise, the latter
Ill
TABLE 17: Rates of conjugation of f1- Cl-1-naphthol by lOOOOQg
supernatant and microsomal fractions of normal lung
1-
Patient
•NAPHTHOL 
( /AM)
Rate of conjugation in 
100000g Supernatant Microsomes 
With PAPS With UDPGA 
(pmol per min.per mg (pmol per min per mg 
cvtosolic protein) microsomal protein)
A: Fresh 2 3.3 0.9
4 6.5 1.9
6 8.6 2.0
8 9.2 2.9
10 13.4 3.0
20 17.8 4.4
B: Fresh 6 10.0 4.7
10 49.9 5.7
20 72.1 7.0
Frozen 2 <0.1 0.8
4 0.1 1.6
6 ND 2.8
8 ND 2.7
10 ND 2.6
20 ND 3.6
C: Frozen 2 16.8 18.3
4 25.3 32.5
6 26.9 37.6
8 28.3 66.4
10 25.7 42.6
20 37.8 89.0
D: Fresh 6 54.5 66.4
20 90.2 60.6
Frozen 2 1.7 41.5
4 0.6 49.7
6 0.7 53.7
8 1.0 75.8
10 0.2 58.6
20 ND 29.3
E: Fresh 20 7.3 144.3
Frozen after
1.5 h on ice 20 <0.1 185.7
Frozen 2 0.3 54.7
4 0.1 94.7
6 <0.1 108.6
8 <0.1 132.1
10 0.1 129.0
20 ND 124.1
F: Fresh 20 1.0 403.0
Frozen after
1.5 h on ice 20 12.8 21.0
Frozen 20 14.0 19.9
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Legends to Table 17 
ND: not detectable.
Homogenates (50%) of normal human lung and tumour tissue were 
centrifuged at 10000g for 30 minutes and the supernatant fractions 
were then centrifuged at 100000g for 60 minutes. The 100000g 
supernatants and microsomal pellet were either frozen overnight, at 
-20°C, before analysis or used as soon as they were prepared. The 
100000g supernatants were used to measure pheol sulphotransferase, as 
outlined in Materials and Methods (Chapter 2, p 53). The resuspended 
microsomal pellets were used to measure UDP-glucuronosyltransferase, 
as described in Materials and Methods (Chapter 2, p 53). The control 
incubations contained no enzyme fractions. Incubations were carried 
out for 10-60 minutes to ensure linearity of the reaction. The 
results shown in the table are the means of up to four 
determinations. Reactions were terminated by removal of 100 yul 
aliquots of the incubation media into tubes with an equal volume of 
methanol containing authentic 1-naphthol and metabolites, which were 
separated and analysed, as indicated previously in Materials and 
Methods (Chapter 2, p 53).
fraction generally produced a higher rate of sulphate conjugation 
than the corresponding incubation with the 10000g supernatant 
fraction. The microsomal glucuronidation was at a greatly increased 
rate than any glucuronic acid conjugation seen with the 10000g 
supernatant fraction.
To enable a comparison to be made between systems with and without 
cellular integrity, the results of 1-naphthol conjugation with the 
tissue taken for short-term organ culture are given in Table 18. 
However, for patients A, B and C the tissue which was set up in 
culture did not metabolise 1-naphthol (results not shown). This was 
probably because the culture conditions were still being established 
and were not functioning correctly at that time. The results from 
patients D, E and F showed that in short-term organ culture, in the 
normal lung, the sulphate pathway predominated with little, if any, 
glucuronic acid conjugation. In the tumour tissue, there was a rise 
in 1-naphthyl-/3 -D-glucuronide production and, generally, a low 
formation of the sulphate ester conjugate when compared with the 
normal tissue. The pattern of conjugation shown in the explant 
cultures was also seen in the freshly incubated subcellular fractions 
from patients D and E and in the frozen tissue from patient F.
(ii) Metabolism of Oestrone and Oestradiol
From patients D, E and F the 10000g supernatant fractions were also 
used to assay sulphate ester and glucuronic acid conjugation with 
oestrone and oestradiol. The chemical structures of these compounds 
are shown in Fig. 38. The rates of conjugation of oestrone by 10000g
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14TABLE 18: Conjugation of f1- C~l-1-naphthol bv short-term organ
cultures of normal human lung and tumour tissue
1
Patient
-NAPHTHOI 
(yuM)
of total radioactivity 
recovered in medium as
Rates of conjugation 
nmoles/hour/mg Drotein
conjugates in the in
Lung 
1-NS 1-NG
Tumour 
1-NS 1-NG
Lung 
1-NS 1-NG
Tumour 
1-NS 1-NG
D 10 a 12.4(2) ND (2) 5.6(2) 4.1(2) 20.0 ND 6.2 4.6
10 b 9.0(2) ND (2) 2.8(2) 5.2(2) 8.2 ND 1.2 2.1
E 5 a 11.2(2) ND (2) 1.3(2) 5.6(2) 1.0 ND 0.1 0.3
10 a 7.4(2) 1.3(2) 1.5(2) 5.7(2) 1.6 0.3 0.2 0.8
5 b 9.1(2) ND (2) 0.3(2) 11.4(2) 0.8 ND <0.1 0.7
10 b 7.6(2) 1.4(2) 0.5(2) 9.5(2) 1.4 0.3 0.1 1.3
F 5 a 9.6(2) ND (2) 9.3(2) ND (2) 0.8 ND 1.2 ND
10 a 6.0(2) 0.3(2) ND 1.0(2) 0.8 0.1 ND 0.3
5 b 14.1(2) ND (2) 1.6(2) 2.2(2) 1.0 ND 0.2 0.2
10 b 10.1(2) 1.0(2) 0.6(4) 4.5(4) 1.8 0.9 0.1 0.8
10 c 82.2(2) ND (2) 26.2(2) 40.5(2) 0.7 ND 0.2 0.3
100 c 87.2(2) ND (2) 15.3(2) 53.2(2) 7.0 ND 7.9 36.9
Legend to Table 18
1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3-D-glucuronide;
ND: not detectable.
Short term organ cultures of macroscopically normal lung and tumour were cultured in
14one of the following ways: fresh with [1- C]-1-naphthol for 90 minutes (faf 
results); for 18 hours and then incubated with [1- C]-1-naphthol for 90 minutes 
(*b* results); for 18 hours and incubated with [1- C]-1-naphthol for 24 hours (*0* 
results). The results shown are expressed as mean values. The figures in 
parentheses indicate the number of determinations.
Figure 38 >  Structures Of Oestrone And
Oestradiol
Oestrone
176-Oestradiol
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TABLE 1Q: Rates of conjugation of oestrone bv 1000Qg supernatant fractions
of normal human lung and tumour tissue
Patient
Oestrone 
( /AM)
Rates of conjugation (Dmol Der min Der mg Drotein in
10000g suDernatant fraction) 
In
Lung
With PAPS With UDPGA
Tumour 
With PAPS With UDPGA
C 15 ND 0.3 0.6 1.1
30 ND 1.2 - -
60 ND 0.1 3.7 11.6
D 15 1.0 1.1
30 1.7 2.1 - -
60 2.0 6.1 —
E 15 <0.1 0.8 0.7 0.8
30 0.1 1.6 - -
60 0.6 2.0 0.6 4.3
Legend to Table 19
ND: not detectable; not determined.
Homogenates (50%) of normal human lung and tumour tissue were centrifuged for 
30 minutes and the supernatant fractions were frozen, overnight, at -20 C, 
before analysis. UDP-glucuronosyltransferase and sulphotransferase were 
measured, as explained in Materials and Methods (Chapter 2, p 53). The 
control incubations contained boiled enzyme fractions. Incubations were only 
carried out for 60 minutes. Further time points were not possible because 
there was a lack of tissue fraction. Reactions were terminated by the 
addition of dichloromethane.
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TABLE 20: Rates of conjugation of oestradiol bv IQOOQg supernatant fractions
of normal human lung and tumour tissue
Patient
Oestradiol 
( yuM)
Rates of conjugation (Dmol Der min Der mg Drotein in
10000g suDernatant fraction) 
in
Lung 
With PAPS With UDPGA
Tumour 
With PAPS With UDPGA
C 15 0.8 ND 0.4 1.3
30 1.6 2.8 - -
60 2.2 ND 0.4 ND
D 15 0.3 0.3 1.0 1.9
30 0.9 0.4 - -
60 10.0 ND ND 1.1
E 15 0.4 0.1 ND 0.3
30 0.1 0.3 - -
60 0.2 <0.1 1.5 1.3
Legend to Table 20
ND: not detectable; not determined.
Homogenates (5055) of normal human lung and tumour tissue were centrifuged for 
30 minutes and the supernatant fractions were frozen, overnight, at -20 C, 
before analysis. UDP-glucuronosyltransferase and sulphotransferase were 
measured, as explained in Materials and Methods (Chapter 2, p 53). The 
control incubations contained boiled enzyme fractions. Incubations were only 
carried out for 60 minutes. Further time points were not possible because 
there was a lack of enzyme. Reactions were terminated by the addition of 
dichloromethane.
supernatant fractions of normal human lung and tumour tissue are 
listed in Table 19. The results obtained using oestradiol as 
substrate appear in Table 20.
The rates of conjugation of both oestrone and oestradiol were 
generally extremely low when compared with those obtained with 1- 
naphthol. The conversion of oestrone to conjugates was <2$ and that 
of oestradiol was <555. With oestrone there was a greater rate of 
glucuronidation than sulphation in both the normal lung and 
corresponding tumour fractions. There were higher rates of 
conjugation in the tumour, particularly with glucuronic acid.
With oestradiol, the normal lung had more conjugation with sulphate 
than with glucuronic acid. The tumour fractions produced both low 
amounts of both types of conjugates. However, in two samples (C and 
D), the sulphation appeared to be lower than in the normal lung.
(2) Normal Human Colonio Mucosa and Tumour Tissue
(i) Metabolism of 1-Naphthol
As with the lung, the colonic tissue not employed for short-term 
culture was homogenized and centrifuged at 10000g. The supernatant 
fractions produced were then used to measure the rates of conjugation 
of 1-naphthol, oestrone and oestradiol, with PAPS and UDPGA.
The rates of conjugation of 1-naphthol with either PAPS or UDPGA by 
10000g supernatant fractions of normal colonic mucosa and tumour 
tissue are listed in Table 21. All the samples of normal colon (A, 
B, C and D) showed the formation of both sulphate ester and 
glucuronic acid conjugates, but the former greatly predominates. A 
similar pattern was seen with all the tumour specimens. The 
formation of the glucuronic acid conjugates in all the samples was 
extremely low in both normal and tumour. The actual percentage 
conversion of 1-naphthol to the glucuronide was only between <1$ and 
5%» Incubations with rat liver 10000g supernatant fractions run in 
parallel in each case, showed over 90% conversion to the glucuronide 
with 1-naphthol, indicating that the incubation conditions were 
satisfactory.
The results obtained from the 1-naphthol conjugation with the tissue 
taken for short-term organ culture are given in Table 22. However, 
no organ cultures were set up for sample D. At 20 yuM, in all three 
samples (A, B and C) of normal colon, the sulphation pathway 
predominated over the conjugation with glucuronic acid. However, it
14TABLE 21: Rates of conjugation of f1- Cl-1-naphthol bv IQQOQg
supernatant fractions of normal human colon and tumour tissue
Patient
1-Naphthol 
(JdM)
Rate of conjugation of(pmol per min per mg protein in
10000g supernatant fraction) 
in
Colon
With PAPS With UDPGA
Tumour 
With PAPS With UDPGA
A 5 111.6 0.6 154.6 5.9
10 54.2 2.5 194.1 7.1
20 69.8 2.9 191.9 23.1
B 5 113.6 1.7 55.4 1.5
10 134.7 6.0 74.7 1.5
20 128.3 7.4 75.5 1.8
C 5 193.7 5.2 154.1 13.8
10 192.1 7.2 177.8 17.2
20 217.4 12.2 272.3 10.8
D 2 498.1 13.3 22.5 2.2
4 548.1 18.0 21.1 2.5
6 518.5 18.9 24.1 4.4
8 668.1 31.3 19.0 2.4
10 267.9 27.4 21.0 2.7
20 588.1 36.9 20.2 6.5
Legend to Table 21
Homogenates (50?) of normal human colon and tumour tissue were centrifuged at 
10000g for 30 minutes and the supernatant fractions were used as soon as they 
were prepared (patients A, B, C). The tissue from patient D was frozen whole 
and the enzyme fractions produced the following day and used as soon as they 
were prepared. UDP-glucuronosyltransferase and sulphotransferase were 
measured, as outlined in Materials and Methods (Chapter 2, p 53)- Each of the 
rates of reaction given in the table is the mean of two determinatiions.
Control incubations contained no enzyme fractions. Incubation was carried out 
for 15-30 minutes to ensure linearity of the reaction. Subsequently, 
reactions were terminated by removal of 100 yUl aliquots of the incubation 
media into tubes with an equal volume of methanol containing authentic 1- 
naphthol and metabolites, which were separated and analysed, as indicated in 
Materials and Methods (Chapter 2, p 53).
Ill
TABLE 22: Conjugation of 1~1- Cl-1-naphthol bv Short-term Organ
Cultures of Normal Human Colonio Mucosa and Tumour Tissue
% of total radioactivity 
recovered in medium as 
conjugates in 
1-Naphthol Colon Tumour
Patient (yuM) 1-NS 1-NG 1-NS 1-NG
Rates of conjugation 
nmoles/24 hours/mg protein 
in
Colon Tumour
1-NS 1-NG 1-NS 1-NG
A 20 6.7(3) 2.7(3) 0.7(3) 1.3(3) 3.8 1.5 0.7 1.1*
B 20 26.4(2) 7.7(2) 11.9(2) 36.5(2) 14.0 4.1 11.6 35.6
C 20 36.6(2) 14.1(2) 4.9(2) 39.4(2) 10.2 3.9 2.6 23.3
Legend to Table 22
1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3-D-glucuronide; 
*: Patient A tissue was only incubated for 6 hours.
Short-term organ cultures of macroscopically normal colon and tumour were 
cultured for 24 hours, at 37 After this time, the culture medium was
changed for one containing [1- C]-1-naphthol and incubated with the tissue 
for a further 24 hours. The amount of radioactivity in the medium at the end 
of the culture was, on average, 70? of the total. Aliquots of the media were 
analysed for 1-naphthol conjugates by TLC, as indicated in Materials and 
Methods (Chapter 2, p 53). The results listed in the table are expressed as 
mean values; figures in parentheses give the number of determinations.
needs to be emphasised that, in the corresponding tumour tissue, the 
glucuronic acid conjugate formation was the major pathway. These 
results were not reflected in the rates of conjugation seen with the 
10000g fractions, i.e. the glucuronic acid conjugation did not 
predominate in the tumour tissue.
(ii) Metabolism of Oestrone and Oestradiol
In addition, the 10000g supernatant fractions were also used to assay 
sulphate ester and glucuronic acid conjugation with oestrone and 
oestradiol. The rates of reaction with oestrone by these fractions 
are shown in Table 23 and those with oestradiol in Table 24.
With samples A and B, the metabolism of oestrone was rather low (<5? 
conversion to the metabolite), when compared with that of 1-naphthol. 
Similar rates of formation of both conjugates, in both fractions, 
were produced. However, samples C and D produced only the sulphate 
ester metabolite with the normal colon. The corresponding tumours 
formed both the sulphate ester and glucuronic acid conjugates in the 
case of D, but only 1-naphthyl-y<3 -D-glucuronide with C. The normal 
colonic fractions metabolised oestradiol to both types of conjugates, 
sample D showing more glucuronide than sulphate formation. The 
oestradiol was conjugated by both pathways by three of the tumour 
samples (A, B and D), but C showed only glucuronidation. Overall the 
conversion of oestradiol to metabolites was low (being <8?) when 
compared with the metabolism of 1-naphthol. It is noteworthy that 
sample D, which had previously been frozen whole, produced the 
highest rates of conjugation. The reason for this is unknown.
TABLE 23: Rates of conjugation of oestrone bv IQOOQg supernatant fractions
of normal colonic tissue and tumour
Patient
Oestrone 
(J* M)
Rate of conjugation (omol per min per mg protein in
10000g supernatant fraction) 
in
Colon
With PAPS With UDPGA
Tumour 
With PAPS With UDPGA
A 60 2.9 3.8 0.2 6.4
B 30 3.4 5.3 2.8 0.4
C 30 1.1 ND ND 18.0
D 30 ND ND 21.4 9.3
60 186.6 ND 9.8 27.8
120 473.3 ND 125.3 146.6
Legend to Table 23 
ND: not detectable.
Homogenates (50?) of normal colon tissue and tumour were centrifuged for 30 
minutes. The supernatant fractions were used as soon as they were prepared to 
measure UDP-glucuronosyltransferase and sulphotransferase, as explained in 
Materials and Methods (Chapter 2, p 53). The control incubations contained 
boiled enzyme fractions. Incubations were only carried out for 60 minutes. 
Further time points were not possible due to a lack of tissue fraction. 
Reactions were terminated by the addition of dichloromethane.
TABLE 24: Rates of conjugation of oestradiol bv IQQQQg supernatant fractions
of normal eolonio tissue and tumour
Patient
Oestradiol 
( /AM)
Rate of conjugation (Dmol Der min Der mg Drotein in
10000g suDernatant fraction) 
in
Colon
With PAPS With UDPGA
Tumour 
With PAPS With UDPGA
A 60 10.6 11.7 10.6 6.9
B 30 12.2 13.5 4.6 1.6
C 30 6.4 3.9 ND 69.5
D 30 53.3 126.3 14.5 8.6
60 178.3 227.5 131.0 51.7
120 276.7 680.0 48.3 133.0
Legend to Table 24 
ND: not detectable.
Homogenates (505?) of normal colon tissue and tumour were centrifuged for 30 
minutes. The supernatant fractions were used, as soon as they were prepared, 
to measure UDP-glucuronosyltransferase and sulphotransferase, as described in 
Materials and Methods (Chapter 2, p 53). The control incubations contained 
boiled enzyme fractions. Incubations were only carried out for 60 minutes. 
Further time points were not possible due to a lack of tissue fraction. 
Reactions were terminated by the addition of dichioromethane.
C: DISCUSSION
( 1 )  L u n g
In all the samples where 10000g supernatant fractions were prepared, 
the tumour tissue showed generally lower sulphation than the normal 
lung. However, with patients B, D and E, the sulphate ester 
conjugation in the frozen tissue was dramatically decreased when 
compared with the enzyme activity seen in the fresh preparations. 
Presumably, this was due to the enzyme sulphotransferase becoming 
denatured. As a soluble cytosolic enzyme (67» 69)» it is liable to 
be more labile than UDP-glucuronosyltransferase, which is membrane- 
bound (57, 58).
The glucuronosyltransferase activity was low in all the 10000g 
supernatant fractions produced from the normal lung. The tumour 
fraction showed greater glueuronidation than the normal lung in 
patients B, D, E and F. Patient F gave a dramatic demonstration of 
activation of the enzyme probably through freezing and thawing. 
However, this was not observed in the results obtained from patients 
B, D and E. Previously, freezing and thawing microsomes has been 
observed to give a small, rather inefficient,activation of UDP- 
glucuronosyl transferase (141).
The pattern of conjugation produced by the subcellular 10000g 
fractions was a reasonable representation of that seen with the 
short-term organ cultures. One of the differences produced was that 
glucuronidation was detectable in the normal lung 10000g
preparations. However, in most of the cultures, 1-naphthyl-/<3 -D- 
glucuronide formation was not detectable in normal lung. There may 
be several reasons for this discrepancy. First, in the organ culture 
system, the two enzymes compete for 1-naphthol. Thus, the quantity 
of products observed will be dependent on both the relative and 
Vmax values. Secondly, the tissue in the organ culture is required 
to generate its own cofactors (UDPGA and PAPS) to produce the 
conjugates. In contrast to this situation, when the 10000g 
supernatant was used for the determination of optimal enzyme 
activities, only exogenous cofactors required for the particular 
enzyme being assayed were added. A further possibility is that, in 
the preparation of the 10000g supernatant fractions, the UDP- 
glucuronosyl transferase may have become activated so that glucuronic 
acid conjugates were produced.
Generally, with 1-naphthol conjugation in the short-term organ 
cultures, squamous cell carcinomas often show little, if any, 
production of the sulphate conjugate, with predominantly glucuronic 
acid conjugates being formed (142 and Chapter 3). Other 
histopathological-types of carcinomas produced both types of 
conjugates, the glucuronide sometimes being greater and the sulphate 
ester conjugation being lower than that in the normal tissue.
With this in mind, the samples used for the subcellular study did not 
always follow this conjugation pattern. The results from patient A 
did not follow the usual pattern with sulphation. Thus, although 
this pathway was lower in the tumour it was still the major 
conjugating route in both normal and tumour tissue. This was probably
because this rare tumour (lymphocytic lymphoma) was not of lung 
origin.
The results from patients B and C did not exhibit the change in 
pathway from normal to tumour usually seen with squamous type 
tumours. Those results obtained from the tissues of patients D, E 
and F do broadly follow the peviously observed pattern. Sample D 
showed both pathways in the tumour, the glucuronidation predominating 
in the 10000g fraction. However, under one culture condition 'a1; 
(as indicated in Table 18, p 150), there was slightly more sulphation 
than glucuronidation. With conditions *b*, the conjugation with 
sulphate ester being slightly less than that with glucuronic acid. 
The contradictory results were probably due to the heterogeneous 
nature of the tumour tissue. The results from patients E and F 
showed the expected pattern of conjugation for squamous cell 
carcinomas.
The increased rate of sulphate ester conjugating ability seen with 
the 100000g supernatant fraction of normal lung compared with the 
10000g supernatant fraction was probably due to the higher specific 
activity with the former under optimal conditions. The glucuronic 
acid conjugation exhibited by the microsomes showed that the normal 
human lung possesses a UDP-glucuronosyltransferase. The activity 
observed with the microsomes appeared higher than that of sulphate 
ester conjugation with the frozen preparations B, C, D, E and F. 
Also, this was true, in two cases (E and F), when the fractions 
were assayed fresh. These results seem to contrast with those
obtained with the 10000g supernatant fraction. The increase in UDP-
glucuronosyltransferase activity could be interpreted as an 
activation of the enzyme by centrifugation in the preparation of the 
microsomes. Others have observed activation of this enzyme activity 
by this preparative process of centrifugation (143). However, the 
reason for this apparent increase in the activity of UDP- 
glucuronosyltransferase is probably due to the method of expressing 
the results. The effect comes about by having a higher specific 
activity of microsomes because of less microsomal protein per g lung 
tissue. Thus, when the rates of conjugation by the microsomal 
fraction with UDPGA and the 100000g supernatant fraction with PAPS 
are expressed pmol of conjugate produced per min per g lung (Table 
25), the results are in sharp contrast to those where quantitation 
was done on microsomal or cytoplasmic protein.
It was found that using oestrone and oestradiol as substrates in the 
lung and tumour tissue, the ability to conjugate these with UDPGA and 
PAPS tumour tissue was very low. In fact, it may be that the 
detected activity could be within the limits of experimental error. 
However, when the metabolism was higher than the control levels, the 
oestrone showed a different pattern of conjugation when compared with 
that of 1-naphthol. The glucuronidation predominated in both 
tissues. With oestradiol, another metabolic profile emerged. The 
normal lung predominantly sulphated and the tumour tissue showed the 
production of both conjugates.
The ability to conjugate these steroids was poor when compared with 
1-naphthol, even though higher substrate concentrations were used and 
gave a different conjugation pattern. However, the difference in 
conjugation of these substrates may be due to different Km values.
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14TABLE 25: Rates of conjugation of f1- Cl-1-naphthol bv IQQQOQg
supernatant and microsomal fractions of normal human lung
Patient 1-NaDhthol 
(yuM)
100000g 
Supernatant 
With PAPS 
(pmol per min 
per mg 
cytosolic 
protein)
Rate of con 
Microsomes
With UDPGA 
(pmol per min 
per mg 
microsomal 
protein)
iugation in 
_1_0_0_0_0_0g 
Supernatant 
With PAPS 
(pmol per min 
per g lung)
Microsomes
With UDPGA 
(pmol per min 
per g lung)
D 6 54.5 66.4 1816.2 10.1
20 90.2 60.6 2057.0 27.8
E 20 7.3 144.3 407.3 86.5
F 20 12.8 21.0 775.0 64.0
Legend to Table 25
The data from patients D and E was that which was produced fresh while the 
enzyme fractions from F were assayed, having been frozen, after standing for 
1.5 hours on ice, and then thawed for use (see Table 17). The rates of
conjugation pmol per min per mg cytosolic or microsomal protein are reproduced 
from Table 17. The data given as pmol per min per g lung, is the same as that 
in the other columns but the results have been quantitated differently.
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(2) Colon
The 10000g supernatant fractions from colonic mucosa and tumour 
produced both 1-naphthyl sulphate and 1-naphthyl--D-glucuronide. 
However, the formation of glucuronic acid conjugates was low. The 
results obtained by using tumours from patients B and D showed 
decreased sulphation when compared with the normal tissue.
The pattern of conjugation produced by these samples, in short-term 
culture, was different from that shown by the 10000g supernatant 
fractions. In short-term culture, the normal tissue gave more 
sulphate ester conjugates than 1-naphthyl- fb -D-glucuronide. The 
tumours gave a predominance of glucuronidation, with decreased 
sulphation when compared with the normal tissue.
The lack of formation of 1-naphthyl- y3 -D-glucuronide with 10000g 
supernatant fractions might be due to the hydrolytic activity of y<3 - 
glucuronidase, which could be released from lysosomes and is present 
in the microsomes (144), and thus, subsequently, could destroy any 
glucuronic acid conjugates formed. However, normally, at the pH(7.4) 
at which the UDP-glucuronosyltransferase was assayed, the hydrolytic 
activity of ^  -glucuronidase has been reported as negligible (145).
Again, as with the lung tissue, the metabolism of the steroid 
compounds was low, when compared with that of 1-naphthol. However, 
oestradiol showed greater rates of conjugation than oestrone. 
Drawing overall conclusions from the data was difficult because the 
conjugation varied from sample to sample. This was probably due to
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such a low conversion to conjugates.
It is noteworthy that rat liver subcellular fractions were able to 
conjugate oestrone and oestradiol (Table 26). This experiment was 
carried out to ensure that the assay method was working. However, it 
is interesting that only low levels of glucuronidation were seen with 
the rat liver 10000g supernatant fraction. It may be that the assay 
is not particularly sensitive, which would explain why so little 
activity was seen with 10000g supernatant fractions of the human 
tissues. Conjugation of oestrone and oestradiol by human lung and 
colon tissues may be achieved if 100000g supernatant and microsomal 
fractions were used instead of the 10000g supernatant fraction. 
Conjugating activity was seen with the rat liver 100000g supernatant 
fraction but only low conjugation was observed with the rat liver 
microsomal fraction. This contrasts with the findings of Rao et.al. 
(129), where microsomal glucuronidation of steroids was 
characterized. However, the lack of glucuronidation of these 
steroids by rat liver microsomes has been found by other workers
(146). Also, this method gives no indication which hydroxyl group of 
oestradiol is conjugated or even whether a double conjugate is 
formed. Further chromatography would be needed to distinguish these 
possibilities.
TABLE 26: Rates of conjugation of Oestrone and Oestradiol bv Rat Liver
Subcellular Fractions
Subcellular
Fraction
Substrate
Concentration
Rate of coniugation 
of oestrone with
Rate of coniugation 
of oestradiol with
( /AM.) PAPS UDPGA 
Dmoles/min/mg Drotein
PIPS UDPGA 
Dmoles/min/mg Drotein
10000g 30 ND • 3.06 ND 3.62
supernatant 60 ND 1.96 ND ND
120 ND ND ND ND
microsomes 30 — ND _ 0.91
60 - 1.14 - 1.07
120 - 1.86 - ND
100000g 30 2.75 - 17.16 -
supernatant 60 0.11 - 21.12 -
120 34.86 - 28.98 -
Legend to Table 26
ND: not detectable; not determined.
A homogenate (20%) of rat liver in 1.15? KC1 was centrifuged at 10000g. 
Some of the supernatant from this was then centrifuged at 100000g. The 
10000g supernatant, 100000g supernatant and the microsomal fractions were 
used to measure the rate of conjugation with PAPS and with UDPGA, using 
oestrone and oestradiol as substrates. The reactions were carried out as 
explained in Materials and Methods (Chapter 2, p 53).
D: CONCLUSION
From the data that have emerged from the experimental work recorded 
in this chapter, it would appear that the use of subcellular 
fractions does not always give the same results as those produced 
from the short-term culture - a system where cellular integrity is 
maintained. Overall, the use of 10000g supernatant fractions from 
lung and corresponding tumours did give a good reflection of the 
results seen in culture. However, it is important to note that 
microsomes from the lung showed that this tissue does possess the 
enzyme UDP-glucuronosyltransferase by the microsomal fraction being 
able to produce 1-naphthyl-^ -D-glucuronide. The formation of this 
conjugate by normal peripheral lung was not seen to any real extent 
in short-term explant culture. Thus the result, showing that 
microsomal fractions have the ability to produce glucuronic acid 
conjugates (expressed per mg microsomal protein), taken on its own, 
would be misleading. Many reasearch workers only use microsomal 
fractions to investigate the ability of cells to glucuronidate and do 
not consider the rates of conjugation per g tissue. Under such 
circumstances, the results produced in the present research, 
expressed per mg microsomal protein may give the impression that 
normal peripheral lung could easily form 1-naphthyl-/3-D-glucuronide. 
However, intact cells produce little, if any, of the glucuronic acid 
conjugate. Thus, by only using microsomal fractions, a misleading 
picture of Phase 2 metabolism may be achieved by not considering the 
mg of microsomes per g of tissue.
The pattern of conjugation produced by colonic mucosa and adeno-
carcinomas, using the 10000g supernatant fractions, did not reflect 
the results from short-term culture. Thus, the patterns of 
metabolism from these subcellular fractions, taken on their own, 
could again be misleading. From these results, the impression formed 
appears to be that the ability of colonic mucosa and tumours to
glucuronidate xenobiotics is low and certainly less than sulphation 
in both normal and tumour tissue. However, using an experimental 
system which contained intact cells, the results with short-term 
culture clearly showed that both normal colon and tumour have the
ability to metabolise 1-naphthol to the glucuronic acid conjugate.
Also, the subcellular fractions give no indication that there is a 
shift in conjugation from sulphation to glucuronidation in the 
tumours when compared with normal tissue.
Although, the use of subcellular fractions can be justified for some 
investigations, any data obtained must be interpreted with great 
care. The results displayed in this chapter do illustrate that
subcellular fractionation experiments can give a misleading picture 
of the drug-metabolising capability of a tissue. However, the use of 
subcellular fractions has produced evidence of enzyme activity, 
which was not detectable in organ culture.
CHAPTER 5
ROUTES OF CONJUGATION OF 1-NAPHTHOL. 3-HYDROXYBENZQ(A)PYRENE. 
OESTRONE AND OESTRADIOL-BY-HUMAN. TUMOUR CELL LINES
INTRODUCTION 
1ESULTS (1)
(2)
(3)
DISCUSSION
(1)
(2)
(3)
Human Bronchial Carcinoma Cell Lines
(i) Metabolism of 1-naphthol by cell lines
(ii) Metabolism of 3-hydroxybenzo(a)pyrene by
cell lines
(iii) Metabolism of 1-naphthol by subcellular 
fractions from the cell lines Ben and E14
(iv) Metabolism of oestrone and oestradiol by a 
homogenate from the cell line Ben.
Human Colonic Carcinoma Cell Lines
(i) Metabolism of 1-naphthol by cell lines
(ii) Metabolism of 1-naphthol by a subcellular
fraction from the cell line COLO 206
(iii) Metabolism of oestrone and oestradiol by a
subcellular fraction from the cell line COLO 206
Metabolism of 1-naphthol by subcellular fractions
from Ben and COLO 206 cell lines and a rat liver
Human Bronchial Carcinoma Cell lines
Human Colonic Carcinoma Cell Lines
Absence of Sulphoconjugation with 1-Naphthol
CONCLUSION
A: INTRODUCTION
In the present investigation, metabolism studies have been carried 
out with human tumour cell lines, which had been established in other 
laboratories. The cell lines selected for study were chosen because 
they were derived from human bronchial carcinoma or human colonic 
carcinoma samples. By this means, a comparison could be made between 
the metabolism observed either with cell lines derived from surgical 
samples or with fresh surgical samples in explant culture (Chapter 
3).
The major advantage of using cell lines was that human tumour 
material was available for experimentation in a planned manner, 
rather than the material arriving unexpectedly from surgery at random 
times. Accordingly, by using cell lines, cells can be grown up in 
sufficient numbers, so that the desired number of experiments can be 
completed. A further advantage of this kind of planned approach, 
true of all culture systems, is that the cells are maintained in a 
defined, controlled environment. When compared with sub-cellular 
fractionation experiments, the use of cell lines gives a system where 
intact cellular integrity is maintained, although the cells are 
growing in vitro and without stromal support.
In addition, cells produce metabolites of compounds as a result of 
the xenobiotics being exposed to all the enzyme systems in the cells 
and not just a fraction of them, as with subcellular experiments. 
Another advantage of using cell lines is that such a procedure gives 
an experimental system which can produce good reproducibility of
results. Also, when cell lines are not needed they can be frozen 
down and stored until required. This use of storage is particularly 
helpful when a cell line can change characteristics. For example, a 
cell line can acquire resistance to a drug and so cells, from 
passages where sensitivity and resistance are observed, can be kept 
and subsequently compared. Yet a further advantage arises from the 
fact that cell lines are produced from a wide variety of tumours and, 
so, comparative study of human tumour material is made possible.
It is important to stress that there are also several disadvantages 
to the use of established cell lines. Cells maintained in culture 
have no stromal support and thus have lost all tissue architecture. 
Such cells have no connection via support tissue with other cells and 
so the in vivo cellular architecture is not reproduced with this 
system. Also, monolayer cell culture leads to a breakdown of cell 
interactions and could produce a modified response to external 
stimuli.
A cell line can be established from a degenerating population of
cells, when rapidly growing colonies of cells appear (147). Thus,
cells which have survived and thrived through such a phase have been 
altered in some way. Therefore, an established cell line is
frequently different from the cells of the tissue from which it 
originated. Such a line may consist of one or several types of cells
(147)» but almost certainly represents a selective cell population. 
Those neoplastic cells which grow in culture may be those most likely 
to thrive under such conditions and not the most representative of
the original tumour. Such a system can also suffer from a loss of
functional characteristics and from an absence of easily defined 
markers to distinguish tumour and normal cells (148). It is possible 
that established cell lines can, with many passages, over time, alter 
by mutation or some adaptation, to permit their survival in vitro. 
The same cell line used in separate laboratories can actually become 
quite different in character (149). Wilson (149) has demonstrated 
that the enzyme pattern of cells can be altered following in vitro 
culture, although some changes are reversible on reimplantation of 
the cells into appropriate hosts, while others have appeared 
irreversible. A further difficulty is that cell lines can also 
become contaminated with fibroblasts, other non-tumour cells, virus 
particles and mycoplasma (150).
f,
Having examined the major advantages and disadvantages of using cell 
lines, it is appropriate to summarise these in tabular form (Table 
27). Some of the characteristics of the human cell lines used for 
the metabolism studies for this project are presented in Table 28.
TABLE 27; The Advantages and Disadvantages of the Use of Cell Lines
Advantages Disadvantages
Cell lines, derived from human 
biopsy material, provide a good 
source of human neoplastic 
material for study.
Cells are no longer organised 
into tissues, which produces a 
lack of cell interaction.
Cell lines provide unlimited 
material for planned experimenta­
tion.
A cell line population may be a 
selective group of cells.
Cells grow in a defined, controlled 
environment.
Cell lines can lose character­
istics, like enzyme markers 
during culture.
Intact cells provide a system 
resembling an in vivo - like 
situation, when compared with 
subcellular fractionation of tissues.
Established cell lines can 
become altered over a period of 
time.
The use of cell lines gives a good 
reproductive system.
Cell lines can be contaminated 
by other cells or viruses.
Cell lines can be stored frozen 
when they are not required.
Cell lines can be derived from many 
tumours and from some normal tissue.
TABLE 28: Characteristics of Human Tumour Cell Lines Used for this
Study
Cell
Line Histoloeical TvDe
Approx Doubling 
Time Passages* Other Features
BRONCHIAL 
CARCINOMA LINES -
BEN Poorly differen­
tiated epidermoid
2-3 days 20-40 Grown direct from 
patient biopsy, derived 
from squamous cell 
carcinoma of bronchus.
GRI Squamous 2 days 30-40 Grown direct from 
patient biopsy, but now 
a sub-population.
MIN Adenocarcinoma 4 days 10-20 Grown from xenograft. 
Produces calcitonin and 
ACTH.
POC Oat Cell 6-8 weeks 2nd&3rd Grown from xenograft.
MAR Oat Cell 6-7 days 18-22 Grown direct from 
patient biopsy. 
Originally produced 
calcitonin and ACTH.
MOR Large Cell 
Anaplastic
2-3 days 25-35 Grown from xenograft. 
Used to secrete mucous.
DRE Large Cell 
Anaplastic
2 days 25-35 Grown from xenograft. 
Used to secrete mucous.
E14 Squamous 3 days >70
COLONIC
CARCINOMA LINES
LoVo Adenocarcinoma 37 hours 1-2 CEA producing.
COLO
205
Adenocarcinoma 20 hours CEA producing. Origin in 
ascites fluid, cultured 
as suspension.
COLO
206
Adenocarcinoma 20 hours
'
CEA producing. Origin in 
ascites fluid, cultured 
as suspension.
*: Number of passages through which the cells were taken during experiments.
-: Not applicable*
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(1) Human Bronchial Carcinoma Cell Lines
14(i) Metabolism of f1- Cl-1-naphthol bv cell lines
14The routes and rates of formation of the conjugates of [1- C]-1-
naphthol by eight different cell lines were very variable (Table 29). 
Two cell lines, Ben and Gri, derived from squamous tumours formed 
predominantly the glucuronic acid conjugate, whilst another squamous 
cell line E14 showed virtually no metabolism. Min,the adenocarcinoma, 
and Mor, one of the large cell anaplastic cell lines, both showed 
significantly more glucuronic acid than sulphate ester formation. 
The other large cell anaplastic cell line, Dre, formed small, but 
detectable amounts of 1-naphthyl sulphate only. Both the oat cell 
carcinoma cell lines, Poc and Mar, showed virtually no metabolism of 
1-naphthol. The details of these results are summarised in Fig. 39.
A further study was undertaken with the Ben cell line. A range of 
concentrations of 1-naphthol, the number <pf incubations and the time 
of incubation were changed. These results are summarised in Table 30.
As can be seen from these results, the production of 1-naphthyl-/3 -D- 
glucuronide by the Ben cell line was substrate dependent up to 50 yULM 
1-naphthol. At 100 yU.M, the production of the glucuronic acid 
conjugate had not increased when compared with that at 50 jxM. This 
was probably due to the fact that, at this higher concentration, some 
toxicity to the cells was observed. Some of the cells could be seen 
to be rounding up and floating in the medium, rather than adhering to
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14TABLE 2Q: Metabolism of f1- Cl-1-naphthol bv human bronchial
carcinoma cells in monolaver culture
Cell
Line
% Radioactivity recovered 
in media as 
1-naphthyl 1-naphthyl-/^ 
sulphate -D-glucuronide
nmoles/mg protein/90 min
1-naphthyl 1-naphthyl*y5 
sulphate -D-glucuroniae
Ben ND 97.2 ND 16.7
Gri <0.1 95.3 <0.1 3.9
Min 10.6 62.6 1.1 6.3
Poc ND 0.2 ND <0.1
Mar 0.1 0.5 <0.1 0.1
Mor 21.7 49.8 1.2 2.9
Dre 18.0 ND 1.0 ND
E14 0.8 0.3 0.1 0.1
Legend to Table 2Q
ND: not detectable, i.e. not above control values.
Values in this table are the means of two separate determinations. 
The two sets of results for each cell line are not true duplicates as 
the two incubations were carried out with monolayer cell ciiLtures, 
which had grown separately.^ The cells (0.1 - 0.5 x 10 ) were 
exposed to 3ml of 10 /aM[ 1— C]-1-naphthol in each incubation. The
figures in this table are not necessarily true rates as the 
determinations were made after 90 minutes incubation. These results 
probably represent an underestimate of initial rates, particularly 
with the cell line Ben, where almost all the 1-naphthol was 
metabolised to the glucuronide conjugate. Protein per dish ranged 
from 1.0 - 5.0 mg.
Fi
gu
re
39
:C
on
ju
ga
tio
n 
of 
1-
N
ap
ht
ho
l 
to 
1-
N
ap
ht
hy
l-B
-D
-g
lu
cu
ro
ni
de
 
an
d 
1-
N
ap
ht
hy
l 
Su
lp
ha
te
 
by
Hu
m
an
 
Lu
ng
 
Tu
m
ou
r 
Ce
ll 
Li
ne
s
-i iv-
cc
O
ID
~ r
CNJ T00
T 1
o
LU
co
sa^nu!iuo5 /  mapid 6uj/ pauuoj pnpojd jo saioiuu
Po
or
ly 
Sq
ua
m
ou
s 
Tru
e 
Ad
en
o-
 
Oa
t 
Ce
ll 
La
rg
e 
C
el
l 
Di
ffe
re
nt
iat
ed
 
Sq
ua
m
ou
s 
ca
rc
in
om
a 
Ca
rc
in
om
a 
A
na
pl
as
tic
 
Ep
id
er
m
oi
d
- 180 -
14TABLE 30: Metabolism of f1- Cl-1-naphthol bv Ben cells in monolaver
cell culture
Concentration
of ri-_ .cl
-1-naDhthol
i Radioactivitv recovered 
in medium as 
1-naDhthvl 1-naohthvl-/3 -D
nmoles/mg/Drotein 
3 hours 
1-naDhthvl 1-naDhthvl- -
( /AM). sulDhate glucuronide sulDhate D-elucuronide
5 ND 32.5 ND 3.7-0.3
10 ND 55.8* ND 11.5-1.3*
20 ND 55.1 ND 25.0-1.8
50 ND 32.3 ND 35.8-1.4
100 ND 13.3 ND 29.4-0.9
Legend to Table 30
ND: not detectable, i.e. not above control values.
Values in this table are the means of four separate determinations. Volume of 
incubation was 1ml. Protein per dish ranged from 0.38 - 0.53 mg.
* These values are the means of six determinations. The values of nmoles/mg 
protein/3 hours are given in the form of (mean + s.d.) of four, or six, 
determinations.
the plastic base of the flask. Even at these high concentrations the 
Ben cell line produced no sulphate ester conjugates at all.
The standard deviations given with the results indicate that there 
was little variation between the metabolism produced in different 
dishes of cells.
3
(ii) Metabolism of f Hl-'R-hvdroxvbenzofalpvrene (3-OH-BPlbv 
cell lines
For all the cell lines studied, the metabolism of 3-OH-BP was lower 
than that observed for 1-naphthol (Table 31). The structure of 3-OH- 
BP is given in Fig. 40. Conjugation of 3-OH-BP was fastest with the 
cell line Ben, in agreement with the results obtained by using 1- 
naphthol. With this cell line, conjugation with glucuronic acid was 
more extensive than with sulphate. In contrast, Gri formed small 
quantities of both conjugates. Min also produced both conjugates, 
but there were only trace amounts of 3-OH-BP-/3 -D-glucuronide. Only 
small, but detectable, amounts of the glucuronide conjugate were 
formed by Mar, the oat cell carcinoma cell line. The Dre cell line 
produced trace amounts of 3-OH-BP-y<3 -D-glucuronide and a small 
quantity of 3-OH-BP hydrogen sulphate, while the large cell 
anaplastic line Mor metabolised the 3-OH-BP to the sulphate estert
conjugate only. Finally, E14 showed virtually no metabolism, 
although traces of sulphate were detected.
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TABLE 31: Metabolism of f Hl-3-hvdroxvbenzo(a)pvrene (3-OH-BP) bv human
bronchial oaroinoma cells in monolaver oulture
°L Radioactivity recovered 
in medium as 
3-OH-BP hydrogen 3-OH-BP-/3-
nmoles/mg Drotein/
Q0 min
3-OH-BP-hydrogen 3-OH-BP-/3-
Cell Line sulDhate D-glucuronide sulDhate D-glucuronide
Ben 1.6 41.0 0.05 0.20
Gri 3.7 6.0 0.02 0.02
Min 2.6 0.2 0.02 <0.01
Poc - - - - *
Mar ND 0.6 ND <0.01
Mor 9.3 ND 0.05 ND
Dre 4.3 0.2 0.03 <0.01
E14 0.9 ND <0.01 ND
Legend to Table 31
ND: not detectable, i.e. not above control values, 
not determined.
Values in Table 31 are the means of two separate determinations. The two sets 
of results for each cell line are not true duplicates as the two incubations 
were carried out with monolayer cell cultures which had grown separately. The 
figures in Table 31 are not necessarily true rates as the determinations were 
made after,. 90 minutes incubation. Each dish of cells was incubated with 3 ml 
of 2 yuM [ H]-3-hydroxybenzo(a)pyrene. Protein per dish ranged between 2.4 - 
5.0 mg.
Figure 40 : The Structure Of 3-OH-BP
(iii) Metabolism of 1-naphthol bv subcellular fractions from the 
cell lines Ben and E14
In order to confirm and extend the above results, the conjugation of
1-naphthol by Ben and E14 was also studied using subcellular
fractions, prepared as described in Chapter 2. Using the 10000g
supernatant fraction from the Ben cell line, together with the
appropriate co-factors, 1-naphthol was metabolised to 1-naphthyl-y3 -
D-glucuronide in a time-and substrate-dependent manner (Fig. 41).
The formation of conjugate was also enzyme dependent. For example,
by doubling the enzyme protein, the percentage conversion of 1-
naphthol to the glucuronic acid conjugate at 20juM increased from 8.355
to 18.9$ after 15 minutes. Several kinetic plots were drawn from the
subcellular studies carried out with the Ben cells for
glucuronidation of 1-naphthol. From the Lineweaver-Burk plot, a
value of V of 0.5 nmoles/ml/mi n (Specific Activity of 1.8 max
nmoles/mg protein/min) and an apparent Km of 33.3 yuM were 
calculated (Fig. 42). Similar experiments with 10000g supernatant 
fractions of the Ben cell line, but with the appropriate co factors 
for sulphate conjugation, showed that the production of 1-naphthyl 
sulphate was extremely low (<0.5$) and was not dependent on the time 
of incubation, the substrate concentration and the enzyme protein 
concentration.
Similar experiments with E14 showed no significant metabolism of 1- 
naphthol to either a glucuronic acid or sulphate ester conjugate. 
The formation of 1-naphthyl--D-glucuronide by E14 was <0.7$ and 
that of 1-naphthyl sulphate <0.4$. These percentage conversions, and
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Figure 41 = Production Of 1-NG At Different
Concentrations Of 1-Naphthol(2-2QMM) At 
Various Times By The Cell Line, Ben
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Figure 42 : A Lineweaver- Burk Plot For The
Production Of 1-NG By Ben Cells 
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that of 1-naphthyl sulphate production by Ben, are probably within 
the limits of experimental error. Since these figures showed no 
dependence on time, substrate concentration and protein 
concentration, they have no particular significance.
(iv) Metabolism of oestrone and oestradiol bv a homogenate from the
cell line.,, ften
To investigate whether Ben cells could conjugate other substrates, 
two steroids were studied using a 50% homogenate, prepared as 
described in Materials and Methods (Chapter 2, p 53). Although the 
homogenate from the Ben cell line was incubated with the appropriate 
cofactors, there was no significant formation of either glucuronic 
acid or sulphate ester conjugates with either oestrone or oestradiol. 
The production of conjugates was <155 and was not dependent on the 
time of incubation, the substrate concentration and the protein 
concentration.
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(2) Human Colonic Carcinoma cells
1li
(i) Metabolism of f1- Cl-1-naphthol by cell lines
All three colonic carcinoma cell lines produced 1-naphthyl--D- 
glucuronide with little, if any, 1-naphthyl sulphate being formed 
(Table 32). COLO 206 appeared to be the line with the highest 
formation of glucuronic acid conjugates and the LoVo cells produced 
the lowest levels (Fig, 43). All three lines showed an increasing 
production of 1-naphthyl-/3 -D-glucuronide with increasing substrate 
concentration up to 20^jlM 1-naphthol. Above this concentration, the 
formation of the glucuronic acid conjugation decreased. This was 
probably due to toxicity of 1-naphthol being exhibited to the cells 
at higher concentrations. The differences in rates of
glucuronidation between the cell lines may be partially explained by 
the amount of protein per cell. COLO 206 have 0.13 Pg protein per 
cell and LoVo has 0.07 Pg protein per cell. COLO 206 has the greater 
rate of glucuronidation.
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Figure 43 : Conjugation Of 1-Naphthol By
Human Colonic Carcinoma Cell Lines
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(ii) Metabolism of 1-Naphthol bv a Subcellular Fraction from the 
Cell line COLO 206
The conjugation of 1-naphthol by COLO 206 was studied, employing a 
subcellular fraction which was prepared as described in Materials and 
Methods (Chapter 2, p 53). The cells were broken open by freeze- 
thawing. Using the 10000g supernatant fraction from the COLO 206 
cell line, together with the appropriate cofactors, 1-naphthol was 
metabolised to 1-naphthyl- fb -D-glucuronide in a time-and substrate- 
dependent manner (Fig. 44).
This formation of conjugation was also enzyme dependent. For
example, by doubling the enzyme protein, the percentage conversion of
1-naphthol to the glucuronic acid conjugate at 20yU.M increased from
14.8$ to 27.8$, after 15 minutes. Several kinetic plots were drawn
from the subcellular studies carried out with the COLO 206 cells for
the glucuronidation of 1-naphthol. From the Lineweaver-Burk plot, a
value of V of 0.1 nmoles/ml/min (Specific Activity of 0.1 max
nmoles/mg protein/min) and an apparent Km of 2.8yUM were calculated 
(Fig. 45). Similar experiments were carried out with the 10000g 
supernatant fractions of the COLO 206 cell line, but with the 
appropriate cofactors for sulphate conjugation. Although, the 
production of 1-naphthyl sulphate was up to 4$ conversion from the 
total 1-naphthol with one determination, the formation of this 
conjugate did not increase with substrate concentration, time and 
enzyme concentration. Thus, it is unlikely that this formation of 
the sulphate ester conjugation was significant.
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Figure 44 : Production Of 1-NG At Different
Concentrations Of 1 -Naphthol ( 2  - 20uM) At 
Various Times By The Cell Line, COLO 206
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It is of interest that incubations with the homogenate of COLO 206 
with UDPGA produced virtually total conversion of 1-naphthol to the 
glucuronic acid conjugate within 15 minutes. However, the percentage 
conversion of 1-naphthol to the conjugate, using the 10000g 
supernatant fraction, was much less during the same time period. 
This was unexpected as an increased rate was expected because of 
increased specific activity.
(iii) Metabolism of oestrone and oestradiol bv a subcellular
fraction from the cell line COLO 206
The conjugation of the steroids oestrone and oestradiol by COLO 206 
was studied, using a homogenate and a subcellular fraction prepared 
as explained in Materials and Methods (Chapter 2, p 53). The cells 
were broken open by freeze-thawing. The homogenate and subcellular 
fraction were incubated with the substrates, together with the 
appropriate cofactors for either sulphate ester or glucuronic acid 
conjugation. The results, summarised in Table 33, show that, 
although sulphate ester and glucuronic acid conjugates were produced 
with both steroids, the conjugation with UDPGA was higher in each 
case. There was an exception to this, in that, at 60 julM, more 
sulphate ester than glucuronic acid conjugates of oestradiol were 
formed.
As with the conjugation of 1-naphthol, the homogenate of COLO 206 
gave higher glucuronidation of oestrone and oestradiol than the 
10000g supernatant fraction. The UDP-glucuronosyltransferase 
activity towards oestradiol was generally higher than that towards 
oestrone.
TABLE 33: Rates of conjugation of oestrone and oestradiol bv a homogenate
or a IQQOQg supernatant fraotion of COLO 206 cells
Substrate
Substrate
Enzvme
Rates of conjugation (Dmol Der min 
Der mg Drotein in either homogenate 
or 10000g suDernatant fraction) bv
concentration COLO 206 cells
(/aM) With PAPS With UDPGA
Oestrone 30 10000g 1.6 5.6
60 supernatant 5.0 13.5
120 0.52mg protein/ 14.0 17.8
incubation
homogenate
120 0.92mg protein/ 12.0 145.0
incubation
Oestradiol 30 10000g supernatant 5.8 15.5
60 0.52mg protein/ 19.5 11.1
120 incubation 15.4 25.4
homogenate
120 0.92mg protein/ 9.1 359.2
incubation
Legend to Table 33
A homogenate (50$) of COLO 206 cells was centrifuged at 10000g for 30 
minutes. Both the supernatant fraction and homogenate were used to 
measure UDP-glucuronosyltransferase and sulphotransferase activities with 
oestrone and oestradiol, as described in Materials and Methods (Chapter 
2, p 53). The control incubations contained boiled enzyme . Incubations 
were only carried out for 60 minutes. Further time points were not 
possible because of a lack of enzyme fraction. Reactions were terminated 
by the addition of dichloromethane.
(3) Metabolism of 1-naphthol bv IQOOQg supernatant fractions from
Ben and COLO 206 cellsf and a rat liver
The conjugation of 1-naphthol was again studied using 10000g 
supernatant fractions from Ben and COLO 206 cells. However, in 
parallel, 1-naphthol metabolism was also investigated, with a 10000g 
supernatant fraction, from rat liver as a positive control. The 
supernatant fractions from the cells and the rat liver were incubated 
with 1-naphthol and with one of the following: UDPGA, PAPS, APS and 
ATP, ATP and inorganic sulphate, the results being shown in Table 34. 
All three enzyme preparations were able to form 1-naphthyl- -D- 
glucuronide. However, only the rat liver supernatant fraction was 
able to produce 1-naphthyl sulphate from PAPS, APS and ATP, and ATP 
and inorganic sulphate. The cell lines produced little, if any, of 
this conjugate. When the rat liver supernatant fraction was added to 
the tubes where the Ben supernatant fraction had been incubated with 
PAPS, 98.9$ 1-naphthyl sulphate from 1-naphthol was detectable. This 
had been formed by the rat liver 10000g supernatant fraction after a 
30 minute incubation at the end of the original incubation time with 
the Ben cell supernatant fraction. Thus ? the PAPS had been available 
to the Ben cell supernatant fraction and not degraded by it.
TABLE 34: Con jugation of 1-naphthol bv IQOOQg supernatant fractions from the
cell lines Ben and COLO 206. and a rat liver
10000g
suDernatant Time
% conversion of 1-naDhthol to
J:-naDhthvl sulDhate
1-naDhthvl-/3 - 
D-glucuronide
fraction (min) With PAPS With APS + ATP With ATP
- sojf
With UDPGA '
Ben 15 ND <0.1 ND 98.3
30 ND 0.2 0.1 -
COLO 206 15 0.2 <0.1 ND 14.6
30 1.1 0.2 0.3 38.3
Rat Liver 15 98.9 18.5 66.7 97.0
30 99.0 28.2 98.3 98.0
Legend to Table 34
-: not determined; ND: not detectable.
Homogenates (50% of cells, 20% of rat liver) were centrifuged at 10000g for 30 
minutes. The 10000g supernatant fractions were used to measure UDP- 
glucuronosyltransferase activity with UDPGA as cofactor. The phenol 
sulphotransferase was measured under three sets of conditions: (i) with PAPS,
(ii) with APS and ATP, and (iii) with ATP and inorganic sulphate as co fact or s. 
The concentration of 1-naphthol was 20 yuM. The control incubations contained no 
enzyme fractions. Incubation was carried out for 15-30 minutes. Reactions were 
terminated by removal of 100 yul aliquots of the incubation media into tubes with 
an equal volume of methanol containing authentic 1-naphthol and metabolites, 
which were separated and analysed, as indicated in Materials and Methods 
(Chapter 2, p 53).
C: DISCUSSION
(1) Human Bronchial Carcinoma Cell Lines
The results summarised in Tables 29 and 31 show a marked variation in 
the routes and rates of conjugation in different bronchial carcinoma 
cells. As the cell lines were derived from various types of tumour, 
this variation is to be expected. However, particularly noticeable 
was the finding that none of the cell lines showed the pattern of 
conjugation using 1-naphthol as substrate observed with normal 
peripheral human lung, i.e. extensive sulphate ester formation with 
little or no glucuronic acid conjugation (134). Thus, the metabolic 
pathways involved in conjugation were different when compared with 
that obtained from normal peripheral lung. In these cell lines, 
sulphation was markedly diminished or absent, whilst glucuronic acid 
conjugation was sometimes increased.
The relative lack of sulphate ester formation displayed, using cell 
cultures of both E14 and Ben cell lines, was also observed, using 
subcellular fractions fortified with the appropriate cofactors. Due 
to the multiplicity of both UDP-glueuronosyltransferase (64, 65) and 
sulphotransferase enzymes (69*73)» it was necessary to assess 
conjugation with UDP-glu euro nic acid and PAPS, using more than one 
substrate. Studies using the human bronchial carcinoma cell lines 
with a second substrate, 3-OH-BP, confirmed a relative lack of 
sulphate ester conjugate formation obtained with 1-naphthol (Table 
31). It is of interest to note that a study with short-term organ
cultures of normal peripheral human lung, using 3-OH-BP as substrate,
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formed the sulphate ester conjugate, although no attempt was made to 
ascertain the formation, if any, of the glucuronic acid conjugate
(151). Small, but significant, amounts of the glucuronic acid of 3- 
OH-BP were formed by several of the cell lines, in particular Ben 
(Table 31). However, when compared with 1-naphthol, 3-OH-BP was a 
much poorer substrate for UDP-glucuronosyltransferase (Tables 29 and 
31), this result being in agreement with the findings of Bock et.al.
(152), who, however, used a number of different tissues from the rat. 
Bock's studies also suggested that 3-OH-BP and 1-naphthol were 
conjugated by the same UDP-glucuronosyltransferase (152). Although 
the results of the present investigation also lend support to this 
hypothesis, the low activity observed, using 3-OH-BP as a substrate, 
precludes a more definite statement.
The results on cell lines produced for the present investigation 
confirm and extend observations found when using short-term organ 
culture of human lung and tumour (reference 142 and Chapter 3). 
Thus, as with surgical samples, the metabolism of 1-naphthol varied 
with the histological classification of the tumour. Quantitative and 
qualitative variations in the rates and routes of conjugation were 
observed dependent, in part, on the tumour cell line. However, none 
of the cell lines showed the extensive sulphate ester formation which 
is seen with normal peripheral human lung (134). The decrease in 
sulphation is accompanied in some cell lines, in particular those 
originating in squamous carcinomas, by a marked increase in 
glucuronic acid conjugation. In the present study, the exception to 
this was the squamous cell line, E14, which showed a remarkable lack 
of conjugating ability when compared with the other squamous cell
lines. This could be related to the fact that E14 had been in 
culture for a longer period, which may have produced a loss of 
metabolic pathways.
The results obtained with the non-squamous cell lines reflected those 
obtained with surgical samples (reference 142 and Chapter 3). Thus, 
the cells showed a small amount of sulphate ester conjugate formation 
but also produced, in some cases, glucuronic acid conjugates. The 
surgical samples from non-squamous lung tumours yielded some 
glucuronic acid conjugates, but also maintained sulphoconjugation, 
although at a reduced level when compared with that obtained from 
normal peripheral lung.
The results of a detailed study with the poorly differentiated 
epidermoid cell line, Ben, are summarised in Table 30. The evidence 
which emerged from this data confirmed the inability of this cell 
line to produce sulphates ester conjugates, even at high 
concentrations. A decrease in the glucuronide produced, at the 
highest concentration, was presumably due to toxicity of the 
substrate. As some cells were observed to be rounding up and 
floating in the media and thus becoming necrotic, less cells probably 
could metabolise the substrate.
It should be noted that the percentage and amount of 1-naphthyl-y3-*D- 
glucuronide formed at 10 yuM 1-naphthol by Ben in monolayer cell 
culture is different in Tables 29 and 30. The reason for this is 
unknown. However, the experiment reported in Table 30 was carried
out some time after the one summarised in Table 29 and during the
time interval between the two experiments, the cells were passaged 
several times. The decrease in glucuronidation of 1-naphthol could 
be due to the fact that the cell line has altered some of its 
characteristics during this interval,
Oestrone and oestradiol were not satisfactory substrates for any 
conjugating enzymes in the Ben cells. However, further experiments 
do need to be carried out with subcellular fractions of these cells, 
as activity towards these substrates may be possible with a purer 
enzyme fraction. However, the initial study carried out with 
homogenate did show that oestrone and oestradiol are unlikely to be 
as good a substrate as 1-naphthol.
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(2) Human Colonic Carcinoma Cell Lines
The results produced from 1-naphthol metabolism with these cell lines 
are summarised in Table 32. All three lines showed a similar 
formation of conjugates: the predominance of 1-naphthyl--D-
glucuronide, with little, if any, 1-naphthyl sulphate appearing. 
There were differences in the actual amounts of conjugate formed 
between the lines, but the broad overall pattern was similar. These 
colonic carcinoma cells appear to be more sensitive to the toxic 
effects of high concentrations of 1-naphthol than the poorly
differentiated epidermoid bronchial cell line Ben, although it must 
be pointed out that the latter was incubated with the substrate for a 
much shorter time, which could explain the difference in toxicity.
However, by eye, cells could be seen floating in the media quite soon 
(e.g. 1 hour) after the introduction of the substrate, whilst
toxicity may increase the longer the cells are incubated with 1-
naphthol.
The pattern of conjugation shown by the colonic carcinoma cells is 
similar, in one respect, to that displayed by the human colonic
tumours obtained from surgical samples, i.e. there is a predominance 
of 1-naphthyl-y6 -D-glucuronide. Human colonic tumours in short-term 
organ culture, using 1-naphthol as substrate, metabolised this to 
both the sulphate ester and glucuronic acid conjugates. The latter 
metabolite usually predominates, but at the substrate concentrations 
used (20-100 yuM), the sulphate ester conjugate was still present 
(Chapter 3). Thus, the colonic carcinoma cell lines do not mimic the
metabolic pattern found in the short-term organ cultures as, in work 
for this investigation, they only produced glucuronic acid conjugates 
in measurable quantities.
The study with a subcellular fraction of COLO 206 confirmed the 
conjugation pattern seen in culture. Thus, this cell line was able 
to form 1-naphthyl-y3-D-glucuronide with little, if any, 1-naphthyl 
sulphate. However, a 10000g subcellular fraction and a homogenate of 
these cells was able to produce sulphate ester and glucuronic acid 
conjugates from the steroids oestrone and oestradiol. Generally, the 
formation of glucuronic acid conjugates was greater than sulphate 
ester conjugates, whilst the rate of conjugation of oestradiol with 
UDPGA was higher than that with oestrone. It is important to note 
that the activity of UDP-glucuronosyltransferase decreased from 
homogenate to 10000g subcellular fraction, and clearly this finding 
needs further study. It is unlikely that the decrease was caused by 
an inactivation of the membrane-bound UDP-glucuronosyltransferase. 
The activity should have increased from homogenate to subcellular 
fraction with the higher specific activity of the enzyme. However, 
a possible explanation of the reduction in glucuronic acid 
conjugation is the presence of the hydrolytic enzymey3-glucuronidase. 
fb -Glucuronidase could arise in the supernatant fraction by leakage 
of lysosomal organelles during the preparation of the subcellular 
fraction. However, this issue also requires further investigation.
(3) Absence of Sulphocon.iugation with 1-Naphthol
The lack of the ability to form 1-naphthyl sulphate was reflected in 
the incubations carried out using a subcellular fraction from COLO 
206. The absence of sulphoconjugation in both Ben, the bronchial 
carcinoma cell line, and COLO 206 could be caused by either the 
absence of a sulphotransferase or an inability to generate the 
sulphate donor PAPS. Alternatively, the lack of sulphate ester 
conjugates could be, of course, due to a very active sulphatase.
However, it would appear that, in the case of Ben, the inability to 
detect sulphate ester conjugates is due to either the absence of, or 
a defect in, the conjugating enzyme. The results in Table 34 show 
that little, if any, 1-naphthyl sulphate was detectable when either 
PAPS or intermediates in the synthesis of this sulphate donor were 
provided. The fact that rat liver 10000g supernatant fraction was 
subsequently able to form the sulphate ester conjugate, indicates 
that the PAPS had not all been degraded before it could be used for 
conjugation.
It is likely that a similar situation is true of COLO 206. However, 
clearly there is a need to check that PAPS and APS are not rapidly 
degraded and, as a result, become unavailable for conjugation.
Overall, the bronchial carcinoma cell lines appeared to reflect the 
metabolism displayed in short-term organ culture of human lung tumour 
samples better than the colonic carcinoma cells mimicked the pattern 
with colonic carcinoma surgical samples. However, as normal colonic 
mucosa metabolises 1-naphthol to both sulphate ester and glucuronic 
acid conjugates, but the former predominates, it is possible that the 
metabolism seen with the tumours from the colon results from the 
presence of normal cells in the tumour samples. This could be a 
reason for the formation of sulphate ester conjugates with the 
surgical samples and the virtual absence of such metabolism with the 
tumour cell lines.
CHAPTER 6
ROUTES OF CONJUGATION OF 1-NAPHTHOL BY XENOGRAFTS IN
SHORT-TERM EXPLANT CULTURE
INTRODUCTION
RESULTS
DISCUSSION
CONCLUSION
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A: INTRODUCTION
Portions of human tumours removed during surgery can be maintained in 
mice whose immunological responses are depressed genetically. These 
animals are termed 'nude1 athymic mice (BALB/c-nu/nu mice) and the 
tumours transplanted to grow in them are called "xenografts". These 
mice appear hairless and the production of this strain is due to a 
recessive gene carried by normally haired albino mice. However, 
although these mice appear hairless, histological sections of the 
skin do show abortive hair follicles (153). Pantelouris (154) 
discovered that the homozygous mouse (nu/nu) lacked a thymus. 
Consequently, this animal is congenitally immunodeficient and can be 
used as a model for heterotransplantation explants, without having to 
carry out immunosuppressive pre-treatment.
Since this important discovery, many different human tumour types 
have been transplanted into nude mice including malignant tissue from 
the central nervous system, lymphomas, carcinomas and sarcomas. 
However, a disadvantage of this system is that there can be long lag 
periods between implantation and growth of tumours. The first report 
of this heterotransplantation was with a colon carcinoma (155). This 
tumour retained its original histological pattern during 32 passages, 
over 4 years. Further evidence is now available that the human 
tumours transplanted to nude mice maintained the same histological 
features as seen prior to implantation (156). Other features of 
original tumours can be compared with established xenografts. For 
example, isozyme patterns, secretory products like ectopic hormones, 
catecholamines and alpha-fetoprotein, and surface markers like
carcinoembryonic antigen are all preserved in the majority of 
xenografts. However, there are exceptions and alteration in some 
characteristics can be seen with certain xenografts which are 
preserved in passage. It is thought that such changes may represent 
the inherent plasticity and adaption of some tumours to culture 
(157)- Xenografts may be polyclonal, and at certain times a 
selection of some of these clones may occur, which could explain the 
alterations.
One of the difficulties associated with the use of these nude mice is 
that the animals must be protected from pathogens, as they can easily 
be infected as a result of deficiencies in their T cell, lymphocyte 
population and immunoglobulin A production. It is important to 
remember that these animals are prone to bacterial, viral and 
protozoan gastrointestinal infections. A further difficulty is that 
skilled labour is indispensable for the maintenance of human 
tumour/nude mouse system for large scale studies.
If the heterotransplanted tumour has a blood supply, vascularization 
of a xenograft is produced by the mouse tissue. It is thought that 
the tumour instigates angiogenesis (the induction of new capillaries) 
by the host (158). The final architecture of the tumour depends on 
the vasculature and ground substance from the tissues of the nude 
mouse (153). Accordingly, experiments carried out, using this 
particular model, must be interpreted with care. This is because, 
although the tumour originates from human patients, the metabolism 
the tumour tissue is likely to display or the response it may show 
when testing anti-tumour chemotherapeutic agents for activity against
cancer tissue, could be greatly influenced by the infiltrating mouse 
tissues.
Nude mice are thought to metabolise drugs differently from
heterozygous mice as it has been reported that the LDl_r.s of many
bu
antitumour agents in this model are higher than in heterozygotes 
(159)• Houchens et.al. (159) attributed this to an increased hepatic 
microsomal enzyme activity. Factors like this do create difficulties 
when attempts are made to use the nude mouse model to extrapolate 
data to humans. However, systems using heterotransplantation do 
allow multiple investigations that are not possible on primary 
tumours from surgery, which can often be very small in size. 
Clearly, the use of a multiple approach is a major advantage, 
although utilizing xenografts as an experimental system is limited by 
changes which can occur during growth and passage into animals (157)•
For the purpose of the present investigation, xenografts growing 
subcutaneously in the dorsal region of the host were removed from 
nude mice and cultured as short-term explants in the same way as that 
used with the human tissue from surgery. As human tumours of lung 
and colon had been used from surgery, heterotransplants originating 
from tumours in these organs were chosen (Table 35). This procedure 
enabled a comparison to be made of 1-naphthol metabolism in explants 
of the xenografts with those of tumours fresh from surgery. It is 
important to stress that the explants of the xenografts might have 
been comprised of cells of mixed origins, combining both human tumour 
and mouse cells. Thus, clearly the metabolism seen with these 
samples must be interpreted with care. A summary of major advantages 
and disadvantages of the use of heterotransplantation is given in 
Table 36.
TABLE ^5: Characteristics of Human Xenografts Used in This
Investigation
Xenograft Tissue of Origin Characteristics
PXN/1 Colonic
Adenocarcinoma
Acinar structures are present with 
necrotic material in lumina. There is 
some lymphoid infiltration. The 
stromal tissue is variable.
P76 Colonic
Ad enocarcinoma
Acinar structures are present with 
little stroma and occasional pockets of 
lymphoid infiltration.
PXN/5 Large Cell 
Anaplastic 
Carcinoma of 
the Lung
Variation in cell type and in 
quantities of fibrous stromal tissue is 
seen. There are always large numbers 
of polymorphs.
PXN/21 Oat Cell Carcinoma 
of the Lung
Original oat cell morphology has 
gradually disappeared. This tumour is 
now invasive and has highly prolifera­
tive mouse stromal tissue.
P246 Adenocarcinoma of 
the Lung
This has some acinar structure, but the 
amount is variable. This is also true 
of the amount of mouse stroma.
Khan Squamous carcinoma 
of the Larynx
The squamous cells are arranged in 
whorls. There is sometimes 
keratinisation present and some 
polymorph infiltration.
The nude mice were inoculated with human tissue samples by Mervyn 
Jones of the Institute of Cancer Research, Sutton, Surrey.
TABLE 36: The Advantages and Disadvantages of the Use of
Heterotransplants in Nude Mice
Advantages
The' cancerous tissue can be 
maintained either as a solid 
tumour or in an ascites form. 
The latter enables the study of 
the cell kinetics of malignant 
tumours.
Xenografts maintain or preserve 
characteristics of the original 
tumours, including the ability 
to produce hormones.
Xenografts display a resemblance 
to the original tumours in 
histology, enzyme production, 
karyotype and sensitivity to 
anti-cancer agents.
Xenografts can provide a means 
of identification of new anti­
cancer agents of clinical value.
The use of xenografts allows 
multiple investigations that are 
not possible on primary tumours 
which are often small in size.
Disadvantages
There can be long lag periods 
between implantation of 
tissue and growth of tumours.
Nude mice need excellent housing 
and special handling because of the 
risk of infection.
Skilled labour is indispensable for 
maintenance of the human tumour/ 
nude mouse system for large scale 
studies.
The characteristics of the 
xenograft can change over several 
passages.
The human tumour has stromal tissue 
originating from the mouse.
Nude mice metabolise drugs 
differently from other mice.
B: RESULTS
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The metabolism of [1- C]-1-naphthol by the xenografts was
variable, as shown in Table 37. PXN/1 and P76, the colonic adeno­
carcinoma xenografts, formed both glucuronic acid and sulphate ester 
conjugates of 1-naphthol, the former being the predominant metabolite 
at the two substrate concentrations studied in each heterotransplant.
The xenografts PXN/21 and P246 both showed a small amount of 
metabolism at the lower substrate concentration (20 , with no
detectable conjugate formation at the higher concentration (100
The large cell anaplastic lung carcinoma (PXN/5) showed only 
glucuronic acid conjugate formation. Khan, the xenograft from 
squamous carcinoma of the larynx, formed predominately the glucuronic 
acid of 1-naphthol together with a small quantity of the sulphate 
ester conjugate. With the higher substrate concentration, increased 
amounts of metabolites were produced by Khan.
In order to extend some of these results, the conjugation of 1- 
naphthol by the xenograft P246 was studied using a subeellular
fraction, prepared as described in Chapter 2. Using a 10000g 
supernatant fraction,together with appropriate cofactors, 1-naphthyl 
sulphate was extremely low (<0.6$) and was neither time nor substrate
dependent. When the same enzyme fraction was used, but incubated
with UDPGA, 1-naphthyl- ^ 3 -D-glucuronide production was low, but
detectable (one determination was up to 7.3$). However, the 
conjugate formation was neither time nor substrate dependent. The 
low metabolism reflects the results found in culture.
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TABLE 37: Metabolism of f1- Cl-1-Naphthol bv Short-term Organ
Cultures of Xenograft Tissue
Xenograft
1-Naphthol 
( jM)
$ of Total Radioactivity 
recovered in medium as 
conjugates:
1-NS 1-NG
Rate of conjugation 
(nmoles of product/ 
mg protein/24 hours) 
With PAPS With UDPGA
PXN/1 20(2) 5.8 25.6 1.6 7.0
100(2) 3.6 21.1 5.5 30.1
P76 20(2) 6.5 61.6 0.6 5.8
100(2) 5.9 46.5 4.8 39.4
PXN/5 100(2) ND 16.7 ND 41.1
PXN/21 20(2) 1.7 6.6 0.7 2.8
100(1) ND ND ND ND
P246 20(2) 1.2 3.3 0.3 0.9
100(2) ND ND ND ND
KHAN 20(2) 0.2 40.4 0.2 20.5
100(2) 1.2 38.1 2.8 79.2
Legend to Table 37
ND: not detectable; 1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-/3-D-
glucuronide. '
The figures in parentheses are the number of determinations. The two sets of 
results for each determination were not true duplicates as the tissue is not 
necessarily homogeneous. The xenografts were removed from the animals under 
sterile conditions. Short-term organ cultures of the xenografts were set up, 
as described in Chapter 2. The tissues were cultured for 24 hours and the 
culture medium was changed for one containing [1- C]-1-naphthol for 
another 24 hours. The volume of each incubation was 1ml. The amount of the 
radioactivity in the medium at the end of the culture was 45$-85$ of the 
total. Aliquots of the media were analysed for 1-naphthol conjugates by TLC, 
as described in Chapter 2. The results were generally expressed as the mean 
values from two different dishes of explants. Some variability was observed, 
this probably being due to the heterogeneity of the xenograft. The results 
always showed a similar pattern. Tissue samples were taken for 
histopathological examination. The amount of protein per dish ranged from 
0.2 to 2.2 mg.
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C: DISCUSSION
As the tumours were derived from different organs and patients, the 
variation in the metabolism shown by the xenografts is to be 
expected. Also, the xenografts have different amounts of stromal 
tissue from the nude mice (Table 36).
The xenografts derived from a colonic adenocarcinomas (PXN/1 and P76) 
handled 1-naphthol in a similar way to that yielded by human colonic 
adenocarcinomas, i.e. both sulphate ester and glucuronic acid 
conjugates were produced, with the latter predominating.
The lung tumour PXN/21 and lung adenocarcinoma P246 showed little, or 
no, metabolism of 1-naphthol. The latter xenograft also showed 
little, or no, metabolism of the substrate with a 10000g supernatant 
fraction of the homogenized xenograft under optimal conditions. The 
small amount of metabolism, shown under culture conditions, produced 
more glucuronic acid than sulphate ester conjugation. Accordingly, 
this did not give a similar pattern of 1-naphthol conjugation to lung 
tumours from surgery, which were histopathologically, non-squamous. 
For example, the xenograft derived from an oat-cell carcinoma did not 
retain sulphation to anything like the extent of such tumours from 
surgery (Chapter 3).
PXN/5, the xenograft derived from a large cell anaplastic lung 
carcinoma, only showed formation of 1-naphthyl- -D-glucuronide. 
This histopathological tumour type from human patients usually 
yielded both types of conjugates, with the production of the
glucuronic acid metabolite predominating (reference 142 and Chapter 
3).
The xenograft, KHAN, derived from squamous carcinoma tissue of the 
larnyx, showed a great predominance of glucuronic acid conjugation, 
with only a small amount of sulphate ester formation. This is 
slightly different from the metabolism shown by squamous carcinomas 
of the lung obtained from surgery (reference 142 and Chapter 3), 
These samples showed almost exclusive formation of the glucuronic 
acid conjugate.
There has been a report that a colonic adenocarcinoma xenograft 
(HT29R) possessed high levels of p) -glucuronidase (160). If this 
were true of the two xenografts derived from colonic adenocarcinomas 
used in this study (PXN/1 and P76), it would not affect the findings 
presented in this chapter. This is because the conjugates, which 
appear in the medium with short-term organ cultures, are a result of 
the overall metabolism of the substrate within the tissue, i.e. a 
balance of the relative rates of synthesis and hydrolysis of the 
metabolites.
D: CONCLUSION
The contribution of the mouse stromal tissue to the observed 
metabolism is unknown. However, it is interesting that the 
xenografts tend to metabolise 1-naphthol in a similar way to the 
human surgical samples. Certainly, like the surgery samples, more 
glucuronic acid than sulphate ester conjugates were formed. Thus, 
the use of nude mice with xenografts as a model for maintaining human 
tumours with a blood supply may be justified for metabolism studies 
of xenobiotics and chemosensitivity testing of new anti-cancer drugs. 
This conclusion would be particularly true if the drug were to be 
metabolised by the tumour. Clearly, further work needs to be done to 
establish the presence, if any, of Phase 1 drug metabolism in the 
xenograft tissue.
CHAPTER 7
ROUTES OF CONJUGATION OF 1-NAPHTHOL BY RODENT COLON AND 
LUNG IN SHORT-TERM. J5XPL ANT CULTURE
INTRODUCTION
RESULTS
DISCUSSION AND CONCLUSION
A: INTRODUCTION
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Traditionally, the metabolism of foreign compounds has been studied 
in animal tissues. Primarily, this has been an accompaniment to 
toxicity testing, in order to improve understanding of the way in 
which the test animal metabolises xenobiotics. Secondly, metabolism 
studies ,with tissues from laboratory animals are undertaken because 
of the ease of the availability of tissue and, also, due to the fact 
that these animals are kept under controlled conditions. However, 
there are a variety of problems which arise when extrapolating 
metabolism data obtained from experimental animals to man. For 
example, there is considerable difficulty, without obtaining some 
human data, in deciding whether the metabolic patterns and toxicity 
from foreign compounds which arise from experimental animals will be 
relevant to the way human beings may handle such xenobiotics
and,thus, whether they will be toxic. For example, N- 
acetylaminofluorene (AAF) is not toxic to the guinea pig and thus, 
this finding on its own, could be taken as an indication that this 
compound would be non-toxic to humans. However, it is thought that 
this compound, AAF, is carcinogenic to many species, including man 
(160a). The first step in activating AAF to the carcinogen is N- 
hydroxylation. The guinea pig is thought not able to carry out such 
a reaction, although many other species, including man, can
metabolise AAF to N-hydroxy-AAF. Thus, without knowledge of 
metabolic pathways both in experimental animals, like the guinea pig
and in man, the relevance of animal metabolism to human metabolism
cannot be decided.
Nevertheless, by using a controlled environment with a relatively
homogeneous genetic population of laboratory-bred animals, a 
reproducible experimental situation can be organized. In this way, 
when a foreign compound is administered to one group of animals, any 
pharmacological or toxic effect can be seen by direct comparison with 
the control group. Any significant difference between the 
experimental and the control groups can be clearly established in 
such a situation. However, it is difficult to decide whether a 
positive toxic response in an animal is relevant to man. Absorption, 
distribution, metabolism and excretion of a compound are all factors 
which contribute to toxicity, but these may differ between man and 
animals and also between different groups of people, particularly as 
the human race is genetically very heterogeneous.
However, most of the experimental work in the present investigation 
has been concentrating on studies of metabolism in human tissue. 
This procedure was undertaken because it was felt that an increased 
knowledge of human metabolism is essential for both better drug 
design and an improved ability to extrapolate data obtained from 
experimental animals to man.
The purpose of the work reported in this chapter was to investigate 
the pathways examined in earlier chapters and to compare the 
metabolism from some animal tissues with that obtained from human 
tissues. Accordingly, normal rat colon and mouse lung were both 
studied. Several mice, having been injected with urethane once (see 
Materials and Methods Chapter 2, p 53) developed lung tumours 
(adenomas). An example of the histopathological appearance of one of 
those adenomas is given in Fig. 46.
Figure 46  = Mouse Lung Adenoma : Fresh x i 6 0
Legend to Figure, 46
This photograph illustrates the histopathological appearance of a 
urethane-induced lung adenoma from a male AJAX mouse. The lungs from 
which this tumour was dissected were studded with pearly-white, 
glistening, discrete round nodules, often situated just below the 
visceral pleura. The tumours are devoid of capsules and tend to 
infiltrate and compress the surrounding pulmonary tissue (Fig. 46). 
These adenocarcinomas usually consist of a uniform adenomatous 
pattern, comprising closely packed columns of cuboidal or columnar 
cells (130).
By use of the adenomas and normal lung tissue from these mice, this 
gave a convenient model for comparison with surgical samples, these 
comprising human lung and tumour tissue from the same patient. 
However, it should be noted that these adenomas are not a 
satisfactory tumour model for lung cancer in man. 
Histopathologically, the tumours most commonly found in humans are 
not adenocarcinomas, but either squamous cell or oat cell carcinomas. 
Also, the production of lung cancer in man usually takes a longer 
time to be produced with, for example, years of exposure to cigarette 
smoke. The induction of lung adenomas in mice with a single 
injection of urethane is in sharp contrast to this.
B: RESULTS
From Table 38, it can be seen that in short-term explant culture, 
colon from the rat metabolised 1-naphthol to both sulphate ester and 
glucuronic acid conjugates. However, it is clear that the formation 
of the glucuronic acid conjugate predominated.
The results of conjugation with 1-naphthol in short-term explant 
culture of mouse lung from both urethane-treated and control animals 
have been summarised in Table 39• In the urethane-treated mice,
glucuronic acid conjugation predominated in the adenomas, normal lung 
adjacent to these tumours, and normal lung at a distance from the 
tumours. However, sulphate ester conjugation was detectable. The 
mice tracheas produced both types of metabolites, although the 
formation of glucuronic acid conjugates predominated.
In the control mice, the same pattern of conjugation was seen in both 
the normal lung and trachea.
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TABLE 38: Conjugation of f1- Cl-1-Naphthol bv Short-term Explant
Cultures of Rat Colon
Culture
mg
protein/
dish
% Radioactivity 
recovered as 
1-NS 1-NG
Rate of Conjugation 
(nmoles 1-NS (nmoles 1-NG 
produced/hour/ produced/hour/ 
mg protein) mg protein)
1 3.87 0.1 ND <0.01 ND
2 5.93 0.4 1.2 0.02 0.06
3 4.03 5.0 23.7 0.03 0.15
4 2.87 2.8 57.1 0.02 0.50
Legend to Table 38
ND: not detectable; 1-NS: 1-naphthyl sulphate;
1-NG: 1-naphthyl-fb -D-glucuronide.
Short-term explant cultures of rat descending colon were cultured for either 90 
minutes (cultures 1 and 2) or 18 hours (cultures 3 and 4) on gelatin sponge in 
4.5^ of the supplemented CMRL-1066 (made up as for human colon) containing 
[1- C]-1-naphthol (10 ^ UM). The amount of radioactivity in the medium at the 
end of the cultures was between 6H% and 87$ of the total. Aliquots of the media 
were analysed for 1-naphthol conjugates by TLC, as described in Materials and 
Methods (Chapter 2, p 53)•
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TABLE ^Q; Conjugation of f1- Cl-1-Naphthol bv Short-term Explant
Cultures from Normal Mouse Lung and Lung Adenomas
Animal
Average % 
recovery of 
radioactivity 
Tissue in medium
%
radioactivity 
recovered as 
1-NS 1-NG
Rate of conjugation 
(nmoles 1-NS (nmoles 1-NG 
produced/ produced/
24 hours/mg 24 hours/mg 
protein) protein)
Tumours
(Adenomas)
72.9 0.4 43.4 2.1-2.9 113.8-44.8
Urethane-
Normal 
peripheral 
lung adjacent 
to tumours
79.4 1.0 45.7 2.7-2.1 109.4-17.6
Treated
Animals
Normal 
peripheral 
lung at a 
distance to 
tumours
80.4 0.9 37.5 3.1-2.2 119.1-17.5
Trachea 73.8 11.3 34.9 38.3-25.1 110.9-60.6
Control
Normal
peripheral
lung
72.2 2.8 47.4 4.6-3.2 65.0-22.4
Animals
Trachea 75.1 11.7 36.3 35.9-17.7 106.9-36.6
Legend to Table 3Q
1-NS: 1-naphthyl sulphate; 1-NG: 1-naphthyl-yO-D-glucuronide,
Short-term organ cultures of normal mouse peripheral lung tissue, tracheas and 
tumour tissue were cultured for 24 hours,at 37 C,on gelatin sponge in 2.5ml of 
supplemented CMRL-1066 medium (made up as for human lung). After 24 hours, the 
culture medium was changed for one containing [1- C]-1-naphthol (20 j j M ,  2.5ml) 
and the tissue was then incubated in this for a further 24 hours. Aliquots of 
the media were analysed for 1-naphthol conjugates by TLC, as described in Chapter 
2, p 53. The protein present in the cultures ranged from 0.10mg to 0.67mg. The 
results are expressed in the form m-s.d. where m is the mean of either five
or six determinations (culture dishes) and s.d. is the standard deviation. Six
urethane-treated mice and five control animals were used. *
* A cautionary note seems appropriate on giving too much precision to the 
interpretation of any (m-s.d.) values obtained from a small number of 
measurements. For example, if one of these measurements deviates widely from the 
central tendency of the others, then this will distort both the resulting mean
and standard deviation. Nevertheless, the (m-s.d.) values obtained were
still used as they do give a reasonable indication of the central tendency and 
spread for almost all the cases considered.
C: DISCUSSION. AND CONCLUSIM
When using organ culture the routes of conjugation of 1-naphthol in 
rat and human colon are clearly different. With normal human colonic 
mucosa in short-term explant culture, 1-naphthol was metabolised to 
both sulphate ester and glucuronic acid conjugates, with the former 
predominating (Chapter 3). This result is in sharp contrast to the 
conjugation of 1-naphthol by short-term explant culture of normal rat 
colon, where glucuronic acid conjugation predominated. However, with 
the rat cultures, the explants comprised of the whole colon wall. 
The human explants were the mucosal layer of the colon wall only, 
without the muscle. However, the comparison is still valid, as 
experiments using isolated mucosal cells from rat colon show the same 
pattern of conjugation as the whole wall colonic explants (161).
The results with mouse lung, provided a contrast to those produced 
with both normal human lung and tumour tissue (see Chapter 3). With 
human surgical samples in short-term explant cultures, the tumour 
metabolised 1-naphthol in a different way when compared with that 
obtained from normal peripheral lung. In this context, there are two 
differences to stress. First, the pathway of metabolism was altered 
in that the human tumour had a lower, or negligible, production of 
sulphate ester conjugates when compared with that yielded from normal 
lung. The formation of glucuronic acid conjugates was seen in these 
human tumours; in the squamous type, this was exclusive, with little, 
if any, 1-naphthyl sulphate production. The normal lung did not 
metabolise 1-naphthol to 1-naphthyl-/^ -D-glucuronide, but only 1- 
naphthyl sulphate. Thus, with the human tissue, there was a bio­
chemical change in pathway from the normal lung to tumour tissue in 
short-term organ culture. However, the animal tissue in culture 
showed no biochemical difference between normal lung and tumour 
tissue. The metabolic pattern remained unchanged between the normal 
mouse lung and adenomas. Secondly, the percentage metabolism 
produced in the tumour was lower than that obtained from normal 
tissue. The percentage metabolism in normal mouse lung and adenomas 
was approximately equal.
Thus, in mouse lung in short-term culture there was a contrast to the 
situation encountered in human peripheral lung in culture. This 
suggested that there was a major difference in the abilities of the 
lungs from the two species to conjugate phenolic substrates. Short­
term organ cultures of mouse lung metabolise 1-naphthol in the same 
way as similar cultures from rat lung (134).
With both examples, rat colon and rodent lung, the metabolism of 1- 
naphthol in the corresponding human tissue was different. Results 
like this, make it difficult to extrapolate data from rodents to man 
when it involves the metabolism of phenolic compounds, particularly 
if it is thought that the xenobiotics act on these extrahepatic 
tissues.
The difference in metabolism of 1-naphthol in these animal and human 
tissues could be due to different levels of hydrolysing enzymes. For 
example, a higher level of aryl— sulphatase in the animal tissues 
would explain the lack of sulphate ester conjugates observed. 
However, the difference between rodent and humans in the conjugation
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of 1-naphthol could be that the sulphotransferase in human tissue has
a higher affinity (lower K ) for the substrate when compared withm
this enzyme in rodent tissue.
Neither rat colon nor mouse lung would appear to be satisfactory 
models for 1-naphthol conjugation in the corresponding human tissues.
v
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A: INTRODUCTION
The rationale for the research work presented in this thesis had been 
the need to examine some drug-metabolising pathways in normal and 
tumour tissue. Sulphate ester and glucuronic acid conjugation 
reactions were investigated, in particular, using human specimens and 
material derived from human surgical samples. In order to carry out 
this study, there were several experimental systems available in 
which human tissue could be used.
All such systems are in vitro methods, each of them having various 
advantages and disadvantages. For the purpose of providing samples, 
human tissues, both normal and tumour, were obtained from surgery and 
studied in short-term explant culture. It is necessary to bear in 
mind that although tissue specimens, once removed, will begin to 
degenerate, the major advantage of using this system is that the 
tissue is maintained with its three-dimensional architecture. Thus, 
this procedure will mimic the in vivo situation quite well as 
cellular inter-relationships are preserved.
It is possible for human tissue, also from surgery, to be homogenized 
and made into subcellular fractions, these then being used with 
optimal incubation conditions to assay enzyme activity; this being a 
widely employed biochemical experimental system. The main advantage 
of such a system is that the technique of producing the tissue 
fractions is relatively easy to implement and the incubations can be 
totally controlled. However, in obtaining the sub-cellular 
fractions, the cells of the tissue are disrupted leading to a loss of
cellular and organelle inter-relationships. Accordingly, this use of 
parts of cells produces an experimental system where the in vivo 
situation is not mimicked at all.
Human tumour cells are now available as cell lines, these being 
derived from surgery or autopsy samples. Such cell lines do not have 
the difficulties of widespread disruption which occurs with sub- 
cellular fractionation. Nevertheless, the tumour cells which grow as 
lines do tend to be a selected population. Thus, various 
characteristics of tumours in vivo may be removed by this process and 
others, unknown to the original tumour, could be introduced by 
passaging. Cell lines derived from normal tissue consist of 
fibroblasts or are derived from foetal tissue and are able to survive 
in culture. However, normal control cells for most tumour cells 
would be adult and epithelial in origin. There are some cell lines 
which are commercially available which are derived from normal adult 
epithelial cells, although these cell lines can become overgrown with 
fibroblasts and are most likely to have altered characteristics. For 
example, normal cells should not be able to survive for long in 
culture, but, as cell lines, they do. For the purposes of having 
true controls for work with the tumour cell lines, normal cell lines 
from lung, bronchus and colon are needed, but are not available. 
Thus, in examining biochemical parameters in the tumour cell lines 
there were no normal controls for comparison. Nevertheless, some 
control is certainly needed to understand how biochemical pathways 
alter, if at all, between normal and cancerous cells in culture.
In the present research, human tumour pieces were investigated as
heterotransplants, maintained in nude mice. These xenografts are 
human tissue preserved and growing in a similar situation to the in 
vivo one. However, the blood supply and stroma of the tumour which 
grows in the mice are clearly not of human origin. The influence of 
mixing mouse and human tissue on the metabolism observed from 
xenografts does present certain difficulties.
There is, of course, no difficulty in obtaining tumour and normal 
tissues from animal models. However, the metabolic pathways present 
in normal animal tissues are not always the same as those found in 
normal human tissue. Thus, the biochemical characteristics of animal 
tumours are not necessarily those of human tumours, which makes any 
direct extensions of findings from animal models to human disease 
hazardous.
B: A SUMMARY OF RESULTS FOUND. IN. THIS. RESEARCH
Having utilized these different experimental systems to study 1-
naphthol metabolism, a comparison of sulphate ester and glucuronic
acid conjugation reactions was then possible. With human surgical
samples in explant culture, normal peripheral lung, incubated with 
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[1- C]-1-naphthol, the major metabolite formed was the sulphate 
ester conjugate with little, or no, glucuronic acid conjugation. 
This confirmed previous published observations by other writers (134, 
162). With human lung tumour tissue, the metabolism of 1-naphthol 
varied with the histological classification of the tumour. In 
particular, the tumour tissue from patients with squamous cell 
carcinoma metabolised 1-naphthol predominantly to its glucuronic acid 
conjugate, with little, if any, sulphate conjugate being formed, 
although other types of human lung tumour (non-squamous carcinomas) 
did show a greater variability in the routes of conjugation. 
However, when compared with the normal lung, the formation of 1- 
naphthyl sulphate was decreased and there was an appearance of the 
glucuronide conjugate. Whole bronchus in culture produced a variable 
pattern of conjugation. Thus, generally, although both conjugates 
were formed, at low concentrations 20 yuM 1-naphthol), the
production of 1-naphthyl sulphate certainly predominated. At similar 
substrate concentrations,bronchus without the cartilage, bronchoscopy 
samples, which usually consisted of bronchial epithelium and lamina 
propria of the bronchus wall, and a primary culture of cells from 
human bronchial epithelium, all formed 1-naphthyl- -D-glucuronide 
predominantly. It is difficult to know which pathway of conjugation 
would predominate in vivo. Thus, the presence of the cartilage,
which appears to be virtually inert on its own, may provide some 
extra inorganic sulphate for the formation of PAPS to be used in the 
bronchial epithelial layer. However, the difference in conjugation 
between the whole bronchus and the tissue from which cartilage has 
been removed, may be due to the fact that by stripping off the upper 
layer containing the bronchial epithelium, cellular damage may have 
been incurred. The influence of cartilage on the bronchial 
epithelial layer may be an artefact of the culture system. Sulphate, 
in some form, could leak out from the cut ends of the cartilage and 
be taken up by the upper epithelial layer. However, for example, it 
is likely that if this occurred with the sulphate anion, a carrier 
would be involved in the transport of this ion across biological 
membranes, as has been reported for erythrocytes (163).
It was established that normal colonic mucosa showed the production 
of both sulphate ester and glucuronic acid conjugates. However, it 
was also found that the formation of 1-naphthyl sulphate predominated 
at low concentrations. At similar substrate concentrations, colonic 
tumour tissue formed both conjugates, but in contrast to the normal 
tissue, 1-naphthyl-y6-D-glucuronide was the most prevalent.
Human lung tissue, both normal and tumour, not used for explant 
culture, was homogenized and subcellular fractions were prepared by 
centrifugation. The incubations, with 1-naphthol, using the 10000g 
supernatant fractions from both normal lung and tumour mimicked the 
pattern of conjugation seen in the short-term culture. Sulphation 
was the predominant pathway in the normal tissue and glucuronidation 
more prevalent in the squamous tumour tissue. There was only
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sufficient tissue from normal lung to make microsomes. The 
incubation of the microsomal preparation with the appropriate 
cofactors showed that the normal lung does possess an active UDP- 
glucuronosyltransferase. However, it is important to stress that, on 
its own, such a result could give a grossly misleading representation 
of the ability of the normal lung to conjugate 1-naphthol. From 
reported work in this area, it is clear that many research workers 
only use microsomal preparations to study glucuronidation. When a 
researcher does this, such an approach would give a different picture 
of the conjugation in normal lung from that obtained with the system 
of short-term culture of whole pieces of tissue, which must be more 
representative of the in vivo situation. Competition for the 
substrate by phenol sulphotransferase and UDP-glucuronosyltransferase 
occurs in vivo and, under such circumstances, the enzyme with the 
lower apparent Kffi, and thus a great affinity for the substrate, 
will produce more conjugates. By preserving tissue architecture, as 
in the explant culture system, the pattern of conjugation of a 
substrate is a reflection of the relative values for competing 
enzymes, the ability of the tissue to generate its own cofactors and 
their availability at the relevant compartment. In contrast, enzyme 
activity observed with a subcellular fraction is an indication of the 
intrinsic ability of a tissue to carry out a reaction.
In the present investigation, the 10000g supernatant fractions from 
normal human lung were also used to assay sulphotransferase and UDP- 
glucuronosyl transferase with oestrone and oestradiol as substrates. 
Both these steroids gave much lower activities than 1-naphthol and 
both showed a different pattern of conjugation. With oestrone, both
normal and tumour tissue from lung showed a predominance of 
glucuronidation. Oestradiol gave a different pattern of conjugation, 
with more sulphate ester than glucuronic acid conjugates being formed 
in normal lung, but producing similar amounts of both conjugates in 
the tumours.
The 10000g supernatant fractions, from colonic mucosa and tumour, 
produced both 1-naphthyl sulphate and 1-naphthyl-^/3 -D-glucuronide. 
However, in both normal and tumour the formation of glucuronic acid 
conjugates was low. Thus, the incubations with the 10000g 
supernatant fractions using 1-naphthol as substrate did not reflect 
the pattern of conjugation seen in the short-term explant culture. 
Here, the glucuronidation was the predominant conjugation pathway in 
the tumour tissue. Again, a cautionary attitude to this finding is 
essential, as the result could be most misleading, taken on its own, 
because it does not mimic the pattern seen in organ culture.
As with the lung tissue, it was found that the metabolism of the 
steroids, oestrone and oestradiol, to sulphate ester and glucuronic 
acid conjugates was very low when compared with the formation of 
conjugates from 1-naphthol.
The results of incubating human bronchial carcinoma cell lines with 
1-naphthol produced a pattern, generally, which reflected the 
conjugation seen in the lung tumours from surgery in short-term 
culture. An extensive formation of 1-naphthyl-y3-D-glucuronide with 
little sulphate ester conjugation was observed by the poorly 
differentiated squamous cell carcinoma cell lines. It was noted that
cell lines derived from non-squamous carcinomas of the lung showed 
variability in the conjugation pathways, similar to that observed 
with such tumours in explant culture. However, the tumour cell lines 
derived from colonic adenocarcinomas did not reflect the conjugation 
pathway pattern seen in short-term explant culture from surgical 
samples. Moreover^the cell lines showed almost exclusive production 
of the glucuronic acid conjugate while the colonic tumours at the 
same substrate concentration formed both conjugates, the 1-naphthyly<3 
-D-glucuronide predominating. However, the formation of 1-naphthyl 
sulphate may be because the colonic tumour explants contain normal 
mucosa cells. The sulphate ester conjugates formed by the "tumour11 
could actually be produced from the normal cells present. Some 
normal cells were occasionally seen in histological sections of 
tumour (Fig. 33). If the sulphate ester conjugation observed in 
tumours was due to normal cells, the cell lines from colonic 
adenocarcinomas may be a good model of conjugation in colon tumours.
The results of culturing explants from xenografts tissues, derived 
from human surgical samples with 1-naphthol produced a pattern of 
conjugation which, in some ways, reflected that seen with human 
tumours in culture. The two xenografts originating from colonic 
adenocarcinomas formed both conjugates, although 1-naphthyl--D- 
glucuronide did predominate. It was further demonstrated that the 
metabolism produced from the lung tumour xenografts was similar to 
the squamous cell carcinoma-type of metabolism observed in short-term 
culture, even though not all the xenografts were derived from this 
type of tumour. However, all the xenografts did produce more 
glucuronide than sulphate ester conjugates.
As a comparison with the work done when using human tissues, short­
term cultures were made with rat colon and mouse lung. Each of these 
rodent tissues produced a sharply contrasting pattern of conjugation 
to the corresponding human tissue. In rat colon, glucuronidation was 
the predominating conjugation pathway, while in the normal human 
colon, sulphation was prevalent. On the other hand, normal mouse 
lung produced a much greater rate of production of glucuronic acid 
than sulphate ester conjugates. In this context, the major metabolite 
from 1-naphthol incubation with normal human lung was 1-naphthyl 
sulphate with little, if any, glucuronic acid conjugate being formed. 
It was interestingly noted that mouse lung adenomas showed the same 
conjugation pattern as the normal mouse lung. Thus, it was confirmed 
that, in the same experimental system, rodent tissues from lung and 
colon do not conjugate 1-naphthol in the same way as human tissue 
from surgery. There was clear evidence that mouse lung adenomas did 
not produce a different pattern of conjugation from the normal 
tissue. Thus, such an animal model does not in any way represent the 
human metabolism of a phenolic substrate like 1-naphthol.
The results of 1-naphthol conjugation in the different experimental
systems are summarised in Table 40. Overall, it would appear that
normal human lung metabolised 1-naphthol to 1-naphthyl sulphate with 
little, if any, glucuronic acid conjugate being formed. There was 
evidence to suggest that human lung tumours metabolised 1-naphthol 
differently when compared with the normal peripheral lung. In
particular, most of the lung tumours showed an emergence of
glucuronidation, the squamous cell carcinomas producing 1-naphthyly<; 
-D-glucuronide with little, if any, 1-naphthyl sulphate. These
TABLE 40: 1-Naphthol Conjugation in Different Experimental Systems
(+ : an indication of the extent of conjugation)
Svstem Tissue Sulohation Glucuronidation
Short-term
Explant
Culture
Peripheral Lung 
Squamous Lung Carcinomas
++++
+ +++
Lung Carcinomas excluding 
Squamous +++ +
Whole Bronchus ++ +
Upper Bronchus Layer
containing epithelial cells + ++
Cartilage (+)
Normal Colon +++ +
Colon Adenocarcinomas + ++
Subcellular 
Fractions 
10000g SN
Peripheral Lung 
Squamous Lung Carcinomas
++
+
+
++
Normal Colonic Mucosa ++ +
Colon Adenocarcinomas ++ +
Cell Lines Bronchial Cell Lines 
- poorly differentiated 
epidermoid +++
Other Bronchial Cell Lines + +
Colonic Adenocarcinoma Cell 
Lines ++
Primary Cell 
Culture Bronchial Epithelial Cells ++
Xenograft Lung ++
Colon + ++
Short-term
Explant
Culture
Rat Colon
Mouse Peripheral Lung 
Mouse Adenoma from Lung
++
++
++
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findings supported the results obtained, in the present work, when 
undertaking studies with human lung cancer cell lines and xenografts 
derived from human tumour specimens.
Experiments with the human colonic tumours showed a similar change to 
the lung tumours in conjugation of 1-naphthol when compared with 
normal colonic tissue. There was a marked shift from sulphation to 
glucuronidation observed from normal colon to tumour tissue.
However, the human colon differed from the human lung in that both 
conjugates were clearly formed in both normal and tumour tissues,
although the proportion of each conjugate produced by normal and 
tumours was different. These findings supported those results 
arising from the study with xenografts derived from human tumour 
specimens. Importantly, it was established that the cell lines
originating from colonic adenocarcinomas produced almost exclusively 
the glucuronic acid conjugate and, accordingly, such lines did not 
reflect the metabolism seen in short-term culture of surgical colon 
tumour samples.
Undoubtedly, there seemed to be a general indication that the normal 
human tissue, from both lung and colon, produced more 1-naphthyl- 
sulphate, while tumours from these organs often formed more 1-
naphthyl- j$ -D-glucuronide in all the experimental systems. The 
exceptions to this were the subcellular fractions prepared from human 
colon adenocarcinomas and the non-squamous lung tumours in short-term 
culture.
C: A DISCUSSION OF THE POSSIBLE REASONS FOR A DIFFERENCE IN
CONJUGATION PATHWAYS BETWEEN NORMAL AND TUMOUR TISSUES.
There are several reasons which could explain the alterations in 
conjugation reaction observed between normal and tumour tissues. 
These are summarised in Table 41.
(1) Hvdrolvtic Enzvmes
The changes in conjugation observed between normal and tumour tissue 
may be affected by alterations in ft -glucuronidase and aryl-- 
sulphatase. These may be elevated in tumours (164, 165).
Accordingly, to explain a lower sulphate ester conjugate production 
in tumour tissue, there would need to be an increased aryl-sulphatase 
when compared with normal tissue. Such an increase has been reported 
in several solid human carcinomas, including colorectal carcinoma 
(165). More recently, however, Morgan et.al. (167) demonstrated that 
only 24JS of tumours from patients with adenocarcinoma of the colo­
rectal regions had elevated levels of arylsulphatase B. Thus, 
elevated levels of arylsulphatase B in the colonic tumour tissue 
could explain some of the differences in conjugation observed in this 
thesis. However, preliminary studies (168) showed little, if any, 
differences in hydrolytic enzymes ( ft -glucuronidases and aryl- 
sulphatases) between normal and tumour tissue from human colon to 
explain the alteration in conjugation pathways.
When working with lung tumours, Gasa et.al. (164) found that there 
were significantly higher activities of arylsulphatases A and B in
TABLE 41: Possible Reasons for Alterations in Conjugation Observed
Between Normal and Tumour Tissues
There could be changes in hydrolysing enzymes.
There could be changes in the ability to generate cofactors for 
conjugation.
There could be alterations in enzyme protein.
Changes may be connected to alterations in cell-surface 
glyco saminoglyc an s.
Changes could be linked to alterations in energy metabolism in tumour 
cells.
almost all the lung tumours of squamous and adenocarcinoma
histopathological typing, when compared with corresponding uninvolved 
normal tissues. In addition, these workers found another aryl-
sulphatase activity in the tumours which was not detected in their 
work with normal human lung. These findings are compatible with the 
results in this project of reduced, or absent, sulphate ester
conjugate formation in lung tumours when compared with normal ones.
However, it has also been reported that many human tumour tissues, 
including those from colon, lung, breast, stomach, uterus, ovary and 
penis, have been shown to possess a higher ft-glucuronidase activity 
than adjacent uninvolved tissue (165). Thus, there do not appear to 
be established differences in these hydrolases to explain the clear 
changes in conjugation observed between normal lung and colon, and 
tumour tissues. The activity of /3-glucuronidase has also been
reported to be high in transplantable experimental tumours in mice
(169) and has been enhanced in a chemically induced sarcoma in a rat
(170).
Nevertheless, the possibility that the difference could be explained 
by alterations of fb-glucuronidase and arylsulphatase activities 
should be further investigated in the same tissues where the 
conjugation reactions are also studied.
(2) The Ability to Generate Cofactors for Conjugation
The differences in conjugation could be explained by changes in the
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ability to generate the appropriate cofactors. If tumour tissue had 
a lower ability or lack of enzymes to enable synthesis of PAPS, this 
might explain the preference for glucuronidation shown by neoplasms 
in the present study. Alternatively, raised UDPGA levels in the 
tumour or increased ability to produce UDPGA when compared with 
normal tissue may be another explanation for this difference.
(3) Enzvme Protein Levels
However, maybe an alteration in enzyme protein(s) could provide the 
explanation for the change in conjugation patterns between normal and 
tumour tissue. Changes in enzyme levels and patterns in both animal 
and human tumours, when compared with normal tissue, have been found 
in various investigations (171-179). In this context, it is 
noteworthy that experiments with both rodent and human foetal and 
neoplastic tissue have demonstrated a biochemical resemblance between 
the cancerous and embryonic tissue (173> 178, 179). Thus, it would 
be interesting to see if drug conjugation pathways in human lung and 
colonic foetal tissues mimicked those seen in human tumour tissue 
from these organs. However, it is generally considered that 
glucuronidation is low, or undetectable, in early foetal or embryonic 
tissues (112). The deficiency of glucuronidation in human babies has 
led to the deaths of many such infants receiving chloramphenicol 
(180). Although there is only a limited amount of evidence, 
sulphation seems to be more important, foetally and perinatally, than 
glucuronidation (181). Mostly, foetal liver is examined for drug 
metabolising ability, but there is a report that human foetal lung 
tissue can produce 1-naphthyl sulphate from carbaryl (182), Thus,
human foetal lung gives a conjugating pattern comparable to the 
normal adult human lung and not similar to human lung tumours.
Nevertheless, if changes in enzyme protein are responsible for the 
differences in conjugation seen in the present investigation, this 
could mean that, for example, in squamous cell carcinomas, phenol 
sulphotransferase may be either absent or defective. This enzyme 
appeared to be absent, or inactive, in the poorly differentiated 
squamous cell line (Ben) derived from a lung tumour (Chapter 5, 
p171). The significance of this to squamous cell carcinomas in 
general, is unknown.
(4) The Relationship to Glvcosaminoglvcans
The relationship, if any, of these changes in conjugation to tumour 
development and progression is obscure. Nevertheless, such changes 
may be connected to alterations in cell-surface glycosaminoglycans. 
In colonic tumours, there is an alteration of the type of 
glycoproteins secreted in the mucous. A large proportion of colonic 
mucins from normal human colon consists of sulphomucins, whereas in 
colonic tumour tissue a marked decrease, or absence, of sulphomucins 
is accompanied by an increase in sialomucins (183). However, it has 
also been found that normal colonic mucosa adjacent to, and remote 
from, colon carcinomas show a shift towards sialomucins (184, 185).
In contrast, in lung tumours, a reduction in sulphated 
glycosaminoglycans is not seen in tumour tissues classified as 
squamous, oat cell or adenocarcinomas (186). There is evidence which
has shown that there is an increase in the total glycoproteins 
observed, as well as there being higher sulphated glycosaminoglycans 
in the tumours than arises from normal tissue (187). Thus, this 
contradicts the finding obtained with the colon. If the sulphation 
of glycosaminoglycans is related to xenobiotic sulphate ester 
conjugation, then much less sulphated glycoproteins should be seen in 
lung tumours. However, sulphate ester conjugation is produced by 
soluble cytosolic enzymes (67)* e.g. phenol sulphotransferase, while 
at least some of the glycosaminoglycan sulphotransferases and the 
cerebroside sulphotransferases are particle-bound, in the latter case 
to either the microsomal fraction of the cell (76) or the Golgi 
apparatus (77). In addition to the increase in sulphated 
glycosaminoglycans in both squamous cell and adenocarcinomas, 
activity of cerebroside sulphotransferase was significantly higher in 
the latter tumours when compared with that in the other histological 
types of tumour and in normal lung (188). A further example of 
biochemical similarity between neoplastic and foetal tissue is that 
chick embryonic lung can synthesise a novel class of sulphated 
glycoproteins (189).
Other changes in glycosaminoglycans have been noted in tumours and in 
transformed cells. With cell lines derived from mouse mammary 
adenocarcinoma, subpopulations of cells had different 
glycosaminoglycans. A cell line which was slow-growing, and did not 
grow in soft agarose, had more heparan sulphate than a cell line 
which was aggressive in vivo and did grow in agarose (190). Thus, 
the cell line, which appeared more poorly differentiated, had less 
sulphated glycosaminoglycans. In this context, it would be
interesting to know the drug conjugation patterns of these cell lines 
to see if they were related to the synthesis of glycosaminoglycans.
As findings in the present investigation indicated that tumour cells 
form glucuronic acid conjugates more than sulphate ester conjugates, 
in contrast to the corresponding normal tissues, it is of interest 
that the tumour promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) 
inhibits the synthesis of a sulphated proteoglycan in cartilage in 
chondroblasts from chick embryos (191). Thus, this promoter induces 
the transformed phenotype which has less sulphation than the normal 
tissue. This finding supports the fact that sulphation as a 
xenobiotic detoxification pathway does not seem to be used as much in 
tumour cells as glucuronidation. The link between the drug- 
metabolising pathway and the production of sulphated 
glycosaminoglycans is that it is assumed (69) that the latter process 
is dependent on the formation of PAPS, as indeed is the former. 
Thus, if the availability of PAPS is diminished, both processes would 
be limited.
(5) Energy Metabolism In Tumour Cells
The fact that tumour tissues show more glucuronidation than 
sulphation could be linked with the rest of the biochemical pathways 
present in the cancer cells which are different from the normal ones. 
There is a tendency for the varied normal patterns of enzyme activity 
found in specialized,differentiated cells to converge toward a common 
pattern in malignant tissue (171). It has been shown that tumour 
cells show a biochemical profile concomitant with growing tissue.
Thus, under these circumstances, anabolic pathways are increased and 
the enzyme activities of catabolic pathways are decreased. These 
alterations in enzyme patterns, in neoplastic tissues of the rat, 
have been clearly defined (172, 173). Also, more recently, the
enzymology of human colonic tumours (174, 175, 176) of human colonic 
cell lines and xenografts (177) and of human lung tumours (178, 179) 
have all been investigated. All show that the tissue has elevated 
levels of enzymes essential in the processes for rapid growth, as for 
example: hexokinase, thymidine kinase and CTP synthetase. It has 
been known since the 1920s that malignant cells exhibit high rates of 
glycolysis. For example, Warburg (192, 193) established that tumour 
cells have the capacity to produce large quantities of lactic acid 
from glucose and display an abnormally weak Pasteur effect. Thus, in 
the presence of oxygen, this production of lactic acid is not 
diminished to anything like the same extent as normal tissue. The 
reason for this is unknown, and cannot be explained by a reduction in 
cytochromes which participate in oxidative phosphorylation in normal 
tissue (194).
As tumours depend on glycolysis more than normal tissue, the levels 
of ATP will be limiting to cellular processes. Glucuronidation 
utilizes glucose which is needed for many processes. However, 
sulphation uses sulphate which is needed for the amino acids 
cysteine, cystine and methionine, these being the components of 
proteins; the vitamins, thiamine and biotin; the cofactors, lipoic 
acid and coenzyme A. Thus, cells could use available sulphate to 
synthesise these cellular components which will be required for a 
growing tissue. When such a cell, or tissue, is challenged by a
xenobiotic and needs to conjugate this compound, it seems logical to 
use a pathway which puts least stress on metabolism: glucuronidation. 
It would be interesting to know whether this is true of other growing 
tissue like foetal or regenerating tissues, particularly from lung 
and colon.
It is important to bear in mind that both glucuronidation and 
sulphation use ATP. However, UDP-glucose is likely to be available 
as it is a precursor for carbohydrate synthesis and sulphate might be 
diverted for the production of essential cofactors. Thus, 
glucuronidation may be the pathway of choice. Also, due to UDP- 
glucose probably being present, the sulphation pathway is much more 
expensive in the consumption of ATP. From conjugation with UDPGA, 
UDP is generated which only needs a single phosphorylation back to 
UTP to be used again for the same reaction. However, with 
sulphation, PAP is generated which is hydrolysed to AMP (Fig. 47). 
This requires two phosphorylations to ATP to be utilized again. 
Thus, sulphation is the more expensive in the number of 
phosphorylations to produce the necessary ATP, the synthesis of which 
is limited in tumour tissue.
Moreover, the NAD+ which is needed for conversion of UDP-glucose to 
UDP-glucuronic acid will be available from glycolysis, if lactic acid 
is produced. A further important advantage of using glucuronidation 
would be if more uracil, from which UDP is synthesised, is present in 
tumours than normal tissue. A number of experimental tumours have 
been reported to use more uracil than orotic acid for nucleic acid 
synthesis (195). The reverse is true for many normal tissues.
Figure 47 = Sulphation And Glucuronidation
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It is clearly possible to extend the empirical work carried out for 
this thesis and to use the present findings as the basis of a variety 
of further sets of experiments. For example, as both
sulphotransferase and UDP-glucuronosyltransferase are known to exist 
in multiple form* more substrates should be used to establish whether 
the pattern of metabolism already observed is true of other 
substrates. Additionally, an examination of the metabolism of 
oestrone and oestradiol with whole cells, in culture, would be 
interesting to compare with the sub-cellular data. In this context, 
other endogenous substrates, like bilirubin and testosterone, could 
be utilized as well as using xenobiotics like morphine. Thus, by 
investigating the activity of sulphotransferase and UDP- 
glucuronosyl transferase with other substrates, with human tissue, a 
knowledge of the distribution of these enzyme activities could be 
collated. Interestingly, the distribution of UDP-
glucuronosyl transferase activities in rat tissues has been summarised 
by Bock et.al. (152), although, of course, this does not reflect that 
seen in human tissues, these workers having reported 1-naphthyly{3- 
D-glucuronide formation with rat lung. A recent report showed that 
p-nitrophenol, which is probably in the same substrate group as 1- 
naphthol, has the same metabolic pattern as 1-naphthol in rat lung, 
i.e. the glucuronic acid conjugate is produced with no detectable 
sulphate ester conjugate (196) Clearly, it would be important to 
know whether p-nitrophenol conjugation shows the same distribution in 
human tissues. In rat liver, conjugation of 1-naphthol and 4- 
nitrophenol by UDP-glucuronosyltransferase with UDPGA is thought to
be carried out by the same form of enzyme (197, 198, 199). Thus, 
homogeneity between activities towards these substrates in human 
tissue seems probable. The experimental work for this thesis 
established that conjugating activity towards oestrone and oestradiol 
was much lower than towards 1-naphthol in both human lung, colon and 
tumours from these organs. This finding could, of course, be due to 
one of two reasons, the first being that these steroids could be 
substrates for different enzymes, the second being that the 
values for the steroids are much higher than for 1-naphthol. However, 
it is interesting that, in rabbit liver, UDP-glucuronosyltransferase 
activities for p-nitrophenol and oestrone have been separated (200). 
Also, in rat liver, there is evidence that testosterone and oestrone 
are not glucuronidated by the same enzyme as p-nitrophenol (201).
However, Burchell (202) has described four forms of UDP- 
glucuronosyl transferase in rat liver. 1-Naphthol has been placed in 
category A and approximates to Bock^ grouping GT^ (152) for rat 
liver. 4-Nitrophenol can be a substrate for forms A and C, and 
oestrone is placed in category C. Thus, there seems to be an 
overlapping of activities with this species and tissue.
Heterogeneity of UDP-glucuronosyltransferase activity has been found
between the steroids, oestrone and oestradiol, and 1-naphthol (203).
Rozhin et.al. (204) showed that bovine adrenal oestrone
sulphotransferase could sulphate many steroid derivatives, but the
K value for oestrone was lower than that for oestradiol. In m
general, phenol sulphotransferase, the enzyme which can sulphate 1- 
naphthol, shows no ability to conjugate oestrone (69).
A further area of experimental work could be to establish the tissue
levels of the UDPGA and PAPS in order to find, for example, whether
tumours are deficient in PAPS. This becomes a possibility because 
PAPS deficiency, as a result of the inability to synthesise this 
cofactor, has been reported in mice (205, 206, 207) and in humans
suffering from spondyloepiphyseal dysplasia (208).
Additionally, much work needs to be done to establish whether human 
tumours in general, glucuronidate 1-naphthol and to find the extent 
to which this is different from the situation when considering normal 
tissue. Not all normal human tissues preferentially sulphate 
phenolic compounds, e.g. bladder (209), which forms glucuronic acid 
conjugates with 1-naphthol. However, it would be interesting to know 
whether total body metabolism of 1-naphthol, i.e. the urinary 
metabolites, can be altered in a person harbouring a tumour which 
could produce 1-naphthyl-^  -D-glucuronide, in culture. If the 
corresponding normal tissue formed the 1-naphthyl sulphate, there may 
be a shift to the glucuronide conjugate in urine, when the patient 
has such a tumour. Thus, this may have potential as a predictive 
clinical test.
E: QUANTITATION OF RESULTS
Throughout this thesis, results have been expressed as either a 
percentage formation of a metabolite or a rate of production of a 
conjugate, quantitated by protein. The expression of results per 
unit of protein was chosen because of the ease with which such 
determinations can be carried out. However, this method of approach 
has some disadvantages, which do need to be recognised in appraising 
the findings. For example, by measuring the total protein in an 
explant of tissue, in a subcellular fraction and in a population of 
cells, a determination of total protein present in these systems is 
made, not the protein concerned with the particular biochemical 
reaction. This situation was highlighted by the fact that the 
protein from whole bronchus was much higher than that from cartilage 
or upper bronchial layer containing the epithelium. Nevertheless, it 
is probable that the cartilage in the whole bronchus contributed 
little to the metabolism of 1-naphthol (Chapter 3> P 72).
In formulating the design for the empirical work for the present 
project, alternatives to quantitation by protein could have included 
determinations of DNA or RNA and cell counts. However, tumour cells 
can often possess more than one nucleus (aneuploid). Thus, the 
amount of nucleic acid present does not necessarily indicate the 
number of cells and gives no idea of the quantity of active enzyme 
protein, and, accordingly, this particular procedure was not 
employed. It was not possible to establish, by counting the number 
of cells in a dish, whether the cell population as a whole, in that 
container, could metabolise the substrate. Some cells in a population
will not be viable. However, by employing the Trypan blue exclusion 
test to the cells, the percentage of those viable can be assessed, 
but with a cautionary reminder that the difficulty with this is that 
cells could become non-viable, after having contributed to the 
metabolism.
Thus, none of the cited methods is without some disadvantage. 
Nevertheless, each one does give an indication of the amount of 
tissue present, which can also be done by weight. Accordingly, it 
was felt that, by expressing the results as a percentage conversion, 
it was possible to give an adequate view of metabolic pattern. The 
major limitation of quantitation by protein and DNA, in these 
circumstances, is that the tumour tissue, in particular, is 
heterogeneous and that cancerous tissue tends to contain necrotic 
cells. If different percentages of cells in each piece of tissue are 
responsible for metabolism, then the expression of results on either 
DNA or protein does not clarify the pattern of conjugation.
f : conclusions
Undoubtedly, the use of short-term explant culture with human tissue, 
from both surgery and xenografts, does give a good indication of the 
metabolic potential of these tissues. By using human samples to test 
the chemosensitivity of drugs, it may be possible to individualize 
treatment for patients. In this context, the preservation of tissue 
architecture should provide a reasonable representation of an in 
vivo-like situation. However, this procedure, like other in vitro 
techniques, does not reveal which cells of a particular tissue are 
responsible for the drug metabolism seen. Clearly, it can be argued 
that attempts could be made to separate out a homogeneous population 
of cells from heterogeneous tissue, but nevertheless, these 
techniques do present many difficulties, not least of which is that 
of damaging the cells in preparation.
The use of cell lines gives a population of cells which are often 
homogeneous. However, it is important to bear in mind that 
metabolism displayed by such a selected group of cells, may not be 
representative of the tumour as a whole.
Throughout this thesis, emphasis has been given to the cautious 
attitude needed when interpreting data from subcellular fractions. 
Continually, it has been stressed that the results from such 
experiments could be misleading when examined in isolation, 
particularly as many researchers only use this technique to examine 
biochemical reactions. Accordingly, it would appear more useful to 
investigate metabolic pathways in different experimental systems.
Nevertheless, not only should care be taken with the interpretation 
of data from subcellular fractions, but such caution is also needed 
with data from tumour cell lines and xenografts. In both cases, a 
selected cell population may be present and often little attempt to 
monitor changes from the original tumour is made. Also, when the 
cell lines and xenografts are of human origin, the metabolic 
potential of the corresponding normal tissue is unknown. This is 
always useful to know as a control and it identifies whether 
metabolism observed in the tumours is unique to these tissues. In 
this way, more information about metabolism in human tumours will be 
accumulated and biochemical differences between normal and tumour 
tissues identified. It is only by using this procedure that improved 
drug design, based on these differences, can begin. In cancer 
chemotherapy, there is a need to look for cell targets that are not 
characteristic of growing tissue in order that side-effects can be 
minimised. The biochemical difference found during work for this 
project may be exploitable in cancer chemotherapy.
As a result of the main findings of the present project, it is 
suggested that, in order to compare and contrast metabolic pathways 
in animal and human tissues, it is essential to use experimental 
systems similar to the ones employed in the work done for this 
thesis. Accordingly, by careful comparison of such pathways, an 
understanding of species differences will emerge which should lead to 
a more precise knowledge of the limitations of extending the design 
of animal models to the study of comparable human situations. This 
approach would be useful in any studies of target organ toxicity and 
would, hopefully, improve the chances of better extrapolation of data 
from experiments with animals to predict toxicity in man.
- d.0 I -
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